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In recent years, the interest in developing biosensors for the detection and monitoring of low 
molecular weight targets is increased. These small molecules play important roles in human 
health, environmental, food, and biomedical field, including different groups such as 
antibiotics, toxin, ions, drugs, steroids, and different chemicals. In this thesis work we studied 
and evaluate the possible novel methods of detection for two different small molecules, 
tetrodotoxin, part of marine toxins and nandrolone, an anabolic steroid. 
Tetrodotoxin (TTX) is a paralytic marine neurotoxin causing seafood poisoning after the 
ingestion of contaminated marine food such as puffer fish and shellfish. Its paralytic toxic 
effects derive from its selective binding to voltage-gated sodium channels and ultimately 
interfering with neural transmission. Symptoms of TTX intoxication include numbness 
sensation in the mouth, headache, vomiting, muscle weakness, and even fatal respiratory or 
heart failure. Puffer fish poisoning is typical of warm waters and was regarded as a problem 
confined to Asian countries, but in recent years, TTX has been reported and detected in 
seafood in many different European countries including Spain, Greece, United Kingdom, 
France and Italy. The hight toxicity and the increase incidence requires fast and cost-effective 
detection techniques. 
The second target that we studied, nandrolone, is an androgenic anabolic steroid (AAS) 
functioning as a growth promoting agent which helps to gain muscle weight. Its AAS 
properties have let to its exploitation as a doping agent in sports and horse racing, whereas 
it is also used as an animal feed additive on the other hand, several studies report the 
presence of nandrolone in dietary supplements as a cross-contaminant and consumption of 
such supplements could lead to accidental doping. Adverse side effects are associated with 
nandrolone accumulation in the body such as endocrine, cardiovascular, skin and psychiatric 
disorders. It is therefore evident that monitoring the presence of nandrolone in human and 
animal biological fluids, meat products and nutritional supplements is essential to protect 
public health and discourage doping practices in sports.  
For both types of these molecules, liquid or gas chromatography-mass spectroscopy is 
routinely used for laboratory-based analysis of field samples. Competitive immunoassays 
have also been developed and are available in the market for their detection. Aptamers are 
biorecognition molecules considered as alternative to antibodies which are suitable for the 
detection of any type of target and have great potential in analytical applications. They are 
artificial synthetic nucleic acids (RNA/DNA) that bind specifically to their target, and they are 
selected through an in vitro iterative process called Systematic Evolution of Ligands by 
Exponential enrichment (SELEX). The development of aptamers for small molecules is a 
challenging task, especially when you deal with small molecules as they lack the multiple 
binding sites in their structures. Although, in our work we sought to develop novel aptamers 
binding to TTX and Nandrolone and exploit them for their detection in different assays. 
For TTX aptamers identification was used a variation of SELEX suitable for small molecules 
(Capture-SELEX), while nandrolone aptamers were identified using a classical SELEX 
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process with nandrolone-Sepharose resin. Both selections were done in combination with 
high-throughput Next Generation Sequencing and binding properties of the selected 
aptamers were characterized. 
Finally for the best identified aptamer 2 different types of assays were developed. For TTX 
was developed a highly sensitive and user-friendly antibody-aptamer sandwich dipstick 
format assay which was successfully applied for the detection of TTX in puffer fish extracts. 
For Nandrolone a label-free colorimetric assay was finally developed using the aptamer for 
its detection based on gold nanoparticles and their aggregation in the presence of target 
molecules after salt addition. 
In my thesis it is discussed the general objectives and subobjectives of this work. Chapter 1 
includes a detailed introduction of the state of art of the research area. It provides a brief 
information about aptamers and their methods of selection against different types of small 
molecules by using different types of selection. Moreover, is given a general view of different 
types of aptasensor used for small molecules detection.  
The detailed selection process of the TTX aptamers isolation is detailed in Chapter 2. Capture 
SELEX is implemented for immobilizing ssDNA on the surface of streptavidin magnetic beads 
and TTX target is free in the solution throughout selection process. The affinity of the selected 
aptamers was confirmed by two different methodologies, APAA and Bead-ELAA. Finally, one 
of the aptamer selected was used hybrid antibody-aptamer sandwich assay for TTX detection 
in puffer fish extracts. 
Chapter 3 describes the proof of concept of a highly specific and sensitive dipstick format 
assay for point of care devices, and its application in real puffer fish sample detection 
including gonads, muscle, skin and liver extracts. Finally, the specificity of this format was 
also evaluated, by analyzing the interference of other marine toxins which can be present in 
the same sample. 
In Chapter 4 is reported the selection performed for the identification of nandrolone aptamers 
and their characterization of the binding properties. Moreover, an easy and rapid colorimetric 
assay was developed for nandrolone detection using the adsorption of aptamer on gold 
nanoparticle which prevent their aggregation, while in the presence of nandrolone, aptamer 
is bind to nandrolone and gold nanoparticles aggregate after the salt addition. 
 
Resum 
L’interès per la detecció de molècules amb un baix pes molecular s’ha incrementat els darrers 
anys. Monitoritzar els nivells de molècules petites amb activitat biològica, com ara els 
antibiòtics, toxines, marcadors moleculars, ions metàl·lics, medicaments i esteroides entre 
altres, es molt important en el camp de la biomedicina, la monitorització ambiental i el control 
i la seguretat alimentària. Els assajos analítics i els biosensors amb alta sensibilitat, 
especificitat, assequibles i portàtils capaços de detectar aquest tipus de molècules petites 
son necessaris per a assegurar la salut pública. En aquesta tesis, s’han escollit dues 
molècules diana: la tetrodotoxina (toxina marina) i la nandrolona (esteroide anabòlic). 
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La Tetrodotoxina (TTX) es una neurotoxina marina paralitzant que pot causar intoxicació 
alimentària després d’ingerir aliments contaminats com ara el peix globus o mariscs. Els seus 
efectes tòxics es deriven de la seva afinitat als canals de sodi cel·lulars, interferint amb la 
transmissió neuronal. Els símptomes per intoxicació amb TTX inclouen sensació de 
adormiment de la boca, mal de cap, vòmits, debilitat muscular, i fins i tot aturades càrdio-
respiratòries. La intoxicació per la ingesta de peix globus es comuna en aigües càlides i ha 
estat típicament un problema associat als països asiàtics. No obstant, i en els darrers anys, 
s’han detectat aliments marins contaminats amb TTX en diferents països Europeus, incloent 
Espanya, Grècia, El Regne Unit, França i Itàlia. La gran toxicitat i l’augment en la incidència 
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1.1 Aptamers as biorecognition molecules 
 
Molecular recognition is a specific biological interaction between two or more molecules 
which exhibit molecular complementarity via non-covalent bonding including hydrogen 
bonding, hydrophobic forces1, van der Waals forces, π-π interactions, and electrostatic 
interactions2. At the cellular level, these molecular recognition or binding events may occur 
between proteins and small molecules to induce signalling processes3, between proteins and 
nucleic acids, such as in DNA/histone interactions4, and between nucleic acids and small 
molecules, such as those displayed by riboswitches5. Taking advantages of these recognition 
principles, researchers have developed target detection methods as well as therapeutics for 
countless diseases. While antibodies have been the gold standard for recognition for several 
decades, aptamers are emerging as an attractive alternative for the specific detection of a 
wide range of target molecules. 
 
Aptamers are a class of single-stranded DNA (ssDNA) or RNA oligonucleotides, which form 
three-dimensional structures enabling their specific binding with a target. Aptamers are 
selected from large library pools using an iterative selection process termed Systematic 
Evolution of Ligands by Exponential Enrichment (SELEX). The word aptamer stems from the 
Latin “aptus”-meaning “to fit”, and the Greek word “meros”-meaning “part”. Aptamers were 
first reported by Ellington & Szostak and Tuerk & Gold, who independently developed 
techniques to select RNA aptamers against specific organic dyes and T4 DNA polymerase, 
respectively6,7 and since then there has been an exponential growth in the number of 
publications detailing the selection and applications of aptamers (Figure 1.1). 























Figure 1.1. Number of publications as a function of the years involving the research in aptamers. (Data extracted 
from PubMed). 
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The ability of aptamers to fold into distinct 3D conformations characterised by stems, loops, 
hairpins, bulges, triplexes, and quadruplexes facilitates the high affinity binding and selectivity 
to their target (Figure 1.2). Aptamers bind selectively to their target through intermolecular 
interactions, such as van der Waals forces, hydrogen bonding, electrostatic interactions 
between charged groups, and π-π stacking of “flat-structured” aromatic moieties8, which 
allow them to interact with a wide variety of target molecules from single molecules to 
complex target mixtures or even whole cells with dissociation constants (KD) typically in the 
low nanomolar range, comparable to those observed for monoclonal antibodies9. 
 
 
Figure 1.2. (A) stem-loop/ bulge (RNA ligand for ATP), (B) G-quartet (DNA ligand for thrombin), (C) Pseudoknot 
(RNA ligand for HIV-1 reverse transcriptase), (D) hairpin (RNA ligand for Bacteriophage T4 polymerase)10. 
 
1.1.1 Aptamers versus antibodies 
 
Aptamers possess similar affinity and specificity as monoclonal antibodies. Despite that, they 
offer multiple advantages including a relative ease of large-scale synthesis at affordable costs 
with no batch-to-batch variation, physical stability, and facile chemical modification11,12 (Table 
1.1). Aptamers can be selected against toxic and non-immunogenic compounds, whereas 
antibodies cannot be developed due to lethal damage of these toxic molecules on the host 
animals prior to the production of antibodies. Further, the production of these antibodies, 
requires sacrificing the host animal and in addition, antibodies are relatively expensive 
compared to aptamers13.  On the other hand, aptamers are not immunogenic or toxic in in 
vivo levels as nucleic acids are not typically recognised by the human immune system as 
foreign agents14,15. Pegaptanib, the first aptamer approved by the US Food and Drug 
Administration agency (FDA) against wet Age-related Macular Degeneration (AMD) 
displayed no immunogenicity in either preclinical evaluation in animals or clinical trials in 
patients16. Due to their relatively small sizes, even compared to antibodies, aptamers can 
penetrate easily through tissues and even cells17. Aptamers have binding affinities that are 
comparable to, and in some examples, even surpass those of monoclonal antibodies. Due to 
the inclusion of counter selection steps in SELEX they are inherently extremely specific, as 
demonstrated by the theophylline aptamer developed by Jenison et al., which showed an 
affinity for its cognate ligand that is 10,000-fold higher than that for caffeine, which differs 
from theophylline by only a single methyl group at nitrogen atom N-718. The arginine aptamer 
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developed by Geiger et al. showed a 12,000 fold stronger affinity with L-arginine than with D-
arginine19. These properties position aptamers as ideal candidates for therapeutics and 
diagnostics. 
 
Furthermore, once the aptamers sequence is identified, they can be synthesized with high 
purity, reproducibly and at a relatively low cost as compared to antibodies (Table 1.1). 
Aptamers can be easily chemically modified with various chemical tags including 
fluorescence probes, quenchers, electrochemical indicators, nanoparticles, or enzymes. 
These modifications can allow the immobilization of aptamers on various solid supports, 
provide stability against nucleases, and allow the incorporation of labels for use in various 
methods of detection.  
 
Table 1.1. Characteristics for antibodies and aptamers. 
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1.1.2 Disadvantages of aptamers 
 
Nowadays, a large number of aptamers have been selected and exploited in different 
applications for a wide range of targets as bacteria/pathogens20,21, proteins22, toxins23, 
viruses19, cells24, and tissues25. However, the process of aptamer production, SELEX, is still 
a long labour-intensive, repetitive process that requires trained personnel. Robots have been 
developed for the automation of SELEX, but conditions and parameters (selection buffer, pH, 
concentrations), need to be optimized per each specific target. Notably, at the in vitro level, 
the rate of the successful selection of the aptamers does not exceed 30%26.  
 
Aptamers, despite displaying high specificity in in vitro levels, may fail to efficiently bind to the 
specific target when used in vivo. This drawback arises due to their specific chemistry which 
renders them hydrophilic. In addition, non-modified RNA aptamers particularly, can degrade 
in the presence of nucleases circulating in blood. A possible solution to overcome this 
drawback is linked to the modification in the DNA or RNA backbone or modified nucleotides27. 
Nevertheless, one should account for the fact that aptamer modifications are sequence-
dependent, and may affect the folding and formation of the structures of aptamers, resulting 
in a loss of their functions28. Meanwhile, drawbacks may arise also from their compositions. 
Aptamers are typically composed of four nucleic acids, resulting in a lower diversity of 
secondary and tertiary structures, whose environment-dependent functionalities add to the 
limitations. To overcome this, modified nucleotides can be incorporated to increase the 
chemical diversity and rigidity of the aptamers29. Aptamers are also characterised by a short 
in vivo circulating half-time followed by rapid renal clearance. For this reason, aptamers are 
combined with polyethylene glycol (PEG), in order to increase the hydrodynamic/molecular 
weight of aptamers above the renal filtration cut off30. 
 
Considering the widespread application of aptamers in biosensors and diagnostic reagents, 
it is predicted that aptamers are one of the fastest-growing biotechnology areas in diagnostics 
and therapeutics31. A comprehensive description of the future perspectives of aptamers was 
published by Research and Markets32 in a report entitled “Global aptamers market-
segmented by type of products and applications-growth, trends and forecasts (2018-2023)”. 
They reported the potential advantages  of aptamers over antibodies in the fields of 
therapeutics and diagnostics and the market value is estimated to reach 401.30 billion $ in 
2023 and is expected to register a compound annual growth rate of 17.89% during the 




As stated above, the standard procedure to synthesize and identify aptamers is known as 
‘Systematic Evolution of Ligands by Exponential Enrichment’ (SELEX). Target-binding 
oligonucleotides are selected from a random library pool of different oligonucleotides (1013-
1015) through reiterative cycles of affinity separation and amplification7,33.  
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Standard SELEX consist of the following five main steps:  
a) designing an aptamer library pool; 
b) performing the SELEX cycle/round; 
c) monitoring the SELEX progression; 
d) cloning of the enriched library and sequencing of selection rounds for characterization 
and structural analyses 
e) characterisation of aptamer candidates. 
 
These steps are generally applicable to most aptamer selections. In general, aptamer 
sequences can be obtained with high affinity and specificity after 8-20 rounds of screening. 
SELEX typically also includes negative and  counter selection steps, to eliminate matrix 
binders and sequences that binding to potential interferents, respectively34–36. 
 
1.1.1 Designing the library pool 
 
The starting point of the SELEX process is a chemically synthesized random library. This 
library consists of random ssDNA sequences (1015 molecules). Most libraries are designed 
to be around 70-120 bases in length with a central random region of 20-80 random bases, 
flanked by two fixed sequences, (17-21 bases), that provide primer hybridization sites for 
PCR amplification, ssDNA production and enzyme digestion (Figure 1.3)37. An aptamer 
library is chemically synthesised by multiple couplings of adenine (A), thymine (T), guanine 
(G) and cytosine (C) through phosphonamidite chemistry38. This random region should 
contain all four bases in an equal distribution. Many researchers reported that an equal 
distribution increases the sequence space and consequently an enhanced possibility to 
select aptamers with the desired binding properties39.  
 
Amplification of the oligonucleotide random library at the beginning and throughout SELEX 
is of considerable importance, as the correct choice of library and efficient PCR amplification 
of the random library contribute to the success of aptamer selection. The diversity within the 
library is determined by the length of the random core region. Generally, as the length of the 
random region increases, the structural diversity within the library also increases. This 
increase in diversity allows for the presence of more complex 3D structures, which are more 
likely to have high-affinity moieties40. 
 
Modified nucleotides can not only improve the nuclease resistance and thermal stability of 
aptamers structure, but also contribute to the diversity of the library. Some nucleotide 
modifications include the modification of pyrimidines at the 5’ position with I, Br, Cl, NH3 and 
N3 and the 2’ position with NH2, F and OCH341 and with NH3, F or 2-OCH3 groups42, 2’ 
fluoropyrimidines43,44, 2’ O-methyl nucleotides45,46, position 5 of pyrimidines47 and position 4 
of pyrimidines using thiol UTP and CTP48. 
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The primer binding regions should not contain regions of internal complementary sequences 
in order to avoid hairpin structures and primer-dimer formation49. Some strategies purposely 
avoid the primer binding regions being part of the target binding sequence, such as tailored50 
and dual SELEX51. These strategies use conserved sequences (7-10 nucleotides), which are 
sequestered by self-complementary sequences, thus minimizing the risk that they become 
part of the target binding motif. An alternative strategy is primer-free DNA aptamer 
selection52, which employs endonuclease cleavage of the doubled stranded DNA template. 
The library is reconstituted after selection by ligation with primer annealing sites. This protocol 
was used to isolate aptamers against HIV reverse transcriptase53. 
 
A further important parameter to consider is the size of the target molecule. The molecular 
size difference between proteins such as bovine serum albumin (66 kD) and small 
molecules such as cocaine (0.30 kD) is broad. Therefore, the surface area available for an 
aptamer to interact with the target varies significantly between different classes of molecules. 
An appropriate length of the random region should strike a balance between the structural 
diversity required for selecting high affinity aptamers and an appropriate surface coverage of 
the target molecule54. Increasingly, the design of an aptamer library is driven by the structural 
traits of its cognate target. This may incorporate the application of computational analyses of 
aptamer-target interactions55. Furthermore, when designing an aptamer library, the random 
core region can be either a complete randomisation or a partial (doped) randomisation56.  
Based on the critical motif responsible for binding with the target molecule, a doped aptamer 
library can be synthesised to reselect optimal aptamers, with the aim of improving their affinity 
and specificity to the target57,58. 
 
Finally, an aptamer library in-solution normally forms energy efficient secondary structures 
by self-folding and this may obstruct the availability of nucleotide bases to interact with the 
target molecule59. To overcome this, the aptamer library at the start of every SELEX round is 
normally heat-denatured13,60. Following this heat denaturing process, the linearised 
oligonucleotides can interact more freely with the target molecule. 
 
 
Figure 1.3. A schematic diagram of ssDNA oligonucleotide. 
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1.2.2 Selection rounds of SELEX 
 
Each SELEX round or cycle involves 5 important steps (Figure 1.4):  
a) co-incubation of library pool with the target of interest to form nucleic acid-target 
complexes,  
b) partition of unbound sequences from the bound sequence-target complex, 
c) Elution of the bound sequences, 
d) amplification of the eluted sequences,  
e) preparation of the enriched ssDNA sequences for the next round of SELEX. 
 
 
Figure 1.4. Schematic overview of SELEX cycle. 
 
1.2.2.1 Co-incubation 
The first step of SELEX process is the incubation of the library pool with the target in an 
appropriate buffer solution and with the proper incubation conditions. Binding of an aptamer 
with the target relies on electrostatic, H-bonds, hydrophilic or π-π stacking interaction, which 
cause the conformational change within the aptamer by forming different 3D structures 
aiming the binding to the target61. Determining the appropriate in vitro conditions is guided 
primarily by the final planned application of the aptamer. It is generally recommended that 
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these conditions remain constant throughout the selection process so optimal binding 
efficiency can be achieved. 
This aptamer-target binding can be affected by physicochemical properties such as 
temperature, pH, and ionic strength62. Nevertheless, ionic composition i.e. sodium (Na+), 
magnesium (Mg2+), calcium (Ca2+) and potassium (K+) of the buffering system can strongly 
affect the oligonucleotide 3D structure63. Nucleic acids are polyanionic molecules and 
negative-negative charge repulsion may inhibit the formation of complex structures and thus 
impede binding with the target without the presence of these counterions. For instance, the 
divalent ions Mg2+ and Ca2+ can influence the degree of DNA folding. A study from Carothers 
et al.64 indicated that carrying out SELEX under low Mg2+ concentrations (1-2,5 mM), 
increased the stringency of selection, leading to the production of high-affinity binding 
aptamers. Other ions such as Na+ are effective in neutralizing negative charges of the 
phosphate molecules on the DNA backbone. Cruz-Aguado and Penner23 demonstrated that 
the binding affinity of the aptamer selected against ochratoxin (OTA), was increased in the 
presence of Ca2+ ions. 
G-rich aptamers that form G-quadruplexes (G4) have several advantages compared to 
unstructured sequences. They are thermodynamically and chemically stable and resistant to 
serum nucleases and they have twice negatively charged density per unit length as compared 
to duplex DNA65. A number of G-rich aptamers have been developed, such as the thrombin 
binding aptamer66, as well as aptamers selected against hematoporphyrin67, and HIV-1 
integrase68. The generation of these aptamers was performed in the presence of K+ in the 




The partition step is the most critical step of SELEX and involves the separation of bound 
sequences to the target from weakly or unbound sequences. There are numerous methods 
for performing this phase, and one of the first methods used was separation via nitrocellulose 
membrane of controlled pore sizes, where nucleic acid sequences bound to the target cannot 
pass through these pores, whereas unbound sequences pass through69. However, in 
membrane SELEX there is a high degree of non-specific binding of the nucleic acid 
sequences to the membrane itself, and thus other strategies were pursued. 
 
The use of affinity columns where the target molecule was immobilised via covalent 
interactions has been widely reported70,71where partitioning is effectively achieved via elution 
of the unbound sequences, followed by release of the bound sequences using affinity elution 
or pH change72. Ciesiolka et al.  performed the selection of Zn2+ binding aptamer by immobilization 
of  metal ion on iminodiacetic acid group-Sepharose column73. 
Microtiter plates have also been used for target immobilisation, where the target is 
immobilised on the surface of the wells of the microtiter plate (polystyrene/streptavidin-
coated/maleimide activated/amine activated), and partitioning is achieved via removal of the 
supernatant following incubation of the library with the immobilised target. The advantage of 
microtiter plates is that a fresh aliquot of target is used every cycle of SELEX, avoiding 
UNIVERSITAT ROVIRA I VIRGILI 




problems of denaturation/desorption of the target during the SELEX process. Examples of 
this include the selection of aptamers for Trichomonas vaginalis74 and shiga toxin75. 
One of the most commonly used methods for partitioning is the use of magnetic beads. As 
with the microtiter plates, there are a wide range of magnetic beads of diverse sizes ranging 
from nanometre to micrometre, with different functionalities e.g. carboxyl, amine, maleimide, 
streptavidin, Ni2+. There are multiple examples of this type of partitioning, including cholera 
toxin76,okadaic acid77, testosterone78,histamine79,estradiol, progesterone, testosterone80. 
 
Electrophoresis-based partition methods have been used to identify aptamers binders to 
proteins such as IgE81, neuropeptide Y82, and Muts protein83. Electrophoresis-based 
partitioning take advantage of the size-based difference in mobility of an analyte when an 
electrical field is applied, thus facilitating separation of target bound and unbound sequences.  
However, this method of partitioning is only useful for large molecules as efficient separation 
is generally not feasible with small molecules. 
 
Whilst some of the above techniques can be used for partitioning when carrying out SELEX 
against small molecules, immobilisation can be challenging as few binding sites are available 
and can also result in a conformational change in the structure of the target.  However, there 
are many examples of SELEX carried out via immobilisation of the small molecule target, as 
detailed in Section 1.4. 
 
Apart from these conventional methods ,other partitioning techniques have been reported 
,such as the use of affinity tags84, centrifugation85, flow cytometry86, and electrophoretic 
mobility shift assays87. Several of these partitioning methods for aptamer selection have been 
reviewed in detail by Gopinath et al.88. Further emerging techniques for effective partitioning 
when carrying out SELEX against small molecules include that of capture SELEX, where the 
library rather than the target is immobilised, and GO-SELEX, where a graphene oxide matrix 
has a high affinity for the single stranded sequences not bound to the target.  These 
approaches are explained in further detail in Section 1.4. 
 
The use of negative and counter SELEX steps is routinely used. Negative SELEX involves 
incubation of the nucleic acid library with the matrix to be used for partitioning e.g., 
nitrocellulose membrane, microtiter plates, magnetic beads, affinity columns, and this step 
removes any matrix binders. Counter SELEX is carried out after negative SELEX and 
involves incubation with molecules that could potentially interfere in the final application of 
the aptamer. Counter SELEX can be carried out sequentially with each of these potentially 
interferents79, or with a combination of them together78,89. This ability to eliminate binders to 
closely related structures/potential interferents facilitates a careful tuning of the specificity of 
the aptamer, which is not possible with antibodies, where the antibodies generated are 
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Following removal of the unbound part of the library, bound oligonucleotides are generally 
eluted from the ssDNA/target complex. Interactions between the bound sequences and the 
target of interest are noncovalent in nature, and so several methods are possible for eluting 
these sequences. Methods used for elution include heat treatment76,90, affinity elution91, 
changes in ionic strength or pH of, and the use of denaturing substances such sodium 
dodecyl sulfate (SDS), ethylenediaminetetraacetic acid (EDTA), NaOH and urea, to disrupt 
hydrophobic stacking of DNA bases or chelation of aptamer-target complexes19,69,91.It is also 
worth noting that complete elution of bound sequences may not always be achievable. Some 
sequences possessing extremely high affinity to the target molecule are often difficult to elute, 
and can be lost during elution92. 
 
An alternative strategy for obtaining bound sequences is to use aptamer-target complexes 
directly as the template for PCR amplification, providing the binding complexes do not 
interfere with the Taq polymerase used in PCR. This strategy has been applied successfully 
in generating histamine-specific aptamers79,progresterone and estradiol aptamer80,and 
testosterone aptamer78. In this approach, the bound target aptamers dissociate from the 
aptamer-bound matrix during the denaturation step of the PCR cycle, and become freely 




The isolated oligonucleotides molecules are subsequently amplified to increase the enriched 
amount of selected aptamer. An effective SELEX procedure must be accompanied by 
efficient PCR amplification to obtain the proper length of amplicons and to retain those 
sequences that form stable secondary structures during the cycles of amplification in order 
to obtain high-affinity aptamers. The most conventional and effective technique for the 
amplification process is done by performing polymerase chain reaction for the ssDNA 
selected or reverse transcription-PCR for RNA sequences after the elution step. When using 
PCR for the aptamer selection, the random DNA or RNA is used as PCR template, and the 
diversity of template sequences can cause non-specific by-products amplicons during PCR 
due to stem-loop secondary structures formation of GC regions. These structures can 
promote polymerase jumping during PCR and generate PCR products of smaller sizes and 
thus prevent evolution to the desired aptamer sequence and structure93,94. 
 
Although optimising PCR conditions, such as primer concentration, annealing temperature, 
and the number of amplification cycles can, moderately, reduce the amount of PCR by-
product formation, it is not always effective. One of the common methods to improve the PCR 
amplification is the addition of DMSO, betadine, glycerol, or formamide to the reaction 
mixture76,95. Moreover, some advanced PCR techniques, such as real-time PCR and 
emulsion PCR have been used in SELEX96,97. Real-time PCR allows the detection of 
amplification in real time by introducing a fluorescent dye such as SYBR green. As SYBR 
green dye binds to double stranded DNA, the intensity of the fluorescent emission increases 
as the reaction progresses98. Other approaches used in RT-PCR include the use of molecular 
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beacons, Taqman probes and Light-cycler probes.  The use of RT-PCR is useful as it avoids 
the over amplification, which sometimes can form PCR by-products, reducing the efficiency 
of aptamer enrichment99.  
 
1.2.2.5 Preparation of single-stranded DNA 
 
In final step of normal PCR, the final product obtained is double stranded DNA (dsDNA), thus 
requiring the generation of single stranded DNA prior to the next cycle of SELEX. One of 
most commonly used methods for the generation of single stranded is the use of biotinylated 
forward or reverse primers, resulting in a biotinylated amplicon, and streptavidin coated 
magnetic beads62-64. The biotinylated dsDNA binds to the streptavidin magnetic beads, the 
duplex is then denatured via low/high pH or heating, and following magnetic separation, the 
unlabelled strand for use in the next cycle of SELEX is found in the supernatant. An 
alternative approach for the generation of ssDNA is the use of asymmetric PCR, which 
exploits a huge excess of one primer over the other, resulting in a mixture of single and double 
stranded DNA.  Following amplification, these are separated using gel electrophoresis and 
the single stranded DNA is excised from the gel and purified68,69.  The use of enzymes of 
exonucleases such as lambda exonucleases49,100 and T7 Gene 6 exonuclease101 is another 
alternative. During PCR amplification, a 5’-phosphate group is incorporated into one strand 
of the dsDNA by using a 5’-phosphorylated primer. Lambda exonuclease transforms dsDNA 
into ssDNA through digestion from the end containing 5’-phosphate, preferentially digesting 
one strand.   Finally, based separation methods can be used, where DNA strands of unequal 
size are produced as a result of chemical or structural modifications of one of the PCR 
primers. The incorporation of a chemical spacer such as hexaethylene glycol (HEGL)102; 
constrained Nucleic Acids (CNA)103 or a GC-rich stem loop structure104  at the 5′ end of the 
primer and downstream of poly-nucleotide extension, act as terminators of DNA 
polymerization. This leads to the production of a PCR amplicon that is partially double 
stranded, with two strands of unequal size that can be separated using gel electrophoresis.  
 
1.1.2 Monitoring of SELEX process 
 
Monitoring of the aptamer’s evolution is critical to ensure the selection of target-specific 
aptamers and to determine if the conditions used during SELEX are appropriate. These 
methods can be classified as direct and indirect methods. In direct methods the evolution of 
aptamers is evaluated in each round using techniques such as surface plasmon resonance 
(SPR), filter-binding assay, enzyme-linked oligonucleotide assay (ELONA), electrophoretic 
mobility shift assay (EMSA), and fluorescence-activated cell sorting (FACS)105–109. 
 
Indirect methods for monitoring SELEX mostly rely on assessing the gradual reduction of the 
sequence diversity of aptamer pools. The advances in next-generation sequencing have 
provided the possibility of massive parallelised sequencing of aptamer populations of each 
round during the selection process110. Moreover, the diversity and structure of aptamer 
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populations can be monitored by methods such as denaturing HPLC, melting and remelting 
curve analysis in real-time PCR-restriction, fragment length polymorphism (PCR-RFLP), and 
nuclear magnetic resonance (NMR)110–114. In comparison with other methods, real-time PCR, 
allows the detection of very low amount of eluted ssDNA. Nevertheless, due to the 
heterogeneity of the SELEX library, particular optimization of different significant parameters 
is crucial to minimize by-product formation during the amplification step. In addition, this 
technique does not provide information regarding changes of binding affinity during selection 
rounds.  In other approaches Eastern and dot blot techniques can be used by combining 
nitrocellulose membrane and the nucleic acids that are modified with a fluorophore or biotin 
molecule115,116. 
In an affinity column-based SELEX, affinity column elution is used to monitor the evolution of 
SELEX73,117,118. In this approach, the target is bound on the column, and the nucleic acids 
are labelled with a radioisotope or fluorescent tag. The amount of nucleic acids eluted is 
analysed and compared with the amount of nucleic acids added to the column, and good 
evolution would result in less and less labelled nucleic acids eluting from the column.  
 
1.1.3 Cloning and sequencing 
 
After several selection rounds of SELEX when the affinity saturation of an enriched library 
has been achieved, previously the final oligonucleotide pool was cloned into bacterial vectors 
and individual colonies (30-100) and Sanger-sequencing carried out to119. However 
nowadays, next generation sequence (NGS) is widely used, and this enables the sequencing 
and analyses of thousands of sequences instead of just a hundred. Subsequently the 
identified sequences of each individual aptamer can be evaluated and analysed using 
bioinformatic tools such as Galaxy, Clustal Omega, AptaSuite and Geneious120–123. The data 
from each pool of the selection rounds are then compared and analysed, with the aim of 
finding the sequences with high affinity and specificity for the target.  The identified sequences 
can also be evaluated using mFold program to predict their two-dimensional (2D) 
structures124, that can be further analysed to identify key motifs that are potentially critical for 
aptamer-target interaction. 
 
1.2.5 The characterization and validation of selected aptamers  
 
Following sequencing, the next step is the characterization and validation of the selected 
aptamer candidatess, including (a) assessing binding affinity and specificity of each 
sequence, (b) determining KD values, and (c) confirming in-solution binding capability. 
Aptamer candidates can be chemically synthesised and modified to perform target binding 
assays. Once the binding assays are completed, the binding affinity of each aptamer is 
ranked, and aptamers with low affinity are excluded from further studies.  The KD values of 
the high affinity aptamers are determined to evaluate the strength of aptamer-target 
interactions and can vary from µM to pM range. The KD is calculated as the value that 
describes the ratio of unbound and bound aptamers, expressed in molar units (M). In order 
to determine the KD value, the concentration of one of the two variables (i.e. aptamer or target 
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molecule) is kept constant while the other is successively varied, followed by the 
measurement of the amount of aptamer-target complexes formed over a range of starting 
concentrations. General methods used for determining the KD value include: (a) surface 
plasmon resonance (SPR)118, (b) enzyme Linked Aptamer Assay (ELONA)125, (c) fluorescent 
binding assay90, (d) MicroScale Thermophoresis (MST), and Equilibrium filtration or 
dialysis19,126. More details per each of the techniques can be found in Section 1.5. 
 
Different types of SELEX 
 
In the past 30 years, the selection of aptamers has been achieved for a variety of different 
molecules, with applications in biology, chemistry, medicine, bioinformatics, environment, 
and food safety sciences. However, the efficiency of conventional SELEX in the discovery of 
aptamers is sometimes more challenging in terms of its cost effectiveness, limited partition 
capability and target limitations. In the first work, Ellington and Szostak et al. and Tuerk and 
Gold et al.6,7 used nitrocellulose filters, affinity columns and gel columns for the separation of 
complex and the unbound sequences. Since that time, various modifications of SELEX have 
been developed (Table 1.2). 
 
To date, more than 32 kinds of SELEX variations have been introduced, however, a standard 
SELEX protocol suitable for all targets or the experimental settings does not exist127. 
Significant improvements have been achieved in some critical points of SELEX: the design 
of the nucleic acid library (e.g. chemical modifications, high fidelity-SELEX, genomic-
SELEX)128, target preparation (e.g. cell-SELEX)129, library/target co-incubation (e.g. atomic 
force microscopy SELEX, capture SELEX)130, complex separation (e.g. capillary 
electrophoresis-SELEX, magnetic bead-SELEX, graphene oxide-SELEX (GO-SELEX), SPR-
SELEX, on-chip SELEX)131,132, PCR amplification (e.g. real time-PCR, emulsion PCR, digital 
PCR)133, sequencing methods (high throughput sequencing-SELEX)134 and entirely novel 
SELEX protocols (in vivo SELEX, robotic SELEX and in silico SELEX)131. 
 
Although the main principles of the SELEX process remain the same, these variants have 





Capillary electrophoresis (CE) SELEX was firstly introduced in 2004 by Mendonsa et al.81,135, 
who selected an aptamer against human Immunoglobulin E (IgE). CE is a separation 
technique that separates the charged molecules based on size due to their different rates of 
migration in an electric field136. CE-SELEX uses this mechanism in order to differentiate the 
target bound oligonucleotides from the unbound oligonucleotides due to the difference in their 
electrophoretic mobility, which makes it a very efficient separation method37. Regardless of 
their size the nonbinding sequences migrate through the capillary with the same mobility and 
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are collected separately from the target-sequence complex. In the next step the bound 
sequences are amplified, purified and ssDNA generated for use in the next selection round138.  
This method enables the selection of optimal candidates with high affinity and specificity, and 
can  markedly reduce the required number selection rounds138. The efficiency and simplicity 
of the selection is attributed to some advantages of this method; (a) as some of the targets 
are rare or expensive CE-SELEX require less sample and use of reagents139; (b) both target 
and sequences are free in solution (not bound on any support matrix), and in this way their 
natural structure is maintained when they bind to the nucleic acids140; (c) CE is not just a 
separation tool, but also an analytical technique, which can monitor the sequence enrichment 
and quality in every selection round. Tang et al.141 compared the selection efficiency using 
CE and affinity chromatography, CE showed two-fold improvement of nearly 87.2% binding 
while affinity chromatography with only 38.5%141. CE-SELEX has been used for aptamer 
generation against several targets, achieving low nanomolar dissociation constants141, but 
has a significant limitation in that the target should be large to allow for efficient separation 
between bound and unbound sequences. Yang et al. did, however, perform a CE-SELEX 
against porphyrin (580 kD), but the selection was not as effective as that achieved with larger 
targets173. 
 
In order to improve the selection procedure and to avoid PCR amplification, an alternative 
CE-based method, called non-SELEX, selects an aptamer without amplification; e.g. non-
Equilibrium Capillary Electrophoresis of Equilibrium Mixtures (NECEEM)142, equilibrium 
capillary electrophoresis of equilibrium mixtures (ECEEM)83,143. In ECEEM the components 
of the equilibrium mixture, which is injected into a capillary prefilled, are separated by capillary 
electrophoresis while equilibrium mixture is maintained between the target and the aptamers. 
Here differences in aptamer KD, results in different fractions of aptamers migration with 
different mobilities. This SELEX technique collected these different fractions and generated 
smart aptamers with different and predefined KD values in only three rounds of selection. 
However, CE-SELEX displays some drawbacks, for example, a very small amount of library 
is allowed to be injected to maintain an adequate resolution. This small quantity limits the 
number of sequences that can be assessed. Further drawbacks are related to the fraction 
collection as the abundance of aptamers in early rounds is often below the limit of detection 
and variability in mobilities requires collection windows to be adjusted. To overcome the 
relatively limited size of the library135 (1012 sequences), Jing et al.144 modified this method 
by using micro Free Flow Electrophoresis (µFFE), where the starting library reaches up to 
1014.  
 
1.3.2 Microfluidic SELEX 
 
Combing conventional SELEX with microfluidics, Hybarger et al.145 developed a fully 
automated system called Microfluidic SELEX (M-SELEX) for the selection of an RNA aptamer 
against lysosome. In contrast with conventional SELEX cycle, using the microfluidic chip 
facilitated the achievement of each SELEX cycle in just an hour, whilst also requiring less 
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sample and reagents.  Luo et al.146, combined magnetic bead SELEX with microfluidics in a 
continuous-flow magnetic activated chip-based separation, for aptamer selection against the 
recombinant botulinium neurotoxin. This aptamer showed high affinity but the aggregation of 
magnetic beads in the microchannel resulted in low aptamer purity and recovery. To 
overcome these disadvantages Qian et al.147, improved the process by integrating 
ferromagnetic structures in the microfluid channel chip, resulting in a successful aptamer 
selection against streptavidin.  An alternative microfluidic SELEX method was suggested by 
Park et al.148 to obtain a prostate-specific antigen-binding aptamer based on an 
acoustophoresis technique using a nanos porous sol-gel microarray material. M-SELEX has 
become a versatile and automated method for the rapid generation of aptamers and recently 
other modified techniques have been established to enhance the efficiency of the selected 
aptamers, including protein microarray-microfluidic chip SELEX149, capillary electrophoresis 
microfluidic SELEX139, and bead-based microfluidic SELEX150. A new platform integrating 
magnetic separation, micropumps, micromixers and temperature control systems for 
enzymatic amplification reactions for aptamers against the influenza A/H1N1 virus was 
recently reported151. 
 
1.3.3 High-throughput Sequencing SELEX 
 
In conventional SELEX the method to identify the individual sequencies of the enriched 
libraries was based on Sanger sequencing analysis. However, in most cases the final library 
consists of thousands of sequences, making it difficult to identify the best aptamer. In addition, 
the best sequences with highest affinity and specificity, are not always those with the highest 
frequencies and thus it is important to apply clustering of related sequences.  High-
throughput-sequencing (HTS) was recently introduced to SELEX, facilitating the sequencing 
of the library through the selection rounds152. Hence, the enriched sequences are visible in 
earlier rounds giving information about the evolution of SELEX. Using HTS, the huge amount 
of raw data from sequencing is analysed in terms of counting sequences and ranking them 
in order of frequency. These sequences can be analysed, ranked, and filtered by cut-off read 
numbers to select candidate aptamers for further testing. Additionally, the use of bioinformatic 
tools can facilitate the characterization of aptamers, structure prediction, aptamer-target 
interaction 153. Since the first HTS performed on 2010 by Cho et al.152, several aptamers 
against different targets have been selected using this approach24,121,154,155. 
 
1.3.4 In vivo SELEX 
 
Aptamers selected in vitro sometimes may not be functional in vivo due to localised 
environment conditions such as temperature, ion atmosphere, pH, and other variables, that 
determine the affinity and specificity of the aptamer.  To address this, researchers have 
developed an in vivo-based SELEX method to select tissue-penetrating aptamers directly 
within animal models. Mi et al.156 performed whole-organism in vivo SELEX in a model of 
intrahepatic colorectal cancer (CRC) metastases. After 14 rounds of selection collecting the 
aptamer that bound to liver metastases, they generated an aptamer that bound to oncogenic 
UNIVERSITAT ROVIRA I VIRGILI 




helicase p68.  In another work Chen et al. identified an aptamer capable of crossing the blood 
brain barrier157. Despite the fact that these examples demonstrate the successful generation 
of aptamers using live animal model, still, the main concern is that nucleic acids are 
susceptible to enzymatic degradation. Moreover, when aptamers are injected systematically, 
elimination through the liver and clearance in the kidney is inevitable. 
 
1.3.5 Cell SELEX 
 
Cell-SELEX employs whole live cells as targets. As in conventional SELEX even here two 
types of screening are done, the oligonucleotide library is primarily incubated with non-target 
cells (counter SELEX) and then with the target cells (positive SELEX).  Compared to in vitro 
SELEX, in cell SELEX molecular targets are in their native conformation and different 
receptors molecules can be screened simultaneously. Cell SELEX was first published in 2003 
by Daniels et al.158 where they successfully selected an aptamer against tenascin-C using a 
glioblastoma-derived cell line, U251. Ara et al.159 successfully screened tumour cell surface 
antigen aptamers, that can be used as molecular and diagnostic markers as well as for cancer 
treatment. Lin et al generated an aptamer that can distinguish the glioma cells from the 
human astrocytes160. Several other cell SELEX-based studies have been published such as 
TECS SELEX161, FACS-SELEX129,162, 3D cell SELEX163, cell internalization SELEX164,165.  
Currently, cell-SELEX is mainly used for cancer-related biomarkers. In general, cell-SELEX 
requires a higher number of cycles,  and is considerably longer than conventional SELEX 
and there is a risk of failure due to the damage of fragile cells166. 
 
Table 1.2. List of some modified SELEX methods which are commonly used. 




Relative ease of selection 
No special equipment 
required 
Equilibrium, in solution 
aptamer-target binding 
Potential for parallel 
aptamer selections for 
multiple targets 
Can be used as medium-
throughput binding assay 
Large number of selections rounds necessary 
(8–20 rounds) 
Relative abundance and rapid enrichment of 
filter-binding aptamers 






Applicable to most targets 
(small-molecules, 
peptides, proteins, and 
cells) 
Potential for serial and 
parallel aptamer 
selections for multiple 
targets 
Rapid selection of 
aptamers (1-6 rounds of 
selection) 
Target or aptamer immobilization: restricted 
interaction surface 
Nonequilibrium, flow binding (if used with fluidic 
devices) 
Fabrication of fluidic devices, and electronic 
instruments and flow pumps required for operation 
Density-dependent co-operativity for non-specific 
interactions  
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Potential for serial and/or 
parallel aptamer 





binding systems are 
available 
Rapid selection of 
aptamers (1–6 rounds of 
selection) 
Target immobilization or encapsulation required 
Fabrication of fluidic devices, and electronic 




Equilibrium binding with 
in-solution target and 
immobilized 
aptamer 
Can be used as a large-
scale binding assay 
 
Limited capacity for aptamer library (<105 
sequences) 
Currently limited to ssDNA aptamers 
Aptamer sequences need to be pre-determined 
(designed or derived from a pre-selected aptamer 
library) 
Relatively large number of selection rounds are 
necessary (~9 rounds) 
Costly and time consuming due to fabrication of a 
microarray with different sequences unique for each 
target 
Single target selections 
Prone to artifactual results due to design of 
sequences 






Limited capacity for aptamer library (<108 
sequences) 
Requires expensive and specialized instrument 
(i.e., Atomic Force Microscopy system) 




Cell SELEX Biomarker discovery 
Therapeutic potential of 
selected aptamers 
Target in native state 
Selection against cell 
Restricted to molecules presented on cell surface 
Prone to artifacts due to dead cells in population 
Target(s) of the selected aptamers are unknown 
Selection of aptamers to an unintended target is 
very likely 
109 
In vivo SELEX Selection of in vivo 
functional aptamers 
Limited capacity for aptamer library (~104 
sequences) 
Relatively large number of selection rounds are 
necessary (up to 14 rounds) 
Selection of aptamers to an unintended target is 
very likely 
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Equilibrium, in solution 
binding 
No immobilization of 
small-molecule target 
Complications of aptamer capture sequence within 
aptamer library random region 
Relatively large number of selection rounds are 
necessary (~13 rounds) 
Depends on target binding-induced conformational 






complexes from free 
aptamers according to 
their electrophoretic 
mobility with capillary 
electrophoresis 
Could effectively identify 
high affinity aptamers in 
few rounds 
Restricted to targets that cause a shift in aptamer 







Rapid partitioning of 
target-bound and 
unbound aptamers 
Limited capacity for aptamer library (~1012 
sequences) 
Restricted to targets that cause an electrophoretic 
shift on nucleic acid aptamers 
Capillary-electrophoresis instrument or fabrication 
of micro-electrophoresis devices are required 
173 
In silico SELEX Could be used to predict 
aptamer affinity, 
specificity, 3D structure 
and aptamer-target 
interaction by computer 




Small size of starting library  




1.4 SELEX type focused more on small molecules 
 
1.4.1 Problems associated with small- molecule binding aptamers 
 
As can be seen in Figure 1.5 only 19% of existing aptamers have been generated for small 
molecules targets. Originally SELEX was presented as a very effective methodology for the 
selection of aptamers for small molecules. However, other larger targets such as proteins or 
cells have more functional groups and structural motifs, implicating higher probability for the 
successful selection of aptamers with high affinity and specificity. On the other hand, small 
molecules play important roles in many fields and the demand for their detection is of 
increasing interest. These molecules include cell signalling molecules, toxins, drugs, heavy 
metals, antibiotics, ions, and pesticides97–100. 
 
UNIVERSITAT ROVIRA I VIRGILI 






Figure 1.5. A chart that represents the selected aptamer per each target type174. 
 
Considering their importance conventional SELEX protocols have been modified to develop 
new and improved protocols aimed at the successful selection of specific aptamers against 
small molecules, and approaches where target small molecules have been immobilised on 
diverse matrices (Table 1.3) as well as approaches where the target small molecules are free 
in solution, have been developed. In the case of small molecules, the number of functional 
groups is limited, and when the selection is not performed with the target free in the solution, 
one of its functional groups will have to be used for the immobilization, thus potentially 
decreasing the amount of possible interaction with the aptamer candidate. Moreover, the 
binding of the target to the matrix for the selection is often carried out in a conjugate form 
rather than for the target alone, and this can negatively affect the applications when the target 
is free in the solution. For example, the aptamer selected for sulforhodamine, displayed 
weaker binding to the target when in solution compared to when the target was immobilized 
on the matrix used for the selection175.  In some other studies, the pool library is exposed to 
target, linked to protein carrier molecules such as bovine serum albumin (BSA), ovalbumin 
(OVA), and keyhole limpet hemocyanin (KLH)176. However, this promotes the aptamer 
selection against a conjugate or linker molecule rather than the unmodified original target.  
To overcome these disadvantages, alternative SELEX methodologies have been developed, 






Virus Cell Small molecules Proteins
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Table 1.3. Commercially available chemically modified matrixes used for the immobilization of small molecules 
for their aptamer selection. 
Chemical moiety of 
ligand 
Matrix chemistry Magnetic bead Agarose 
COOH CHO hydrazine  Adipic acid dihydrazide Agarose 
COOH CHO (EAH 
Sepharose only) 
amine M-270 Amine EAH Sepharose 4B 
Affi-Gel 102 Gel 
CH sepharose 4B 
Carboxy Link Coupling Resin 
NH2 aldehyde  AminoLink PlusCoupling Resin 
AminoLink Coupling Resin 
NH2 cyanogen bromide  CNBr-Activated Sepharose 4B 
CNBr-Activated Sepharose 6 
MB 
NH2 N-hydroxy succinimide 
(NHS) 




Pierce NHS-Activated Agarose 
NH2 N-nucleophiles carbonyl diimidazole  Pierce CDI activated Agarose 
Resin 





NH2 SH (Dynabeads 
only) 




ECH Sepharose 4B 
NH2 SH OH 
(Sepharose only) 
epoxy M-270 epoxy Epoxy-Activated Sepharose 6B 
SH iodacetyl  SulfoLink Coupling Resin 
SH heavy metal ions 
alkyl and aryl 
thiol  Activated Thiol Sepharose 4B 
Halides addition to 
C=O C=C N=N 
  Thiopropyl Sepharose 6B 
 
 
1.4.2 Magnetic beads-based SELEX 
 
One of the main challenges of performing SELEX with a small molecule target is the 
partitioning of bound and unbound sequences. Magnetic beads are the most widely used 
solid matrix for the selection of aptamers against small molecules, that simplify the separation 
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process of target-ssDNA and unbound-ssDNA through the aid of a magnet rack. These beads 
are super magnetic spherical polymers with a uniform size and a define surface allowing a 
variety of chemistries for the coupling reaction with different molecules (Table 1.3). The use 
of magnetic beads reduces the volumes needed to perform aptamer selection, additionally, 
since magnetic beads are thermally, they can be used directly in PCR to amplify the target 
bund DNA, avoiding any potential loss of sequences during elution. Many different aptamers 
have been selected against small molecules using magnetic beads. Kiani et al.179 have used 
streptavidin-coated magnetic beads to isolate digoxin aptamer, Duan et al.180 and Mairal et 
al.,79 used carboxylic beads for chloramphenicol and histamine aptamer isolation, 
respectively. Bruno and Kiel et al.76 and Lin et al.77 have used tosylactivated magnetic beads 
for the selection of an aptamer against biotoxin and okadaic acid-mAb respectively. 
 
Figure 1.6. Schematic representation of Magnetic bead-based SELEX. 
 
Briefly, as in SELEX with large molecules, the first step involves the immobilization of the 
target molecule through interaction of functional groups on the bead surface and the 
functional group of the target (Figure 1.6). Sequences that bind the target are separated from 
those they do not bind via multiple washes whilst the magnetic beads are separated from the 
supernatant by placing close to magnetic stand. The sequences are amplified for the next 
cycle of SELEX. As previously mentioned, a critical component of SELEX to increase the 
aptamer specificity, is the introduction of negative and counter selection steps. Negative 
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selection is the selection against non-target components that are present in the target 
sample, such components include selection buffer and unmodified matrix (naked or activated 
magnetic beads). Counter selection is performed against molecules structurally similar to the 
target, as well as potential interferents that may be present in the sample where the aptamer 
will finally be applied. 
 
An interesting one-pot SELEX approach was developed by Jauset-Rubio et al.80 using the 
benefits of counter-SELEX and next generatin sequencing for the simultaneous identification 
of aptamers against the steroids estradiol, progesterone, and testosterone. Results of binding 
studies showed nanomolar affinity of the aptamers toward the specific targets, with 




Graphene oxide (GO), chemically exfoliated from oxidized graphite, is considered as a 
promising material for SELEX for small molecules.  The novel approach of using GO in 
SELEX was first described by Park et al.177 who selected an aptamer against the Nampt 
protein. In principle, oligonucleotides are bound to the GO surface through π-π stacking 
interactions between the nucleobases and sp2 atoms of GO. Adsorption of dsDNA on GO is 
very weak due to the shielding of nucleobases by the phosphate backbone, whilst ssDNA 
binds very strongly181. In one approach, the oligonucleotides of a random library are adsorbed 
on GO and incubated with the target, and high affinity binders are desorbed from the GO and 
then extracted, amplified, and subsequently re-adsorbed to the GO for the next round of 
SELEX.  Another approach is where the target is pre-incubated with the ssDNA/RNA library, 
and following incubation, added to the GO, and the unbound ssDNA binds to the GO, and 
centrifugation used to separate the GO-bound ssDNA from the target bound ssDNA.  
Alternatively, a combination of these approaches can be used, where the library is primarily 
incubated with the counter targets, and then added to the GO. ssDNA bound to the target is 
separated from the ssDNA bound to the GO via centrifugation, and the target is then added 
to the GO, and high affinity binders are desorbed from the GO via interaction with the target 
molecule (Figure 1.7). 
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Figure 1.2. Schematic representation of GO-SELEX. 
 
Nguyen et al.182 developed multiple GO-SELEX selection of aptamers against different types 
of pesticides; tebuconazole, inabenfide, and mefenacet.  In another selection done by Gu et 
al.183, three different screening processes were used to obtain aptamers against okadaic acid 
(OA). In the first step the ssDNA was firstly incubated with the target (OA) than with GO. In 
latest rounds a negative selection step was introduced in order to disqualify weakly bound 
ssDNA. Moreover, they performed an important step for increasing the aptamer specificity, 
which is the involvement of counter molecules which may co-exist with the target in a 
heterogeneous environment. In this work, the Kd values for aptamer selected against 
Okadaic acid were slightly lower than that of the aptamer screened by Eissa et al.184, who 
used immobilized okadaic magnetic beads for the aptamer selection. Comparing these 2 
types of selection,  the use of graphene oxide method allows the target to be free in the 
solution throughout the selection, enhancing the successful application of these aptamers in 
detecting contaminated samples with OA in its native conformation state183. 
Another successful aptamer selected using GO SELEX, was against the mycotoxins, patulin 
(PAT),185 and T-2 toxin186.  
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1.4.4 Capture SELEX 
 
Capture SELEX was originally designed by Stoltenburg et al.178, and in this approach the 
library rather than the target molecule is immobilised.   The nucleic acids used in the library 
generally have the format of fixed sequence for primer binding (20-25nt), random sequences 
(30-40nt), fixed docking probe sequence (8-12nt), random sequences (5-20nt), fixed 
sequence for primer binding (20-25nt). As always, the library is amplified and ssDNA 
generated, and the generated ssDNA is then immobilised onto a solid matrix such as 
agarose187 or magnetic beads178 (Figure 1.8). Streptavidin coated beads are normally used, 
and these are functionalised with a biotinylated probe complementary to the docking probe, 
thus achieving immobilisation of the library. Pre-elution and background elution steps are 
sued to remove any unbound or weakly bound sequences.  A counter SELEX step can then 
be introduced, incubating the functionalised beads with the counter molecules.  Sequences 
with affinity to the counter molecules are displaced and this displaced DNA separated, and 
the beads then incubated with the target molecule.  Sequences with affinity to the target 
molecule are effectively displaced, and this displaced DNA is then amplified, ssDNA 
generated and again immobilised on a fresh set of beads, and the process repeated until 
evolution has been completed (Figure 1.8). 
 
 
Figure 1.8. Schematic representation of Capture-SELEX. 
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In the case of agarose beads the library usually needs to be packed in an affinity 
chromatography column, and the target-binding-library need to be separated using 
centrifugation, which is not as gentle as separation through the magnetic rack in the case of 
magnetic beads. However, the cleaning process of magnetic beads is laborious, and if the 
cleaning is incomplete, some non-specific library sequences may remain.  
 
Capture SELEX facilitates immobilisation-free SELEX and has been used successfully to 
select both DNA and RNA aptamers against small molecules188, including cadmium189, 
penicillin190, quinolone191, lipopolysaccharide192, amongst others (Table 1.4). However, 
capture SELEX requires careful optimisation of experimental conditions such as buffer 
composition, temperature and time of incubation130, and typically requires a high number of 
cycles to complete evolution. 
 
Table 1.4. Example of different specific aptamers selected via Capture SELEX. 
Aptamer targets Target type Library sequence (5’ to 13’)  KD Ref. 






Zinc Metal ions CATCAGTTAGTCATTACGCTTACG-N50- 
ATTGTGAAGTCGTGTCCCTATAGTGAGTCG
TATTAGAA 





Forward PCR prime site-N17-
TTTTGTGGGTAGGGCGGGTTGGTTTT-N17- 
Reverse PCR prime site 

























Cadmium Toxic metal ACCGACCGTGCTGGACTCT-N30-
AGTATGAGCGAGCGTTGCG 
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Characterization of aptamers for small molecules 
 
Following completion of SELEX, next generation sequencing and bioinformation data 
analysis, the best aptamer candidates are selected and chemically synthesised for the further 
analyses.  
 
The assays that are currently used for the characterisation of aptamers against small 
molecules include the apta-PCR affinity assay (APAA), enzyme linked aptamer assay 
(ELAA), surface plasmon resonance (SPR), isothermal titration colorimetry (ITC), capillary 
electrophoresis (CE), and AuNPs colorimetric assay. Each of these assays have some 
limitations and are not suitable for every target. Furthermore, the successful performance in 
one assay does not guarantee their functionality in another one. In the work of McKeague et 
al.207, an inconsistency in the binding affinities in different assays tested when using the same 
aptamer for ochratoxin A (OTA) detection was observed.  
 
1.5.1 Enzyme linked aptamer assay (ELAA) 
 
Enzyme linked aptamer assay (ELAA) is an alternative of the conventional enzyme linked 
immunosorbent assay (ELISA) where antibodies are replaced with aptamers as 
biorecognition element. In some studies both bead and plate-ELAA approaches have been 
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used80. In most cases, this assay is performed by coating a fixed amount of target on a 
microtiter plate or magnetic beads, followed by the incubation with a range of concentrations 
of biotinylated aptamer candidates. Following thorough washing to remove any unbound 
aptamers streptavidin-horse radish peroxidase (SA-HRP) is added, and after a further 
washing, the enzyme substrate 3,3′,5,5′-Tetramethylbenzidine (TMB) is added followed by 
acid, and the generated colour measured. A binding isotherm is platted and the KD value 
elucidated from the plot. ELAA assay has not only been utilised to determine the KD values 
for different molecules125,208, but has also been used in many bioanalytical applications for 
the target-specific detection of okadaic acid183, steroids80,dopamine209, OTA210,and 
deoxynivalenol (DON)211. However, the assay procedure usually involves multiple binding 
and washing steps, which can be time consuming. 
 
1.5.2 Surface plasmon resonance (SPR) 
 
SPR technology offers label-free detection and real time quantitative analysis and provides 
binding constant determination212. Briefly, when polarized light strikes an electrically 
conducted surface of a metal (gold or silver), at a particular angle, it can excite electrons on 
the metal surface, causing an electro density wave to propagate along the surface.  
Bioreceptors can be immobilised on the metal surface directly via chemisorption or on 
polymer coated metals via chemical crosslinking, and the change in the plasmons resonance 
upon interaction between the immobilised bioreceptor and its cognate target, measured.  
SPR has been used extensively to monitor evolution and for the determination of KD for a 
wide range of molecules including vascular endothelial growth factor213,tubulin214, thrombin 
and thyroid transcription factor 195, prostate-specific antigen215, and retinol binding protein 
4216, and has also found application for small molecules, including kanamycin B217, codein218, 
S-adenosyl-l-homocysteine219, adenosine and alpha toxin220. 
 
Because of the low refractive change index of the molecule interaction of some small 
molecules, it is difficult to detect these interactions only by conventional SPR techniques and 
AuNPs have been combined with SPR sensor for adenosine detectio221, whilst Luo et al. 
developed a method using the salt-induced AuNPs aggregation and SPR for bisphenol A 
detection222.  Although SPR is useful tool that shows in real time the binding kinetics of the 
interaction, the instrumentation associated with SPR technology is quite expensive and 
needs trained personnel, which narrows its use in many laboratories. 
 
1.5.3 Microscale Thermophoresis (MST) 
 
MST is another useful method for the characterisation and determination of the interaction 
between aptamers and small molecules. MST measures the motion of molecules along 
microscopic temperature gradients and detects changes in their molecular size, charge, and 
hydration shell when the target is bound to the aptamer. The thermophoretic movement is 
measured in thin glass capillaries through µm sized temperature gradients.  Entzian and 
Schubert223 used this method to determine the KD of an adenosine triphosphate (ATP) 
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aptamer using a range of aptamer concentrations from pM to mM and the KD was found to 
be 34.4±4.4 µM . MST is a useful immobilization-free technique that can be used with small 
molecules, such as 17β estradiol224, testosterone78.   
 
1.5.4 Apta-PCR affinity assay (APPA) 
 
Apta-PCR Affinity Assay (APPA) is a simple method based on the PCR amplification of an 
aptamer that is bound to the target molecule, which in turn is immobilized on the surface of 
the matrix and offers rapid information regarding the affinity and specificity of studied 
aptamers. The use of this assay for analysing aptamer small molecule interactions has 
already been demonstrated78,224. In this assay the target is immobilised on a solid matrix 
(magnetic beads), usually the same one that is used during the selection process or a 
different one to demonstrate the absence of matrix participation in the binding event80. The 
process is followed by the incubation with different concentrations of unmodified aptamer, 
PCR amplification of the complex bead-target-aptamer, followed by gel electrophoresis. The 
intensity of the bands is measured using Image J, and isotherm plotted and used to determine 
the KD. 
 
1.5.5 Isothermal Titration Calorimetry (ITC) 
 
Isothermal Titration Calorimetry (ITC) is a widely used biophysical technique used for the 
measurement of affinity based on the enthalpies of affinity interactions225. ITC determines the 
enthalpy change occurring upon molecular interaction at a constant temperature where only 
the thermal effect is measured.  ITC provides the stoichiometry of interaction and a set of 
thermodynamic binding parameters: the equilibrium binding constant (KD) and the change in 
enthalpy (ΔH) and entropy (ΔS) of the binding. One of drawbacks limiting the use of ITC is 
the need for a high amount of the interacting materials, and, furthermore, these molecules 
need to be soluble in water and stable in the solution. 
ITC has been used for analysing large molecules like thrombin226 but recently it has been 
used for characterisation of the specificity of an aptamer selected against cocaine, measuring 
the interaction between the aptamer and cocaine and its metabolites, ecgonine, benzoyl 
ecgonine, ecgonine methyl ester and norcocain227. 
 
1.5.6 Biolayer interferometry (BLI) 
 
An interesting real-time optical analytical method for characterizing the binding of aptamer 
with small molecules is biolayer interferometry (BLI)228. BLI signal is based on target 
conformation, hydration, and dipole moment using a microfluidic chip, a charge coupled 
device (CCD) array, and a helium-neon laser. This method uses fibre optic biosensors to 
monitor changes in the optical thickness of the sensor layer that occur with biological binding 
events. Briefly, the laser irradiates the sample, the beam is reflected and refracted within the 
channel followed by detection with the CCD array, interaction between aptamer and the 
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molecule, causes a wavelength shift in the interference spectrum of the reflected light229.  In 
recent years BLI has been used for quantitative determination of KD for proteins230 as well as 
with small molecules including toxins229,antibiotics tenofovir, ampicillin, tetracycline231, 
hormone norepinephirine232,233, and dinophysistoxin-1234.  
 
1.5.7 Equilibrium filtration or dialysis 
 
Equilibrium filtration or dialysis has been demonstrated as a very useful method to study the 
affinity of aptamers for small molecules. In both approaches, a target and its aptamer are 
mixed in a series of microfuge tubes, in which the amount of aptamer is kept constant, but 
the amount of target is linearly increased until the samples reach equilibrium. Thereafter, 
separation of aptamer-target complexes from unbound target molecules is performed by 
applying a molecular weight cut-off membrane such as a size exclusion filter or a dialysis 
chamber. Both methods utilise radio-isotope labelled target molecule, and the exact amount 
of unbound target is quantified by measuring the amount of radioactivity inside the filter or 
dialysis chamber using a scintillation counter235. Since input concentrations of the aptamer 
and target analyte are known, a series of numbers that describes the amount of aptamer 
bound at each target concentration can be calculated in order to determine the binding 
capacity of the aptamer. 
Equilibrium-based methods have been applied in many aptamer studies, messenger 
adenosine 3',5'-cyclic monophosphate (cAMP-1)126, analysing L-arginine specific aptamer19. 
However, equilibrium-based methods assume free movement of small molecules across a 
membrane, which may not always be the case for some molecules, such as ATP. A study by 
Huizenga and Szostak demonstrated an incomplete passing of ATP through the 
membrane236. Moreover, both methods utilise radioisotope labelled targets, thus a radio-
isotope certified laboratory is required to undertake these assays which is not always 
available. 
 
1.5.8 Fluorescent binding assay 
 
Mann et al.90 described fluorescent binding assays for the selection of ethanolamine-binding 
aptamers.  The assay utilises convenient chemical synthesis and modification of 
oligonucleotides. By labelling an aptamer with a fluorophore, such as FAM237, Alexa 488238 
or Cy3239, quantification of aptamers can be achieved through the measurement of 
fluorescent intensity. The assay requires the immobilisation of a target molecule to a solid 
support (i.e. polystyrene microtiter plates, magnetic beads, agarose beads and sepharose 
beads). Then, a constant amount of the immobilised target can be incubated with a range of 
fluorophore-labelled aptamer concentrations. Following incubation, any excess unbound 
aptamers are removed by multiple washing steps, and bound aptamers are then eluted from 
aptamer-target complexes using denaturing substances such as SDS, EDTA or urea. 
Fluorescent intensity of the eluted aptamers can then be determined by fluorometry using 
appropriate excitation and emission wavelengths corresponding to the fluorophore used for 
aptamer labelling, followed by the calculation of saturation curves by using fluorophore 
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calibration plots. Due to simplicity, low cost, and user-friendly features, the method has been 
used to determine the binding features for aptamers targeting small molecules such as, 
chloramphenicol240, L-tryptophan241, polychlorinated biphenyls242, and okadaic acid184. 
 
Aptamer-based biosensors  
 
Thousands of DNA or RNA aptamers have been identified for various targets, such as 
proteins, peptides, amino acids, antibiotics, viruses, whole or part of cells, metal ions, and 
even small chemicals, with high specificity and affinity, and they have been applied in 
therapeutics and analysis243.  
A biosensor is an analytical device that detects changes in biological processes and converts 
them into an electrical signal by using as recognition element enzymes, antibodies, nucleic 
acids or aptamers. An aptasensor is a class of biosensor where the biological recognition 
element is a DNA or RNA aptamer, in which the aptamer recognizes the molecular target 
against which it was previously in vitro selected. The aptamer-target reaction is independent 
of both the type of detection system and the kind of transducer employed. Aptasensors can 
be easily multiplexed to detect a variety of aptamer-target reactions simultaneously244. 
According to their transducing element biosensors can be divided into (a) optical 
transduction, (b) electrochemical detection and (c) mass sensitive detection. Several 
aptasensors for the detection of different targets ranging from small ion molecules to large 
proteins have been reported, using optical transduction, mass-sensitive or electrochemical 
detection245,246. Within the following section, examples of aptasensors that have been 
developed for the detection of small molecules are detailed. 
 
1.6.1 Optical-based aptasensors 
 
Because of their chemical and physical properties, ability to absorb and scattered the light 
with high efficiency in a wide range of colours, AuNPs are widely used as labels in sensing. 
Moreover, the phenomena of physical or chemical adsorption between aptamers and AuNPs 
has been very well studied247,248.  
 
In gold nanoparticle aggregration colorimetric assays, the aptamer is adsorbed onto the 
surface of AuNPs thus preventing their aggregation and maintaining the red colour of non-
aggregated gold nanoparticles. Upon the target introduction, the aptamers are displaced from 
the surface of the AuNPs, and following addition of salt, the AuNPs aggregate, resulting in a 
change in colour to blue-purple249. 
This technique has been widely used for detection of different small molecules including 
histamine250, metal ions, Hg2+ 251, cocaine252, theophylline253, aminoglycosides254, 
serotonin255, malathion pesticide256, streptomycin detection in blood serum and milk257, 
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Ochratoxin A in red wine, as well as cocaine in spiked synthetic urine and saliva, 
respectively258.  
AuNPs are very effective quenchers of fluorescence, and Chen et al. exploited this for the 
determination of Kanamycin A in milk samples. Dye-labelled aptamer was adsorbed onto the 
surface of AuNPs resulting in fluorescence quenching. Upon addition of Kanamycin A, the 
dye-labelled aptamer was displaced from the surface of AuNPs and the recovery of 
fluorescence intensity259. 
AuNPs have also been used to enhance the sensitivity and selectivity of the resonance 
scattering (RS) in detection of tetracycline in milk260,and  metal ions261. In this work, an 
aptamer-modified nanogold resonance scattering (RS) probe (AussDNA) is used for the 
detection of Hg2+. In principle, in the presence of Hg2+, nanogold particles aggregate to large 
nanogold clusters, generating a linear increase of RS intensity at 540 nm. Whenever the large 
nanogold clusters are removed by membrane filtration, the excess AussDNA in the filtrate 
solution exhibits a catalytic effect on the new Cu2O particle reaction between NH2OH and 
Cu2+-EDTA complex at 60 °C. In the addition of Hg2+, the excess AussDNA is decreased, 
resulting in the decrease of Cu2O particle RS intensity at 602 nm in a linear response to Hg2+ 
concentration in the range of 0.1-400 nM, with a detection limit of 0.03 nM Hg2+ 261. 
Overall, the aforementioned studies demonstrate AuNPs aptasensors are suitable for the on-
site detection of small molecules, due to its excellent simplicity, but its accuracy and 
reproducibility is slightly low, because the interaction between aptamers and AuNPs is rather 
delicate depending on the sensing environments. Therefore, this method is more for 
qualitative rather than quantitative analysis. Another limitation of AuNP-based colorimetric 
assays is the tendency of AuNPs to aggregate non-specifically in the presence of salt and 
other molecules present in the complex biological fluids 248,262. 
Other types of optical aptasensors require conjugation of the aptamer with and optically active 
molecule. Applying fluorescent probes such as quantum dots (QDs), nanoclusters, carbon, 
and fluorescent dyes, which show enhanced or quenched fluorescence intensity along with 
the binding between aptamers and their targets, fluorescent aptasensors achieve quantitative 
determination of target molecules based on the variation of fluorescence signal intensity263.  
GO is one of quencher nanomaterials that has the capability to capture the radiative energy 
emitted by the fluorophores. Using this advantage, Wang et al.264 developed an experiment 
where simultaneous labelled aptamer with two different fluorophores were used for the 
detection of two different mycotoxins, ochratoxin and zearalenone. In the presence of the 
dual targets, the labelled aptamers were released, and form GO and the fluorescence in 
different length were measured. In other studies the combination of the fluorescent dye FAM 
with magnetic reduced GO also exhibits excellent sensitivity and has been applied to the 
detection of patulin265, deoxynivalenol211, and cylindrospermopsin266. Apart from GO, 
molybdenum carbide nanotubes are used for the fluorescence quenching is bisphenol A 
detection267. A simple ratiometric fluorescent sensing platform was proposed by Ahmadi et 
al.268 for detection of patulin using target-induced strand displacement composed of two 
fluorescent dyes, FAM and Carboxytetramethylrhodamine (TAMRA). 
Sabet et al.269 apply a fluorescence quenching-based method, in which aptamer-conjugated 
quantum dots (QDs) are adsorbed to AuNPs, thus quenching the fluorescence of the QDs, 
which is restored upon addition of AFB1 due to displacement of the aptamers from the 
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AuNPs.  Wang et al.270 developed FRET aptasensor for the simultaneous determination of 
AFB1 and FB1 levels using quantum dots with different emission peaks (GQDs and RQDs) 
and magnetic GO/Fe3O4 as the single acceptor.  
Wu et al.271 use two pyrenes molecules instead of one so to increase the fluorescence 
intensity in cocaine detection. The cocaine aptamer was split in 2 parts, each of them labelled 
with a pyrene, and the binding was measured by time-resolved fluorescence.  
SPR technology is commonly utilised for the study of molecular binding interactions between 
free analyte molecules in solution and probe molecules which are linked to or immobilised 
onto the sensor surface in real time272–274. Although SPR has been widely used in biological 
analytes it is still a challenge for its detection of small biomolecules as the binding of small 
molecules with its aptamer causes too little change in refractive index for detection. In order 
to overcome this drawback, AuNPs have been combined with SPR aptasensor to enhance 
the signal, as in the case of adenosine detection which produce a detection range from 1x 
10-9 to 1x 10-6 M221. Additionally, a GO-AuNPs composites SPR aptasensor in combination 
with a split aptamer was used for signal amplification in adenosine detection275.  
 
1.6.2 Electrochemical aptasensors 
 
Electrochemical aptasensors are classified in impedimetric, amperometric/voltammetric, and 
potentiometric sensors, and have been demonstrated to be useful tools for detection of 
biological small molecules including neurotransmitters, metabolites, vitamins, amino acids, 
dietary minerals246, antibiotics276–278, mycotoxin279, and alkaline metals280. In order to 
enhance the specificity and sensitivity of the electrochemical aptasensors for small 
molecules, nanomaterials such as are carbon nanotubes (CNTs), graphene, quantum dots 
(QDs), conducting polymers (CPs), and metal nanoparticles (MNPs),and AuNPs281. For 
example, incorporation of AuNPs can assist in improving their electrochemical signal in using 
two different approaches. The first approach is the enlargement of electrode surface by 
attachment of AuNPs on electrode, which might increase the amount of capture probes on 
electrode thus the electrochemical signal intensity can be enhanced.  
Several electrochemical aptasensors have been developed for the detection of cocaine282. Li 
and co-workers developed a sensitive electrochemical aptasensor for cocaine detection 
using AuNPs self-assembled on a gold electrode283. Following the same principle Zhu et 
al.284, reported kanamycin detection conducting polymer-Au nanocomposite on screen-
printed electrode (SPE). In another study AuNP was combined with multiwalled carbon-
nanotubes-reduced graphene oxide nanoribbon for the detection of insecticide acetamiprid 
in soil, water and food samples through impedimetric aptasensor285. Omidina et al.286 
developed an aptasensor for phenylalanine detection using the electrochemical transduction 
method where 5-thiol-terminated aptamer is covalently attached onto a gold electrode. Other 
examples include 17β-estradiol detection287, l-histidine based on the switching structure of 
aptamer and gold nanoparticles-graphene nanosheets (GNPs-GNSs) composite288. 
Other studies were focused on the detection of neurotransmitters such as serotonin289. The 
aptamer which was previously immobilized on a gold electrode through gold-thiol binding was 
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labelled my methylene blue in two different positions, where the aptasensor intermediate-
labelled methylene site has the higher response in comparison to terminal methylene labelled 
site.  
Cyclic voltammetry and electrochemical impedance spectroscopy were used for measuring 
the aptasensor signal in every step. Dopamine detection has been studied in different 
aptasensors290. An amperometric aptasensor for dopamine was fabricated on the basis of 
the electrostatic interactions between a negatively charged RNA specific aptamer and a 
positively charged cysteamine-modified gold electrode291. Moreover, the aptasensor 
specificity and stability when use in serum ,was improved via regulating the electrostatic 
immobilization of the aptamer in the next work from the same group292. 
 
1.7 Lateral flow aptamer assays 
 
The majority of before mention techniques require trained personnel, expensive 
instrumentation and are often laboratory based, limiting their use at point of care settings. In 
recent years, lateral flow assays (LFA) have gained significant attention due to their ease of 
use and high sensitivity. LFAs were first reported in 1956 by Plotz and Singer, and since then, 
hundreds of LFAs have been developed for the detection of a wide range of targets as it is 
summarized in Table 1.6. 
 
Low development costs and ease of production of LFAs have resulted in the expansion of its 
applications to multiple fields in which rapid tests are required (Table 1.5). LFA is a paper 
based platform composed of a membrane such as nitrocellulose, which consists of a sample 
pad, conjugate pad, test and control line, and the absorbance pad, all assembled on a plastic 
backing pad which provides mechanical support293. LFA is based on affinity interaction, the 
sample is added to the sample pad and later migrates towards the conjugation pad via 
capillary action. The liquid in the sample hydrates a detection label in the pad consisting of a 
molecular recognition element (antibody or aptamer) coupled to a reporter molecule, which 
is always present in excess amount. If the target is present, it will form a complex that results 
in an appropriate response on the test line, while a response on the control line indicates the 
proper liquid flow through the strip. The read-out, represented by the lines appearing with 
different intensities, can be assessed by eye or using a dedicated reader294,295. 
Although there are different applications of LFA for different targets, still, the device has a 
complex architecture, and many critical elements need to be considered during instrumental 
design to improve the sensitivity and the cost of the format.  
 
Table 1.5. The advantages and limitations of lateral flow assay. 
Advantages Limitations 
Low cost Speed of capillary action cannot be controlled 
Fast analysis of results Generally qualitative or semi-quantitative 
User-friendly Batch reproducibility can vary 
Microfluidic Cross-reactivity can occur 
UNIVERSITAT ROVIRA I VIRGILI 




Generally, does not require sample 
pre-treatment 
Hook effect 
No or little requirement for electricity Can be difficult to construct a successful conjugate 
Wide range of applications Optimization is difficult 
Can be multiplexed  
 
 
Different lateral flow assay formats have been reported exploiting aptamers as the bio affinity 
element as detailed below. 
 
1.7.1 Sandwich aptamer lateral flow assay  
 
The sandwich assay format is the most commonly used format for testing large molecules, 
which have multiple binding sites, and can exploit dual aptamers, a combination of antibodies 
and aptamer or split aptamer. 
a) Sandwich aptamer lateral flow assay using pair of aptamers 
Ahmad Raston et al.296 used the vaspin dual aptamer (V1 and V49) in the paired aptamers 
lateral flow assay format, by using a AuNPs-secondary aptamer (V49) aptamer as a reporter 
molecule. The streptavidin-biotinylated aptamer V1 was used in test lined while the 
streptavidin-biotinylated complementary sequence to V49 aptamer was immobilized on the 
control line. In the presence of vaspin, the complex between the target and V491-AuNPs is 
captured by the V1 aptamer immobilised on the test line and a red band is observed. For the 
control experiment, complementary V49 aptamer on the control zone will capture the 
remaining AuNPs-V49 aptamer resulting in a second red band, the control line, 
demonstrating that the assay was working properly. Other examples of targets analysed in 
sandwich assay format, with some differences in bioconjugate preparation, are Ramon 
cancer cells297 and arboviruses, including the Chikungunya and the Tick-borne encephalitis 
virus298. 
b)  Sandwich aptamer lateral flow assay using split aptamer 
To overcome the absence of dual aptamers in LFA development, sandwich assay format 
using split aptamer fragments is used as an alternative solution. Zhu et al.299 developed this 
novel assay by using two DNA probes that only assemble in the presence of the target ATP. 
One thiolated split aptamer (aptamer part 1) was chemisorbed on AuNPs and the other split 
aptamer was biotinylated (aptamer part 2) and immobilised on the nitrocellulose membrane 
by streptavidin-biotin interactions. DNA probe complementary to the aptamer part 1 AuNP 
bioconjugate was immobilised (DNA1) on the control line. In the presence of ATP, a complex 
between aptamer part 1AuNP/ATP/biotinylated aptamer part 2 was formed on the test line 
giving a red band. Excess aptamer part 1 AuNP was captured on the control line by 
hybridisation with DNA1. 
c) Sandwich aptamer lateral flow assay using a combination of antibodies and aptamers 
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As dual aptamer selection can be challenging for some types of molecules, especially those 
with limited binding domains for aptamer binding, a different approach of sandwich assay 
consists in combination of 2 different biorecognition molecules, antibodies and aptamer, that 
bind to different sites of the target. One example is the detection of salivary a-amylase (sAA). 
In this case, AMYm1 aptamer was modified with biotin and linked to streptavidin-AuNPs 
(aptamer-Biotin-SA-AuNP). On the test line anti-sAA antibody was immobilised and sAA 
protein was immobilised on the control line. In the presence of sAA, the complex between the 
target and aptamer-Biotin-SA-AuNP was captured by the antibody immobilised on the test 
line and the excess of bio conjugate (aptamer-Biotin-SA-AuNP) was captured on the control 
line, resulting in two red bands. In the absence of target, the bioconjugate was captured on 
the control line and only one band was observed300. 
 
1.7.2 Competitive lateral flow aptamer assay 
 
As low molecular weight molecules often lack a second binding site for the use of sandwich 
format, competition or inhibition assays are mostly used for their detection293,301. Differently 
from the sandwich format, in competition assay the presence of control and test line indicate 
the absence of the target, while the presence of only control line indicates the presence of 
the target. In the case of competitive LFAs, a decreasing intensity of the band at the test line 
with increasing concentration of the target analyte in the sample is observed. In competitive 
assays two different scenarios are employed, in the first, target in the sample solution that 
will be analysed will compete with the immobilized target on the test line for binding to AuNPs-
aptamer conjugate302, in the second scenario, DNA, partially complementary to the aptamer-
AuNP conjugate, is immobilised on the test line and competes against the target analyte to 
bind to the gold nanoparticle labelled aptamer303. Various solutions have been proposed for 
the control line including the inclusion of additional bases to the aptamer for subsequent 
hybridisation with the complementary to these bases immobilised at the control line. 
Moreover, a great importance should be given to the design of the DNA probe. If the 
sequence of the DNA probe is too short, the binding affinity to the aptamer can be weak, and 
this can lead to problems with specificity. Conversely, if the DNA probe is too long, the binding 
affinity can be too strong, resulting in reduced competition. 
A simple and sensitive aptamer-based lateral flow test strip for zearalenone (ZEN) was 
successfully developed by Wu et al.304 using the competitive format. Under the optimized 
conditions, the visual limit of detection of the strip was as low as 20 ng/mL. This format was 
based on the competition between the complementary sequence DNA1 on the test line and 
ZEN in the sample for binding to AuNPs-Aptamer. In the absence of ZEN, AuNPs-Aptamer 
is bind through complementary base pairing to DNA 1 on the test line and DNA 2 on the 
control line, resulting in two red lines. When ZEN is present, the complex AuNPs-Aptamer 
preferentially binds to ZEN and as result the test line is decreased or diminished. Other 
examples of small molecule application in lateral flow are summarized in Table 1.6. 
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Table 1.6. Aptamers in lateral flow (adapted from reference 324) 
 

















0.32 nM Competitive 
assay 
SA Anti-Cy5 antibody - 306 
Arbovirus 
(Chikungunya 
virus and TBEV) 








































AuNPs-DNA probe 308 
E.coli O157:H7 3000 live 
cells 







E.coli 8739 6000 live 
cells 







IgE 0.7 pM Sandwich assay Anti-IgE 
antibody 
Anti-M13 antibody Aptamer-phage 310 
Ochratoxin A 
(OTA) 
4.7 nM Competitive 
assay 













2.48 nM Competitive 
assay 
SA-biotin-cDNA SA-biotin-poly A AuNPs-aptamer 312 
































AuNPs-DNA probe 313 
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SA-biotin-poly A AuNPs-DNA 1/DNA 
2-AuNPs-Aptamer 
315 





















-conglutin 55 pM Competitive 
assay 













AuNPs-DNA probe 302 
Cortisol 2.7 nM Lateral flow Immobilized 
cysteamine 
Cysteamine AuNPs-aptamer 317 
Zearalenone 20 ng/mL Competitive 
assay 
SA-DNA1 SA-DNA2 AuNPs-aptamer 304 
Dopamine 50 ng/mL Lateral flow SA-Biotin-DNA 
probe 
Streptavidin-DNA AuNPs-aptamer 318 
Ochratoxin A 1 ng/mL Lateral flow SA-Biotin-DNA 
probe 
Streptavidin-DNA AuNPs-aptamer 312 
HER2 10 nM Lateral flow SA-Biotin-DNA 
probe 
SA-DNA probe AuNPs-aptamer 319 
Ampicillin 185 mg/L Competitive 
assay 
Biotin-CRP  α-mouse antibody AuNPs-aptamer 320 
Creatine kinase 
MB 
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The marine toxin tetrodotoxin (TTX) poses a great risk to public health safety due to 
its severe paralytic effects after ingestion. Seafood poisoning caused by the 
consumption of contaminated marine species like puffer fish expanding in non-
endemic areas has increased the need for fast and reliable detection of the toxin to 
effectively implement prevention strategies. Liquid chromatography-mass 
spectrometry is considered as the most accurate method whereas competitive 
immunoassays have also been reported. In this work, we sought to develop an 
aptamer-based assay for the rapid, sensitive and cost-effective detection of TTX 
detection in puffer fish. Using capture-SELEX combined with Next Generation 
Sequencing, novel aptamers were identified, and their binding properties were 
evaluated Finally, a highly sensitive and user-friendly hybrid antibody-aptamer 
sandwich assay was developed with superior performance compared to several 
assays reported in the literature and commercial immunoassay kits. The assay was 
successfully applied to the quantification of TTX in puffer fish extracts, and the results 
obtained correlated very well with a competitive magnetic bead-based immunoassay 
performed in parallel for comparison. This is one of the very few works reported in the 
literature of such hybrid assays for small molecule analytes whose compatibility with 
field samples is also demonstrated. Ongoing work is focused on the development of a 
lateral flow assay exploiting this sandwich format which will facilitate the rapid on-site 





Tetrodotoxin (TTX) is a very potent neurotoxin produced by marine bacteria and it is 
associated with severe seafood poisoning after consumption of puffer fish 
(Tetraodontidae family)1. Its paralytic toxic effects derive from its selective binding to 
voltage-gated sodium channels and ultimately interfering with neural transmission2. 
Symptoms of TTX intoxication include numbness sensation in the mouth, headache, 
vomiting and muscle weakness3, and fatal respiratory or heart failure have also been 
reported4. This low molecular weight toxin (319.3 g/mol) was originally isolated from 
puffer fish in 19095,6 and was later also found in other marine7 and terrestrial8 species. 
Even though it was initially believed that TTX was produced by the pufferfish itself, 
marine bacterial species have been postulated to be able to produce TTX9 suggesting 
that symbiotic marine bacteria could be the primary source of TTX that bioaccumulates 
in puffer fish and other marine species, and finally reaches humans through the food 
chain. As recently reported, there are more than 30 different bacteria genera capable 
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of producing TTX that have been isolated among which the most common is Vibrio 
sp.10. To date, however, there is still some discussion regarding the pathway of TTX 
bioaccumulation in marine ecosystems11. 
Puffer fish poisoning is typical of warm waters and was regarded as a problem confined 
to Asian countries1,12, including Thailand5, Taiwan13, Singapore14, Cambodia15, 
Bangladesh16, India17,18. However, toxic puffer fish species have expanded to other 
regions, and there have been an increasing number of reports of incidences in the 
Mediterranean Sea, which has been attributed to the opening of the Suez Canal (the 
‘Lessepsian migration’), which resulted in the migration of species from the Red Sea 
to colonize the Mediterranean Sea19–22, the Aegean Sea23, the Adriatic Sea24, Oman25 
and there have also been reports of the incidence of tetrodotoxin in Australia26, and 
the United States27, highlighting the widespread distribution of the toxin.  
Additionally, TTX has been recently found in shellfish, particularly in European 
countries such as the United Kingdom28, Greece29, the Netherlands30, Spain31, Italy32, 
and France33, although usually at very low concentrations. Therefore, it is now 
considered that TTX poses a major food safety risk even in non-endemic areas. 
TTX is highly toxic. Puffer fish poisonings have revealed that ingestion of 0.18–0.2 mg 
of TTX might be near the minimum dose for developing TTX symptoms and 2 mg is a 
lethal dose34. In Japan, where puffer fish is considered a delicacy and highly consumed 
despite its potential toxicity, a limit of 2 mg TTX equiv./kg has been used as a criterion 
to judge the acceptability of puffer fish as food35 and a guide with the edible parts and 
species of puffer fish that are allowed for consumption has been published36. In USA, 
strong restrictions exist for the import of pufferfish (FDA,2017)37. In Europe, fish of the 
family Tetraodontidae and products derived from them must not be placed on the 
markets (EC (European Commission), 2004a; 2004b)38,39. Regarding shellfish, no 
regulation exists. Nevertheless, the European Food Safety Authority (EFSA) has 
recently published that concentrations below 44 μg of TTX equiv./kg shellfish meat do 
not result in adverse effects in humans34. 
There are about 30 TTX analogues40. Toxicity equivalency factors (TEFs) for these 
TTX analogues are essential for the evaluation of relative risk but, unfortunately, 
information on relative potencies of TTXs is limited. Although the use of different cell 
lines in toxicity assays has been questioned, it is evident that most analogues are much 
less toxic than TTX41,42 Additionally, the parent TTX is usually the most abundant34.  
Bioassays, instrumental analysis and immunological methods are typically employed 
to detect TTXs in field samples, based on the toxic effects, physicochemical properties 
and antigenic specificity of the toxin, respectively43. Ethical concerns and low specificity 
of the mouse bioassay, the most frequently used method, encouraged the 
development of alternative strategies. Liquid chromatography coupled with mass 
spectrometry (LC-MS/MS)28,29 has been widely exploited for TTX detection and it 
provides more sensitive, specific, and accurate results than bioassays. However, 
instrumental analysis techniques are expensive, time consuming, labor intensive and 
require sample pretreatment, trained personnel and significant laboratory 
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infrastructure. Immunological methods such as ELISA using specific TTX antibodies 
can provide quantitative and sensitive detection44,45 and commercial ELISA kits are 
readily available. The small size of TTX requires the use of hapten-carrier protein 
bioconjugates for antibody development, requiring careful consideration in the 
preparation of these bioconjugates.  The development of antibody pairs for sandwich 
assay development is hindered by the small size of the TTX, thus requiring the design 
of competitive assays46,47. Competitive immunoassays are more difficult to optimize, 
and the preparation of toxin-reporter molecule conjugates required for some types of 
immunoassays can also be challenging43. Nevertheless, antibody-based biosensors 
have been reported and are particularly useful for rapid screening purposes48–50.  
Aptamers are biorecognition molecules considered as alternative to antibodies which 
are suitable for the detection of virtually any type of target51–53. Aptamers are single-
stranded synthetic oligonucleotides which can bind their target molecule with high 
affinity and specificity owing to the specific structural conformations they adopt. 
Systematic Evolution of Ligands by Exponential enrichment, commonly known as 
SELEX, was developed for the generation of aptamers and it is based on iterative 
rounds of binding, partitioning and amplification54,55. Compared to antibodies, 
aptamers show several advantages for biosensing applications including in vitro 
selection, the possibility to bind any kind of target, high affinity and specificity, 
reproducible chemical synthesis, stability at various environmental conditions, 
reversible denaturation, and easy site-directed modification51,53.  
The development of aptamers for small molecules is a challenging task52,56. One of the 
main hurdles is target immobilization on a solid matrix to allow selection through 
traditional SELEX approaches. Altering the native structure of the target to facilitate 
immobilization can prevent the aptamer from binding to the target in solution in its 
natural form, and an absence of functional groups can completely hinder 
immobilization as the small size of the targets also limits the availability of binding sites. 
An alternative selection strategy, termed capture-SELEX, based on library 
immobilization and use of the target in solution, was first reported by Stoltenburg et 
al.57. This approach is ideal for small molecules since the target molecule can be used 
in solution, and the potential structure-switching properties of the selected aptamers 
can be exploited for characterization and assay development52,56. The capture-SELEX 
strategy has been successfully used for several targets including aminoglycoside 
antibiotics57, cadmium58, penicillin59, quinolone60, and lipopolysaccharides61.  
The path from aptamer discovery to assay development for small molecules is not 
trivial. The usual format is competitive assays which can be difficult to develop as 
discussed earlier in the case of antibodies. Sandwich assays are hindered by the small 
size of the targets and to the best of our knowledge, no sandwich aptamer assays have 
been reported for small molecules. Alternatively, split aptamers can be generated and 
have been exploited in a sandwich format for the detection of small molecules62. 
However, the trial-and-error nature of the process of generating split aptamers, 
possibly resulting in lower binding affinities of the individual fragments and further 
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requirements for modifications are among the factors discouraging researchers from 
undertaking this complex and costly task. In fact, to date, split aptamers have only 
been reported for 15 small molecules62. Hybrid antibody-aptamer sandwich systems 
on the other hand have emerged as an attractive alternative offering the best of both 
antibody and aptamer biorecognition molecules, together with the advantages of 
sandwich assays63. Even though several examples have been reported for the 
detection of protein targets using such hybrid systems, only a handful of examples 
exist for small molecules, including trinitrotoluene64, tetracycline65 and aflatoxin B166.  
Two TTX aptamers have been reported, the first one by Shao et al.67, who did not 
provide details regarding the selection process or the aptamer affinity, and the second 
by Gu et al.68 who used a variation of the capture-SELEX strategy with magnetic 
reduced graphene oxide to immobilize the ssDNA library and identified a TTX aptamer 
with high affinity (KD of 44 nM). In this work we sought to apply the capture-SELEX 
strategy to develop novel TTX-binding aptamers and apply them for the detection of 
the toxin in puffer fish. Two selections were performed in parallel, using two different 
types of streptavidin-magnetic beads to facilitate library immobilization. Next 
Generation Sequencing of various pools from the selections enabled the identification 
of aptamer candidates and different approaches were used to evaluate their binding 
properties. Finally, a highly sensitive hybrid antibody-aptamer sandwich assay was 
developed and successfully exploited for the detection of TTX in puffer fish.  
 




Tetrodotoxin of 98.8% purity (TTX) was purchased from Tocris Bioscience (Bristol, UK) 
and Latoxan (Valence, France) and standard solutions at 1 mg/mL were prepared in 
0.1 M sodium acetate buffer pH 4.8. Certified reference materials of saxitoxin (STX) 
and domoic acid (DA) were obtained from the National Research Council of Canada 
(NRC, Halifax, Canada). The mouse monoclonal anti-TTX antibody (CABT-L3089, CD 
Creative Diagnostics) was obtained from Deltaclon S.L. (Spain). Sulfo-NHS-acetate, 
maleimide-activated microplate strip wells, Dynabeads M-270 streptavidin magnetic 
beads (Dynabeads SA-MB; 10 mg/mL, 2.8 μm diameter, 200 pmol biotinylated 
oligonucleotide/mg particles binding capacity), DreamTaq DNA polymerase and 
lambda exonuclease were from Fisher Scientific (Spain). The DNA purification kits 
(Oligo Clean & Concentrator kit and DNA Clean & Concentrator kit) were from Ecogen 
(Spain). Okadaic acid potassium salt (OA) from Prorocentrum concavum, 11-amino-1-
undecanethiol hydrochloride (MUAM), cysteamine, L-arginine, 1,6-anhydro-β-D-
mannopyranose and streptavidin-horseradish peroxidase (SA-HRP) were purchased 
from Merck (Spain). Maleimide-activated magnetic beads (30 μm diameter, protein 
binding capacity ≥ 15 mg/ml) were from Cube Biotech (Germany) and SiMAG-
streptavidin magnetic beads (SiMAG SA-MB; 10 mg/mL, 1 μm diameter, 80 – 200 pmol 
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biotinylated oligonucleotide/mg particles binding capacity) from Chemicell (Germany). 
Streptavidin-polyHRP80 (SA-pHRP) was from Bionova (Spain) and the TMB Super 
Sensitive One Component HRP Microwell Substrate from Surmodics (USA). All 
oligonucleotides were synthesized by Biomers.net (Germany).  
 
2.2.2. Capture-SELEX process 
 
The library used for the selection was based on a previous report (5’-ATACCA 
GCTTAT TCAATT-N10-TGAGGC TCGATC-N40-AGATAG TAAGTG CAATCT-3’)32. 
The docking site (5’- TGAGGCTCGATC-3’, 12 nucleotides) was flanked by two 
random regions of 10 and 40 nucleotides. Library immobilization on streptavidin-
magnetic beads (SA-MB) was achieved via hybridization of a docking probe (5’-biotin-
TEG-GTC-HEGL-GATCGAGCCTCA-3’, where TEG and HEGL are triethyleneglycol 
and hexanethyleneglycol spacers, respectively) with the docking site of the library. Two 
different types of SA-MB beads were used for two parallel selections, the Dynabeads 
M-270 streptavidin and the SiMAG-streptavidin. The binding buffer used was PBS with 
1.5 mM MgCl2. A total of 23 selection rounds were performed using the TTX precursors 
L-arginine and 1,6-anhydro-β-D-mannopyranose as counter selection molecules 
during the last six rounds. Detailed description of the selections performed can be 
found in the Supplementary Information.  
 
2.2.3. Next Generation Sequencing (NGS) and data analysis 
 
Different rounds from the selections were chosen for NGS. Target elution fractions 
from rounds 6, 9, 16, 23 and counter elution fraction from round 23 for both selections 
were individually amplified with different forward primers (containing distinct barcode 
sequences) and a common reverse primer. The resulting dsDNA for each round was 
column-purified and sequenced using Ion Torrent NGS. The fastaq raw data was 
imported into the Galaxy web server (https://usegalaxy.org/) and the quality of the data 
was evaluated with the “FASTQC” tool which also provided general statistics. The 
format of the data was converted to fasta and datasets containing only library-length 
sequences (90-110 bp) were created. Each dataset was finally collapsed to identify 
unique sequences within the first megabyte of data. The 100 most abundant 
sequences from all the datasets were compared to identify the ones preferentially 
enriched in the target pools. Multiple sequence alignments were performed with Clustal 
Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/) to determine sequence families, 
while sequence motif analysis was performed using MEME (https://meme-
suite.org/meme/tools/meme). Ten aptamer candidates were finally selected, five from 
each selection, for further characterization.  
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2.2.4. Determination of affinity dissociation constants (KD)  
 
Apta-PCR Affinity Assay (APAA)69 The APAA was performed using TTX immobilized 
on maleimide-activated magnetic beads (TTX-beads) in combination with unmodified 
aptamer sequences. The preparation of the TTX-beads is described in the 
Supplementary Information. For the binding studies, 50 µL of different concentrations 
of each aptamer (up to 600 nM in binding buffer) were incubated with 2 µL of the TTX-
beads for 30 min under rotation at ambient temperature. The supernatants were 
discarded, the beads were washed three times with 100 µL of PBS with 0.05% v/v 
Tween-20 (PBST) and finally re-suspended with 20 µL of binding buffer. Bound 
sequences were detected after PCR amplification using library-specific primers and 
agarose gel electrophoresis. Analysis was performed in duplicate for each 
concentration. The intensity of the DNA bands was estimated with the ImageJ software 
and the Gel Analysis option, plotted against aptamer concentration using GraphPad 
Prism 6 software and the KD of each aptamer was finally determined using the “One 
site Specific binding with Hill slope” model.   
Bead-Enzyme Linked Aptamer Assay (Bead-ELAA)70 TTX-beads were used in 
combination with 5’-biotin-modified aptamers. TTX-beads (2 µL) were mixed with 
different concentrations of each biotinylated aptamer in binding buffer (50 µL of up to 
450 nM) and incubated for 30 min at ambient temperature under rotation. The 
supernatants were discarded, and the beads were washed three times with 100 µL of 
PBST. Next, 50 µL of 50 ng/mL of SA-pHRP in PBST were added and incubated for 
20 min. After a final washing step (five times with 100 µL of PBST), 50 µL of TMB 
substrate were added, and following a brief incubation at room temperature, an equal 
volume of 1 M H2SO4 was added to stop color development. The supernatants were 
separated from the beads using a magnet, transferred to a 96-well microtiter plate and 
the absorbance was recorded at 450 nm. The KD of the aptamers were calculated as 
described above. All measurements were carried out in duplicate. 
 
2.2.5. Hybrid antibody-aptamer sandwich assay for TTX determination 
 
A sandwich assay was developed using an antibody for capture and an aptamer for 
detection of TTX. Specifically, 50 µL of 5 μg/mL anti-TTX monoclonal antibody in 50 
mM carbonate buffer pH 9.4 were used to coat the wells of a MaxiSorp immunoassay 
plate overnight at 4°C. The wells were washed three times with 200 µL of PBST, 
followed by blocking with 200 µL of 1% w/v BSA in PBST for 30 min. The wells were 
washed again and incubated with 50 µL of different concentrations of TTX in PBS for 
1 h. After washing, 50 µL of 500 nM biotinylated aptamer in binding buffer were added 
and let to incubate for 1 h, followed by washing. Fifty microliters of 100 ng/mL SA-HRP 
in PBST were then added, followed by a final incubation of 30 min and washing. TMB 
substrate (50 µL) was added and color development proceeded for 6 min. Sulfuric acid 
(50 µL of 1 M) was added to stop color development and the absorbance was recorded 
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at 450 nm. All incubation steps were performed at ambient temperature (22 – 25 °C) 
unless stated otherwise. All five aptamer candidates were initially screened in 
combination with the antibody at a constant TTX concentration (32 µg/mL = 100 mM) 
and the aptamer providing the highest signal was chosen for the final assay. A 
calibration curve was constructed using serial 2-fold dilutions of TTX in the range of 
0.039 – 40 ng/mL (0.12 – 125 nM). Duplicate measurements were performed, and the 
data was fitted to a four-parameter sigmoidal model using Graph Pad Prism 6 software. 
The limit of detection (LOD) was interpolated from the curve as the bottom of the fitted 
curve plus three times its standard deviation (bottom + 3xSDbottom). The precision of 
the assay was evaluated using duplicate measurements of different concentrations of 
TTX analyzed on four different days. The inter-assay coefficients of variation (% CV) 
were calculated as the standard deviation for each measurement divided by the 
average. The cross-reactivity of the assay with possibly interfering marine toxins such 
as domoic acid, okadaic acid and saxitoxin was finally studied under the conditions 
detailed above using each toxin at 40 ng/mL.  
 
2.2.6. Fish samples and TTXs extraction 
 
Fish extracts were obtained from a previous work71. One oceanic puffer fish 
(Lagocephalus lagocephalus, Linnaeus, 1758) (TTX-free individual) and one silver-
cheeked toadfish (Lagocephalus sceleratus, Gmelin, 1789) (TTX-containing individual) 
were caught in 2014 in Alicante (Spain). Puffer fishes were dissected, and gonads, 
liver, skin and muscle were retrieved. A double TTX extraction was performed with 
0.1% v/v acetic acid as previously described71. Extracts were obtained at a tissue 
concentration of 200 mg equiv./mL. 
 
2.2.7. Detection of TTX in puffer fish 
 
The compatibility of the hybrid sandwich assay with field sample analysis was initially 
evaluated with a spiking experiment. The TTX-free extracts from the L. lagocephalus 
puffer fish organs (gonads, liver, skin and muscle) were spiked with TTX at 1.5 ng/mL 
and recoveries were calculated after interpolation in the TTX calibration curve 
constructed in PBS buffer as detailed above. The L. sceleratus TTX-containing fish 
extracts were then analyzed. The amount of TTX in these extracts was calculated after 
interpolation in the calibration curve constructed in PBS and also in calibration curves 
constructed in parallel using the respective extracts from the TTX-free L. lagocephalus 
puffer fish. The extracts were diluted 1/1000 with PBS for all experiments. For 
comparison, the extracts were also analyzed with a magnetic bead-based competitive 
immunoassay as detailed in the Supplementary Information. 
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TTX is a very small molecule with only one (amine) functional group (Figure 2.1A). Its 
covalent linking to a solid matrix to facilitate the partitioning of bound from unbound 
sequences with traditional aptamer selection approaches would significantly alter its 
structure and possibly complicate the recognition of the native molecule by the 
aptamers. Capture-SELEX was thus considered as the most appropriate selection 
strategy using the ssDNA library immobilized on magnetic beads and the target in 
solution, rendering the whole molecule accessible for aptamer binding. The design of 
the ssDNA library was based on a previous report57. Besides the primer annealing 
sites, the library contained two random regions separated by a docking sequence, 
which provided an immobilization site to streptavidin magnetic beads through its 
hybridization with a complementary biotinylated docking probe. Previous studies 
exploiting the capture-SELEX strategy reported the use of Dynabeads M-270 SA-
MB59,60 and the library design from the original study57. Different affinity media like 
streptavidin agarose beads and home-made avidin-magnetic beads were reported in 
other studies, in combination with libraries containing only one random region whose 
immobilization was achieved via a biotinylated complementary to one of the primer 
annealing sites58,61. The distribution of the random sequences on the SA-MB, which 
could be partially determined by the availability of immobilization sites on the beads 
and the specific three-dimensional structures of the sequences, could potentially affect 
the evolution of a selection based on the capture-SELEX strategy. In this work, two 
different types of streptavidin-magnetic beads were used to perform two parallel 
selections. Even though Dynabeads and SiMAG SA-MB differ in size (2.8 µm and 1 
µm, respectively), their maximum binding capacity is almost identical. Taking into 
consideration the higher cost of the Dynabeads SA-MB as compared to the SiMAG 
ones, selections with both bead types were performed in an effort to reduce the overall 
selection costs and investigate the effect of the properties of the beads on their 
performance for capture-SELEX applications. 
Two selections were performed using the conditions summarized in Table S1 (SI). 
Starting with 500 μM of TTX and 2 h incubation steps (background and target elution 
steps), the gradual decrease of TTX concentration and duration of the incubation steps 
led to the completion of the selections after 23 rounds using 50 μM of TTX and 30 min 
incubations. TTX precursors L-arginine and 1,6-anhydro-β-D-mannopyranose72 were 
added as counter selection molecules during the last seven selection rounds to 
improve the specificity of the selected sequences (Figure 2.1A). The evolution of the 
selections was monitored by PCR amplification of the background and target elution 
fractions (Figure 2.1B). Interestingly, when Dynabeads SA-MB were used, few 
sequences eluted in the presence of buffer alone resulting in lower intensity bands 
after PCR amplification, as opposed to SiMAG beads. This could be a consequence 
of a better distribution of the docking probe on the larger surface of the Dynabeads 
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facilitating a more efficient hybridization of the random sequences. By the end of the 
selections, where both the TTX concentration and incubation times were decreased 
10-fold and 4-fold, respectively, as compared to the initial conditions, the pool from the 
Dynabeads selection appeared to be more enriched in TTX-specific sequences than 




Figure 2.1. Selection of TTX-binding aptamers. (A) Structures of the target TTX (upper panel) and the 
counter selection molecules (lower panel). (B) Evolution of the selections using Dynabeads and SiMAG 
SA-MB. DNA eluting in the presence of buffer alone or TTX under the specific conditions from the 
selected rounds was detected after PCR amplification. 
 
2.3.2. NGS and identification of aptamer candidates 
 
High-throughput sequence analysis of multiple rounds from each selection was 
performed using Ion Torrent NGS. Five rounds were chosen from each selection, and 
these were rounds 6, 9, 16, 23 and 23-counter (Figure 2.1B). Rounds 6 and 16 were 
chosen because they were performed before a significant change in selection 
conditions such as duration of incubation steps (2 h in round 6 → 1 h in round 7) or the 
concentration of TTX (100 μM in round 16 → 50 μM in round 17). Additionally, in round 
9, a significant enrichment in target-eluting sequences was observed by pilot PCR, 
especially when Dynabeads SA-MB were employed. Finally, round 23 was chosen as 
the last selection round. A comprehensive bioinformatics analysis was carried out 
using various tools from Galaxy webserver and other servers as detailed in the 
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Table 2.1. NGS data analysis of selected pools from the two selections. 
Selection round Total sequences % GC 
Sequences 
90 – 110 bp 
% Unique 
sequences 
(a) Selection with Dynabeads SA-MB 
D6 43,188 42 41,225 99,5 
D9 228,862 42 206,990 98,0 
D16 82,059 43 76,140 78,2 
D23 32,789 41 31,207 62,8 
D23-counter 36,727 41 34,937 60,8 
(b) Selection with SiMAG SA-MB 
C6 46,902 43 45,334 99,4 
C9 54,139 42 50,880 99,2 
C16 72,199 42 68,414 95,8 
C23 81,705 41 58,299 73,7 
C23-counter 111,076 41 76,770 71,5 
 
Enrichment was observed by the end of both selections. The pools in round 6 were 
highly diverse containing more than 99% of unique sequences. By the end of round 23 
though, the percentage of unique sequences decreased to 62.8% and 73.7% for the 
Dynabeads and SiMAG SA-MB selections, respectively. Furthermore, the enrichment 
of the counter selection pools from the last round for both selections was very similar 
to the respective target pools from the same rounds. Interestingly, faster enrichment 
was achieved when Dynabeads SA-MB were used as by round 16 the percentage of 
unique sequences dropped to 78.2% whereas it was 95.8% for the selection with the 
SiMAG beads. Favorable orientation and spacing between sequences on the 
Dynabeads SA-MB could potentially contribute to faster evolution.  
Comparison of the composition of the target and counter selection pools in rounds 23 
revealed the presence of most of the sequences in both datasets. This finding was not 
surprising since the counter selection molecules used were structurally almost identical 
to parts of the TTX molecule. Nevertheless, it was considered that sequences with 
lower affinity binding to small parts of the target structure could be eliminated during 
the successive rounds of counter selection/target selection. The evolution of the 20 
most enriched sequences (highest counts per million, CPM) in the target pool datasets 
from rounds 23 was monitored and their distribution in the pools from rounds 16, 23 
and 23-counter is shown in Table S2.2. A few sequences appeared to have been 
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selectively enriched in the TTX pools as compared to the counter selection pools and 
these were included in the analysis. Rounds 6 and 9 were excluded since low 
enrichment was observed. 
A 7 to 89-fold enrichment was observed for the sequences selected with Dynabeads 
SA-MB which was calculated as the ratio of abundance in round 23 to round 16. The 
selection performed with the SiMAG beads exhibited 2 to 73-fold enrichment. This data 
again demonstrates that the Dynabeads-based selection appears to be more 
successful with a higher enrichment of selected sequences. A direct comparison of the 
datasets from the last selection rounds with TTX and the counter selection molecules 
revealed that the top 20 sequences were slightly more abundant in the counter 
selection dataset than in the target dataset when Dynabeads were used (Figure S2.1). 
The opposite was observed for the SiMAG-based selection (Figure S2.2). Notably, 
sequences selected with one type of beads were not found in the pools from the 
selection conducted with the other type of beads. Despite theoretically starting from 
the same initial library, and using the same selection conditions, each of the SELEX 
evolved differently, resulting in different sequences being selected, depending on the 
beads used for library immobilization. This can be explained in part, to be due to the 
fact that even though the starting aliquots are taken from the same initial library, each 
aliquot can contain a different combination of diverse sequences. Additionally, the size 
and nature of the beads can affect the number of docking probes, and thus individual 
sequences of the immobilized library, captured on its surface, and this can affect the 
accessibility of the target to the individual sequences. 
Multiple sequence alignment of the 100 most abundant sequences in rounds 23 from 
both selections was also performed to identify possible sequence families. As can be 
seen in Figure S2.3 for the selection carried out with the Dynabeads, only one major 
cluster was observed and it contained the most abundant sequence in this dataset, 
identified as sequence 1, which constitutes 2.1% of the total unique sequences (Table 
S2). The second and third most abundant sequences, identified as sequences 2 and 
3, were encountered at lower percentages (1.1 and 0.9%, respectively), did not appear 
to belong to any family. Only one major sequence family was also observed in the 
dataset from the SiMAG beads selection (Figure S2.4), containing the second most 
abundant sequence (sequence 2 at 1.8%). The first and third most enriched sequences 
(2.3 and 1.3%) do not appear to belong to any cluster.  
The three most enriched sequences from the two selections were ultimately chosen 
for further characterization. These were annotated as D1, D2 and D3 for the 
Dynabeads and C1, C2 and C3 for the SiMAG selections. Additionally, two sequences 
identified in the two datasets from rounds 23 with preferential abundance in the target 
pools compared to the counter target pools (sequences 21 and 22 in Table S2.2 and 
Figures S2.3 and S2.4) were also selected and were annotated as D4, D5, C4 and C5. 
The sequences of all aptamer candidates are shown in Table S2.3. 
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2.3.3. Screening of the aptamer candidates  
 
The ten selected aptamer candidates were initially evaluated under conditions 
mimicking the selection process to choose the most promising ones for further 
analysis. Each aptamer was immobilized on SA-MB via hybridization to biotinylated 
docking probe. Aptamer displacing to the solution after incubation with TTX was 
detected after PCR amplification and agarose gel electrophoresis as detailed in the 
Supplementary Information. Whilst displacement was observed for all the aptamer 
candidates, significant displacement in the presence of TTX was observed for aptamer 
candidates D3, D4, D5, C2 and C3 which were finally chosen for further evaluation 
(Figure S2.5). Moreover, the ssDNA-folding was observed in the predicted structures 
of the five selected TTX aptamers shown in Figure S2.7, using M-fold program 
(http://www.unafold.org/mfold/applications/dna-folding-form.php.).  
 
2.3.4. Binding properties of the aptamer candidates 
 
Characterization of the binding properties of aptamers for small molecular weight 
targets like TTX using classical methods is usually hindered by the size of the 
molecules. A variety of approaches have been reported for affinity studies52,73, 
including microscale thermophoresis74,75 and isothermal titration calorimetry49 but 
these require specialized equipment not typically. Our group has previously reported 
the use of magnetic beads for the immobilization of small molecule targets and 
detection of aptamer binding by PCR and colorimetry69,70,75. We have developed 
microtiter plate-based assays using long-chain crosslinkers to spatially separate the 
target from the plate surface and facilitate aptamer binding69,70, and also used gold 
nanoparticle aggregation assays76. These methods are easy to perform and require 
material and equipment found in almost any laboratory.  
For the TTX aptamers, three of these methods were exploited. The calculated KD 
values are shown in Table 2.2 and the respective binding curves in Figure S2.6. For 
APAA, TTX was immobilized on magnetic beads whereas bound unmodified aptamer 
was detected after PCR amplification and gel electrophoresis. All aptamers 
demonstrated similar binding affinities with affinity dissociation constants in the range 
of 73 – 114 nM. Aptamers C2 and C3 selected using the SiMAG SA-MB showed 
slightly better KD values compared to the ones selected with the Dynabeads SA-MB 
(D3, D4 and D5). Biotinylated aptamers were used for bead-ELAA in combination with 
TTX immobilized on magnetic beads. Colorimetric detection of bound aptamers was 
achieved using SA-pHRP and TMB substrate. As with APAA, all KD values determined 
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 KD (nM) R
2
 
D3 103 ± 24 0.9780 7 ± 1 0.9915 
D4  96 ± 16 0.9827 29 ± 13 0.9811 
D5 114 ± 46 0.9435 89 ± 58 0.9570 
C2 77 ± 6 0.9729 25 ± 6 0.9859 
C3  73 ± 12 0.9659 29 ± 7 0.9829 
 
 
2.3.5. TTX detection with a hybrid antibody-aptamer sandwich assay 
 
Once the binding properties of the five aptamer candidates were verified, the final 
objective was to design an aptamer assay for the detection of TTX in relevant samples. 
Detection of small molecules is usually accomplished with competitive-type assays 
since the size of the targets usually does not permit the simultaneous binding of more 
than one biorecognition elements. We have previously demonstrated competitive 
assays using the small molecule target immobilized on magnetic beads69 or on 
microplate wells70, and here we pursued a robust hybrid antibody-aptamer sandwich 
microtiter plate assay. It was hypothesized that the unique cage-like structure of TTX 
could potentially allow the formation of an antibody-TTX-aptamer complex enabling the 
detection of TTX with a sandwich assay. Even though hybrid antibody-aptamer assays 
have been reported before for high molecular weight targets like proteins and cells63, 
examples for small molecule targets are rare. Nevertheless, these assays are very 
attractive because they combine the advantages of both types of biorecognition 
elements while at the same time providing the sensitivity/specificity of sandwich assay 
formats. Using a monoclonal anti-TTX IgG antibody to coat the wells of a microtiter 
immunoplate, the five TTX aptamers were initially screened in order to choose the most 
suitable one for sandwich assay development. Indeed, all aptamers were able to form 
a sandwich with the antibody and allow the detection of TTX (Figure S2.8). Aptamer 
D3 however was by far the most successful one leading to more than 2-fold higher 
signal compared to the signals obtained with the other aptamers and it was chosen for 
final assay development. The sensitivity of the hybrid assay employing the monoclonal 
TTX antibody for capture and the D3 aptamer for detection was then evaluated at 
concentrations of TTX ranging from 39 pg/mL – 40 ng/mL, equivalent to 122 pM – 125 
nM. The assay was very sensitive with an LOD of 310 pg/mL (970 pM) and EC50 of 
1.1 ng/mL or 3.4 nM (Figure 2.2A). Using TTX samples analyzed on different days, 
average inter-assay coefficients of variation (CV) of less than 5% were calculated, 
UNIVERSITAT ROVIRA I VIRGILI 




demonstrating the high precision of the assay (Table S2.4). Finally, the high specificity 
of the assay was exhibited by the absence of interference from other marine toxins 
such as domoic acid (DA), okadaic acid (OA) or saxitoxin (STX) the latter sometimes 
simultaneously present in puffer fish77 or shellfish32 (Figure 2.2B). Various assays and 
biosensors have been reported in the literature for the detection of TTX and some are 
summarized in Table S5. To date, the two previously published TTX aptamers have 
been exploited for the development of fluorescence68,76,78, fluorescence combined with 
amplification53 and electrochemical79 assays and the LODs achieved ranged from 
0.265 pg/mL to 319 ng/mL. Competitive immunoassays have also been reported using 
monoclonal TTX antibodies49,50,80 and their sensitivity was 0.3 – 2.5 ng/mL. The 
performance of the assay developed in this work is therefore superior or at least 
comparable with many of the previously published assays employing aptamers or 
antibodies. Very importantly, the majority of previously reported assays are quite 
complicated to perform as opposed to the simple sandwich assay demonstrated in this 
work. Commercial TTX kits are available, and they are based on competitive 
immunoassays. Examples include the microplate kits from CD Creative Diagnostics 
and United Biotechnology with LODs of 1 – 10 ng/mL as well as the rapid lateral flow 
tests from CD Creative Diagnostics and UNIBIOTEST with a sensitivity of 0.1 – 2 
µg/mL. It is thus evident that the hybrid antibody-aptamer format of the assay described 
herein has great potential for use in lateral flow tests, facilitating the facile and rapid 
on-site detection of TTX in field samples especially when combined with a simple 
method for sample preparation. It is also one of the rare examples of such hybrid 
assays for the detection of a small molecular weight analyte since there are reports for 





Figure 2.2. Hybrid antibody-aptamer assay for the detection of TTX. (A) TTX calibration curve with the 
monoclonal IgG antibody-D3 aptamer pair. (B) Specificity of the assay.  
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2.3.6. Application of the assay to puffer fish analysis 
 
The hybrid antibody-aptamer sandwich assay was finally employed for the analysis of 
field samples. Extracts from different tissues (gonads, liver, skin and muscle) of a L. 
lagocephalus puffer fish were prepared as controls since our previous report showed 
the absence of TTX in these tissues71. The extracts were diluted, spiked with TTX and 
analyzed with the assay as explained in the Experimental Section. As shown in Table 
3, excellent recoveries were achieved in the range of 93.5 – 109.1%, thus 
demonstrating the absence of matrix effects and the compatibility of the assay with 
such samples. Extracts from tissues of a L. sceleratus puffer fish previously shown to 
contain high levels of TTXs71 were then analyzed. Since TTX may co-exist with several 
other naturally occurring TTX analogues, the hybrid sandwich assay is expected to 
provide a global TTX response (TTXs) depending on the specificity of both antibody 
and aptamer. The TTXs content was determined using calibration curves constructed 
both in PBS (afterwards applying the corresponding recovery factor) and in the 
respective tissue extract from the TTX-free puffer fish. As expected, TTXs contents 
with both strategies were very similar. High TTXs levels were observed, especially in 
the gonads and liver tissues where TTXs usually bioaccumulate (Table 2.3). The TTXs 
content in these tissues were 2.5 – 5-fold higher than the permissible levels in Japan 
(2 mg TTXs/kg). For comparison, the samples were analyzed in parallel with a 
competitive magnetic bead-based ELISA (detailed in the SI) which was previously 
developed and exploited a different monoclonal antibody23,81. Some differences were 
observed, which may derive from the specificity of the assays towards the different 
TTX analogues. It is necessary to take into account that the cross-reactivity factors for 
the different TTX analogues may vary according to the biorecognition molecule (which 
in the case of the hybrid sandwich assay are both the antibody and the aptamer) and 
also the format of the assay. Nevertheless, comparable results were obtained with both 
methods. Very good correlation was also observed with previous analysis carried out 
with LC-MS/MS71, the TTXs contents trend in the different tissues being the same: 
gonads > liver > skin > mussel (Table S6). The establishment of the cross-reactivity 
factors for the different TTX analogues present in these tissues would facilitate the 
comparison with LC-MS/MS results. However, pure TTX analogues are not 
commercially available, and their production is not an easy task. The elucidation of the 
TEFs alongside the cross-reactivity factors, which ideally should be similar, would 
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Table 2.3. Detection of TTX in puffer fish extracts. Recovery (%) of TTX spiked in diluted extracts from 
a TTX-free fish (L. lagocephalus). TTXs content (mg TTX equiv./kg of tissue) in extracts from a TTX-
containing fish (L. sceleratus) were determined using calibration curves constructed in PBS buffer and 
in the respective extract from the TTX-free fish. 
Tissue 
% TTX recovery  
(L. lagocephalus) 
TTXs content (L. sceleratus) 
(mg TTX equiv./ kg) 
Hybrid antibody-aptamer 
sandwich assay Competitive magnetic 
bead ELISA 
PBS Extract 
Gonads 109.1 9.46 9.94 5.24 
Liver 93.5 5.99 5.01 2.84 
Skin 107.7 0.98 1.28 0.19 






TTX has emerged as a major food hazard because of its high neurotoxicity and its 
presence in seafoods found not only in Asian but also European waters. Traditionally, 
bioassays have been used to detect TTX, however instrumental analysis using liquid 
chromatography in combination with mass spectrometry is currently employed for 
monitoring of field samples. Microplate immunoassays and antibody-based biosensors 
can also provide the required sensitivity and specificity, provided that highly specific 
antibodies are used. Aptamers are cost-effective alternatives to monoclonal antibodies 
and since their discovery in the early 1990s, they have been used for the detection of 
not only large targets such as cells and proteins but also small molecular weight targets 
like toxins. To date, only two TTX specific aptamers have been reported and have been 
exploited for the development of fluorescence and electrochemical assays, which are 
quite elaborate and are not compatible with rapid and facile on-site analysis and have 
not been employed for the analysis of field samples. In this work, capture-SELEX 
technology in combination with high-throughput NGS analysis was exploited for the 
discovery of novel TTX aptamers. Assays using magnetic beads were developed for 
the verification of the binding properties of the selected aptamer candidates which 
exhibited KD values in the low nanomolar range. The specific properties of the 
streptavidin magnetic beads used to immobilize the library and perform the two parallel 
selections appeared to affect the speed of evolution and the enrichment achieved even 
though the binding properties of the selected aptamers were not significantly affected. 
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Finally, a simple hybrid antibody-aptamer sandwich assay was demonstrated with high 
sensitivity, precision and specificity. Its sensitivity was superior or at least comparable 
to commercial kits based on competitive immunoassays and other existing aptamer 
and antibody-based assays and biosensors. The excellent performance of the assay 
was further demonstrated by the reliable determination of TTXs levels in puffer fish 
with an excellent degree of correlation with measurements obtained with a competitive 
magnetic bead-based immunoassay and liquid chromatography-mass spectrometry. 
This is the first demonstration of an assay employing an aptamer for the detection of 
TTX in puffer fish, and, in general, is one of the very few examples reported in the 
literature of such hybrid antibody-aptamer sandwich assay for small molecular weight 
analytes. The sandwich format of the assay is particularly attractive and ongoing work 
is focused on its transfer to a lateral flow assay to allow the rapid and facile analysis of 
samples at the point-of-need. The evaluation of cross-reactivity factors for different 
TTX analogues with this hybrid antibody-aptamer assay as well as its applicability to 
the analysis of shellfish, where the detection of lower TTXs contents is pursued, is also 
in progress.  
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2.6 Supplementary information 
 
2.6.1. Selection process 
 
For library immobilization on magnetic beads, the biotinylated docking probe was first 
captured on the streptavidin magnetic beads (SA-MB) according to the manufacturer’s 
instructions, using a 1.5-fold molar excess of the docking probe over the theoretical 
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binding capacity of the beads. The library and the subsequent pools, prepared in 
binding buffer (BB, PBS with 1.5 mM MgCl2), were annealed (2 min at 95ºC and slow 
cooling to 4ºC) and then incubated overnight at 22ºC under rotation for immobilization 
on the SA-MB/docking probe complexes. For the first round, 100 μL of SA-MB were 
used for the immobilization of 0.2 nmol of the library whereas for subsequent rounds, 
20 – 40 μL of SA-MB were required according to the amount of ssDNA pool prepared 
at the end of each round. Unbound oligonucleotides were removed by extensive 
washing of the beads (5 x 500 μL of binding buffer) and the SA-MB/docking 
probe/library complexes were finally resuspended with binding buffer to 10 mg/mL. 
Selection was initiated with a temperature pre-elution step for 15 min at 28ºC under 
gentle agitation. After removal of the supernatant, the beads were resuspended in the 
same volume of binding buffer and a background elution step was performed. Finally, 
the beads were resuspended in the same volume of binding buffer containing 
tetrodotoxin for the target elution step, which was performed under the same conditions 
as the background elution to select sequences eluting in the presence of the target 
molecule. During the last six rounds, tetrodotoxin precursors L-arginine and 1,6-
anhydro-beta-d-mannopyranose were included during the background elution step as 
counter-selection molecules. A total of 23 rounds were performed and the specific 
conditions used for each round are shown in Table S2.1 (Supplementary Information). 
The supernatants from the three elution steps were collected via magnetic separation 
and were used for pilot PCR experiments to monitor the progress of the selections. To 
this end, 2 μL of each fraction (pre-elution, background elution and target elution) were 
added to 10 µL of PCR master mix containing library-specific forward and 
phosphorylated reverse primers. Pilot PCR was performed using an initial denaturation 
step of 2 min at 95°C followed by 6 – 16 cycles of (15 sec at 95°C, 15 sec at 55°C, 30 
sec at 72°C). For the preparation of ssDNA for succeeding rounds, PCR reactions were 
performed using the optimal number of amplification cycles found by pilot PCR, 
followed by asymmetric PCR and lambda exonuclease digestion. For asymmetric 
PCR, the PCR master mix contained only the forward primer and 20 µL of PCR reaction 
per 100 µL of master mix and amplification was performed for 12 cycles. Remaining 
dsDNA in the asymmetric PCR reaction was digested by lambda exonuclease for 1.5 
h at 37°C, followed by enzyme deactivation for 10 min at 80ºC and column purification 
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Table S2.1. Conditions used for the selections. 
Selection round Duration* (min) Tetrodotoxin (µM) Counter-selection 
R1 – R4 120 500 no 
R5 120 100 no 
R6 120 100 no 
R7 – R13 60 100 no 
R14 – R16 30 100 no 
R17 – R23 30 50 yes ** 
 
* background, counter and target elution steps 
** L-arginine and 1,6-anhydro-β-D-mannopyranose 
 
2.6.2. NGS analysis 
 
Table S2.2 Distribution (%) of highly abundant sequences in the different pools from the two selections. 
Sequences were ranked according to their abundance in the TTX pool from round 23.  
Sequence 
Dynabeads SA-MB SiMAG SA-MB 
R23 R23-counter R16 R23 R23-counter R16 
Most 
abundant 
1 2.125 2.373 0.095 2.321 1.438 0.041 
2 1.138 1.351 0.063 1.825 1.478 0.061 
3 0.884 0.873 0.197 1.308 1.062 0.040 
4 0.477 0.492 0.016 0.985 0.841 0.014 
5 0.436 0.435 0.137 0.768 0.371 0.020 
6 0.359 0.381 0.051 0.666 0.448 0.009 
7 0.314 0.321 0.035 0.535 0.474 0.056 
8 0.311 0.332 0.034 0.459 0.363 0.017 
9 0.285 0.366 0.007 0.359 0.259 0.005 
10 0.263 0.298 0.012 0.354 0.284 0.034 
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11 0.250 0.289 0.102 0.277 0.211 0.012 
12 0.244 0.384 0.007 0.270 0.231 0.003 
13 0.228 0.335 0.007 0.268 0.175 0.000 
14 0.224 0.226 0.009 0.235 0.109 0.011 
15 0.192 0.163 0.003 0.228 0.135 0.002 
16 0.192 0.160 0.028 0.191 0.165 0.000 
17 0.179 0.232 0.003 0.184 0.122 0.026 
18 0.179 0.169 0.060 0.184 0.150 0.023 
19 0.176 0.166 0.009 0.163 0.126 0.006 




21 0.087 0.031 0.007 0.028 0.007 0.000 
22 0.026 0.000 0.000 0.026 0.005 0.000 
 
 
Figure S2.1. Abundance of highly abundant sequences in the last selection round of the target and 
counter selection molecules pools using Dynabeads SA-MB for library immobilization 
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Figure S2.2. Abundance of highly abundant sequences in the last selection round of the target and 
counter selection molecules pools using SiMAG SA-MB for library immobilization. 
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       Forward primer                               Docking site                                                                                                Reverse primer 
     ATACCAGCTTATTCAATT          TGAGGCTCGATC                                        AGATAGTAAGTGCAATCT 
  46 ATACCAGCTTATTCAATTTCAAGCGGTTTGAGGCTCAATCAAGGTTAGAAAGAGAGTA--TTGTGAGTATAGAATATGGCGAGATAGTAAGTGCAATCT  
  35 ATACCAGCTTATTCAATTTAGCGGGGAGTGAGACTCGATCGTGACGGCGATCAAAGGATAGTATGAAAGTCAAATGAGGTGAGATAGTAAGTGCAATCT  
  63 ATACCAGCTTATTCAATTTGCGGGGATATGAGGCTTGATCTGCGTAAGCGATGG-TGAAAGTTTTAATTTTATTAGAGGTGAGATAGTAAGTGCAATCT  
  76 ATACCAGCTTATTCAATTTCGGGAGATATAAGGCTCGATTAATGCGAAAGAAAT-GACAGCGTATAAGGTAAAAAGGGGCGAGATAGTAAGTGCAATCT  
  84 ATACCAGCTTATTCAATTTCGAGAGGTATGAGACTCGATCAAACTGAGAAGCAG-TTCAAGTTAGGCCAAAAAATGAGGTGAGATAGTAAGTGCAATCT  
   4 ATACCAGCTTATTCAATTTCAAGATGTATGAGGCTCGATCCTGTGGAGAGAGTG-TATAAGTATGATAATTCAGAGAGGGGAGATAGTAAGTGCAATCT  
  82 ATACCAGCTTATTCAATTTCAAGCAACATGAGGCTCGATCAGGTCGAAAGACAC-TGGATCGTTGATAGTATAAAGAGGGGAGATAGTAAGTGCAATCT  
  17 ATACCAGCTTATTCAATTTCAACACAAATGGGGCTCGATCTAGGATCGAGATGT-AGCTGTATAAAAAA-ACAGAGGCGAGAGATAGTAAGTGCAATCT  
  22 ATACCAGCTTATTCAATTTCAACACAAATGGGGCTCGATCTAGGATCGAGATGT-AGCTGTATAAAAAAAACAGAGGCGAGAGATAGTAAGTGCAATCT  
  77 ATACCAGCTTATTCAATTTCCAGGAATATGAGGCTCGATCAAGCGCGTATGTGC-AGCTTGATATAAAAAGAAAAGAGGTGAGATAGTAAGTGCAATCT  
  41 ATACCAGCTTATTCAATTTGAAGGTAGGTGAGGCTCGATCCGTTTCGGATAACG-AGGAAAAATCTTGAAAAAAAGAGGTGAGATAGTAAGTGCAATCT  
  81 ATACCAGCTTATTCAATTTGAACGGTAGTGAGGCTCGATCGGTAGCGATAGCAG-GGTCTAAAGCTGTTTAACAAGAGGGGAGATAGTAAGTGCAATCT  
  75 ATACCAGCTTATTCAATTTAAGAGGGGATGAGGCTCGATCAGCCAGGGAACTGA-TCGAAAAAAAGGGAGGGTCGTATACAAGATAGTAAGTGCAATCT  
  30 ATACCAGCTTATTCAATTTAAGCGGGAGTGAGGCTCGATCGGCCGGATAAGGGC-GTGACGGGAAAATTAAGTATGGGGCAAGATAGTAAGTGCAATCT  
  57 ATACCAGCTTATTCAATTTGAGGTGGGATGAGGCTCGATCGAGGGACTAGGAAC-GAGAGAAGAGGAATAAAGTTAAGGCGAGATAGTAAGTGCAATCT  
  96 ATACCAGCTTATTCAATTTGGGGTGGGATGAGGCTCGGTCGATAGACTAATAAT-AATATAGGAAGAATGGTTTAGAGGCAAGATAGTAAGTGCAATCT  
  95 ATACCAGCTTATTCAATTTGGAGGAGAATGAGGCTTGATCAAAATAGACATAAT-AAAAATGAGGCGTAATCAAAAGGGAGAGATAGTAAGTGCAATCT  
  58 ATACCAGCTTATTCAATTTCAAAGAAGGTGAGGTTCGATCCGAGGGGAACCGGG-AACGAGTAGAATATATAAAAGAGGCGAGATAGTAAGTGCAATCT  
   9 ATACCAGCTTATTCAATTTGGGGCGGGATGAGGCTTGATCCAAAGCGAAACAAA-AAGGGCAGTAGCGTAACAAAAAGGCGAGATAGTAAGTGCAATCT  
  59 ATACCAGCTTATTCAATTTGGTGGAAAGTGAGGCTCGATCCGAAACGTAGCGAT-GAGGAGAGAAGATTAAAGAAGAGGGGAGATAGTAAGTGCAATCT  
  33 ATACCAGCTTATTCAATTTCGAAGGGGTTGAGGCTCGATCGTAAGATTAACAGC-AGAGGAGAATAAAGCGTCGTGAGGGGAGATAGTAAGTGCAATCT  
  52 ATACCAGCTTATTCAATTTCAGCGGGGATGAGGCTTGATCTTAGATCGATGAGT-AGTACAAACAAGTCTCAAAAGAGGGGAGATAGTAAGTGCAATCT  
  61 ATACCAGCTTATTCAATTTGAGCAGGGATGAGGCTCGATCATAGCGCTAAGGCA-TGATCAGCTGAGAAAACAATGAGGGGAGATAGTAAGTGCAATCT  
   6 ATACCAGCTTATTCAATTTCAAGTGGGATGAGGCCCGATCAGGAGTTAAAAGTG-TGGA-ATAAAGGGGAGATATGAGACGAGATAGTAAGTGCAATCT  
  56 ATACCAGCTTATTCAATTTGGCAGATATTGAGGCTCGATCAACAGCGGTATCCA-TGATGAGATAATGGAAAAGAGGCCCGAGATAGTAAGTGCAATCT  
  12 ATACCAGCTTATTCAATTTGACAAAGTGTGGGGCTCGATCAGAGAATGAATTAT-AGCGGGATGTGAGGCGAAACAAGGGGAGATAGTAAGTGCAATCT  
  97 ATACCAGCTTATTCAATTTGTCAGAGATTGAGGCTCGATCTAACAGGGTGAGGA-AAGCTGTAAGAAAAAGTAGGGGCTCGAGATAGTAAGTGCAATCT  
  40 ATACCAGCTTATTCAATTTCGGGATAAATGAGGTTCGATCTTATGTAGTAAATA-TAGATACAGTAGGTAAAAATGAGGAGAGATAGTAAGTGCAATCT  
  36 ATACCAGCTTATTCAATTTCAAGGGAAGTGAGGCTCGATCCAAAGCTGTAAAAG-AACCAACCGGAGGTTATCGTGAGGGGAGATAGTAAGTGCAATCT  
  98 ATACCAGCTTATTCAATTTGAAGGCATATGAGGCTCGAAAACAAAAAGTAGAAG-AAGAA------AGTGGGAATGAGGGGAGATAGTAAGTGCAATCT  
  93 ATACCAGCTTATTCAATTTGAAGGCATATGAGGCTCGAAAACAAAAAGTAGAAG-AAGGA------AGTGGAAATGAGGGGAGATAGTAAGTGCAATCT  
  80 ATACCAGCTTATTCAATTTGAAGGCATATGAGGCTCGAAAGCAAAAAGTAGAAG-AAGAA------AGTGGAAATGAGGGGAGATAGTAAGTGCAATCT  
  68 ATACCAGCTTATTCAATTTGAAGGCATATGAGGCTCGAAAACAAAAGGTAGAAG-AAGAA------AGTGGAAATGAGGGGAGATAGTAAGTGCAATCT  
  54 ATACCAGCTTATTCAATTTGAAGGCATATGAGGCTCGAAAACGAAAAGTAGAAG-AAGAA------AGTGGAAATGAGGGGAGATAGTAAGTGCAATCT  
  39 ATACCAGCTTATTCAATTTGAAGGCATATGAGGCTCGAAAACAAAAAGTAGGAG-AAGAA------AGTGGAAATGAGGGGAGATAGTAAGTGCAATCT  
   1 ATACCAGCTTATTCAATTTGAAGGCATATGAGGCTCGAAAACAAAAAGTAGAAG-AAGAA------AGTGGAAATGAGGGGAGATAGTAAGTGCAATCT  
  15 ATACCAGCTTATTCAATTTGAAGGCATATGAGGCTCGAAAACAAGAAGTAGAAG-AAGAA------AGTGGAAATGAGGGGAGATAGTAAGTGCAATCT  
  53 ATACCAGCTTATTCAATTTGCGAGTAAGTGAGGCCCGATCTAATAGGTGTTATG-AAAGAGAAAAAAAGATATAGGAGGTGAGATAGTAAGTGCAATCT  
  62 ATACCAGCTTATTCAATTTGACAAGAAGTGAGGCTCGATCGAAGAATTGAACGG-TAAGGTGAGGATGTAAATATGAGGGGAGATAGTAAGTGCAATCT  
  34 ATACCAGCTTATTCAATTTGAGAAACGGTGAGGCTCGATCTGACGAATGTCAGG-AAAAGCAAGTAAAGAAAGATGAGGGGAGATAGTAAGTGCAATCT  
  66 ATACCAGCTTATTCAATTTGACGCACTGTGGGGCTCGATCATAAGGAAGTAAGG-AGAATGAAGGAATAAAACATGAGGTGAGATAGTAAGTGCAATCT  
  86 ATACCAGCTTATTCAATTTGGAGAGATATGAGGTTCGATTGAGAAGAAAAGTAAATGATGTAAAAG-AGGCAGAAGAGGTGAGATAGTAAGTGCAATCT  
  71 ATACCAGCTTATTCAATTTGCGGGGACATGAGGCTCGATCGCGACGGAGTGCGAGTGTTGGATTAT-AGGTAGTAGAGGCAAGATAGTAAGTGCAATCT  
  10 ATACCAGCTTATTCAATTTGAGGATGAGTGAGGTTCGATCTAAAATAAAAGAGTGGTTAAATAGTA-GAAATAGAAGGGCGAGATAGTAAGTGCAATCT  
  99 ATACCAGCTTATTCAATTTGAGGTGGAATGAGGCTCGATCTCGGATAAGGAATAGGCAAAAGTTAA-AAGATAGTGAGGCAAGATAGTAAGTGCAATCT  
  72 ATACCAGCTTATTCAATTTGAAAGCGTGTGAGGCTCAATCGAAACTACTAGGAACAGAATTTAAAG-AAAAATCCAAGGCGAGATAGTAAGTGCAATCT  
  47 ATACCAGCTTATTCAATTTCAACGGAAGTGAGGCTCGATCCATAGAGAGTAAATGGGTGGGGTATA-CAGAAATGAAGGCGAGATAGTAAGTGCAATCT  
  89 ATACCAGCTTATTCAATTTCAAAGGAAGTGAGGTTCGATCAAATAAAACCAAAACCCGAAGGGAAG-TGGAAAACAAGGCGAGATAGTAAGTGCAATCT  
  26 ATACCAGCTTATTCAATTTGACCGTGAGTGGGCTC-GATCATTACACAGGGAAGATAAAGCGCAGG-TGACATGAGAGGCGAGATAGTAAGTGCAATCT  
  20 ATACCAGCTTATTCAATTTGCGGGGATTTGAGGCTCAATCATGTATATGTCATAAGAAGGGTCGTA-TCAATTTAGTGGTGAGATAGTAAGTGCAATCT  
  87 ATACCAGCTTATTCAATTTGAGGAGATTTGAGGCTCGATCAAGTATTGACGATAATGCGGGATAAT-GAGATAATGAGGGGAGATAGTAAGTGCAATCT  
   5 ATACCAGCTTATTCAATTTGAAAGCGTATGAGGCTCAATCCCGTTAATCGTATTAACATATCACTA-ATTAAATAAAGGCGAGATAGTAAGTGCAATCT  
  79 ATACCAGCTTATTCAATTTCGGGAAAAGTAAGGCTCGATCATAATCAGAGATGGAAAGAAATAATA-TGAGGCTAAATGGGAGATAGTAAGTGCAATCT  
  14 ATACCAGCTTATTCAATTTGCGTAGGG-ATGGCTC-GATCTACAGAGGAATAAAGCGTAAATGAGA-GTATAAATGAGGGGAGATAGTAAGTGCAATCT  
  90 ATACCAGCTTATTCAATTTGCGTAGGGATGGGCTC-GATCTACAGAGGAATAAAGCGTAAATGAGA-GTATAAATGAGGGGAGATAGTAAGTGCAATCT  
  94 ATACCAGCTTATTCAATTTGGAGGCAGGTGAGACTCGATCAGAAGCAAACAAGATATTAAAAGGTA-AGTAACAAGGCTCGAGATAGTAAGTGCAATCT  
  74 ATACCAGCTTATTCAATTTGCGGTAGTGTGAGGCTCAATCCAAGGTGCATAGGAAATAAAGGATCC-ACAGAAGTAAGGCGAGATAGTAAGTGCAATCT  
  19 ATACCAGCTTATTCAATTTCAGAAATAATGAGGCTTGATCGGAAAAGAATGTTAGGTGAGATGTAA-AAGAGGCCAAATAGAGATAGTAAGTGCAATCT  
  65 ATACCAGCTTATTCAATTTCAGGAAGCGTGAGGCTCGAGTATAAGGATGACAAAAAGA------GA-GAATATTAGGGCGAAGATAGTAAGTGCAATCT  
  85 ATACCAGCTTATTCAATTTGAGGCGGGTTGAGGCCGATCA-TAGTAGCTAGAAAGAAAGAATAAAA-CAAAATTCGAGGGGAGATAGTAAGTGCAATCT  
  37 ATACCAGCTTATTCAATTTCGACAAGAATGAGGCTCAATCACTAAAACATCTTGAAGGCTACGTCA-AAGAAAAAAGGGCGAGATAGTAAGTGCAATCT  
 100 ATACCAGCTTATTCAATTTGCGGGAAAGTGAGGCCCGATCATGGGAAATTTATTCAAAGCAACGGA-AAAGAAATATGGCGAGATAGTAAGTGCAATCT  
  73 ATACCAGCTTATTCAATTTGAGGAAGGGTGAGGCTCAATCAAATAAGGAGCTTCATGAAAGGTGTA-AATACAAAGAGGCGAGATAGTAAGTGCAATCT  
  55 ATACCAGCTTATTCAATTTGGCGGGGTGTGAGGTTCGATCTGGTAGATCCAGAAATTGGTATAGAA-GATAAATGAGGTGAAGATAGTAAGTGCAATCT  
  11 ATACCAGCTTATTCAATTTGCGGCAGGGTGAGGCTCGATCCGGATCCGGGTCGACAAAAGACAATA-AGAAAAATCAGGCGAGATAGTAAGTGCAATCT  
   7 ATACCAGCTTATTCAATTTCAGGGATTATGAGGCTCAATCAAATAAATAGAGAAAAGAAAGAAACG-ATATATGAGGGTCGAGATAGTAAGTGCAATCT  
  38 ATACCAGCTTATTCAATTTGAGCGGGAATGAGGTC-GATCAGAAGATTAGTAAAAGAAGAATAAGG-ACGTAAAAGGGGCGAGATAGTAAGTGCAATCT  
   8 ATACCAGCTTATTCAATTTGGCGGGGTGTGAGGCTCGATCCACCGGATCGGATATAACCTATAAAA-A-AGTGAGAAGGCGAGATAGTAAGTGCAATCT  
  67 ATACCAGCTTATTCAATTTGGCGGGGTGTGAGGCTCGATCCACCGGATCGGATATAACCTATAAAA-AAAGTGAGAAGGCGAGATAGTAAGTGCAATCT  
  29 ATACCAGCTTATTCAATTTGAGGGATTATGAGGCTCGATCATTTAAGCGAAGGATGAACGAAAGTA-AAGAAAAAAGGGCGAGATAGTAAGTGCAATCT  
  21 ATACCAGCTTATTCAATTTGAGGGGGGATGAGGCTCGATCAGAGAATTGGGGAAAGTACGTAAATG-ATAAAATGAGGGTGAGATAGTAAGTGCAATCT  
  44 ATACCAGCTTATTCAATTTGGAGGGACATGAGGCTCGATCGGAGAAATTGGGGCTAGGGTAGAAAG-AACAAAAGGAGGTGAGATAGTAAGTGCAATCT  
  60 ATACCAGCTTATTCAATTTGCGGGGAGATGAGGCTCGATCGGCGGAGTGGGGCCGATCACAAAGAT-GGACATATTAATGGAGATAGTAAGTGCAATCT  
  24 ATACCAGCTTATTCAATTTAGCGGGGGGAGAGGCTCGATCGCGGGGACGGCGCAGAGAGTAAATTA-CAATAAAGGAGGTGAGATAGTAAGTGCAATCT  
  50 ATACCAGCTTATTCAATTTCATGGGGGATGAGGCTCAATCATAGGACTGAACAAAATAGTAAGGTA-GGCAAGATCAGGTGAGATAGTAAGTGCAATCT  
   3 ATACCAGCTTATTCAATTTAATGCGGGGTGAGGCTCAATCAAGGAAAGATATAAGTAAGCAAAAAG-GTCAAACAAGGGCGAGATAGTAAGTGCAATCT  
  31 ATACCAGCTTATTCAATTTAATGCGGGGTGAGGCTCAATCAAGGGAAGATATAAGTAAGCAAAAAG-GTCAAACAAGGGCGAGATAGTAAGTGCAATCT  
  45 ATACCAGCTTATTCAATTTGACGAAAGTTGAGGCTCGATCGGTGTGAGATCGATTAATAATAAGCA-GTTGAGGAAGGGCGAGATAGTAAGTGCAATCT  
  83 ATACCAGCTTATTCAATTTGAAGAGAACCGAGGCTCGATCAACAGTGAGACGAGAAATGATGCTGT-ATTTATTAAGGGCGAGATAGTAAGTGCAATCT  
  32 ATACCAGCTTATTCAATTTGAAAGCGTATGGGGCTCGATAAAGTGTATCAAAGGGTAAACAAATA--TTAAGTGAGAGGGGAGATAGTAAGTGCAATCT  
  92 ATACCAGCTTATTCAATTTGGGGTGGGTTGAGGCTCGATCGACAGATCGTAAAAACGTAAAATAAA-GAGGCTAGTCGTGGAGATAGTAAGTGCAATCT  
UNIVERSITAT ROVIRA I VIRGILI 




       
 
Figure S2.3. Multiple sequence alignment of the 100 most abundant sequences in the TTX target pool 
from round 23 of the selection performed with the Dynabeads SA-MB. Identical bases are shaded, and 













       Forward primer                               Docking site                                                                                                Reverse primer 
     ATACCAGCTTATTCAATT          TGAGGCTCGATC                                        AGATAGTAAGTGCAATCT 
  23 ATACCAGCTTATTCAATTTCGGGGGTTCTGAGGCTCAATCAAAAGAAAGGATACTGTGTACAGTTT-GTAGAGAAAAGGCGAGATAGTAAGTGCAATCT  
  91 ATACCAGCTTATTCAATTTCAGGGGGTATGAGGCCCGATCAAGATACGAGATAAAAACAGAGGTAA-GAGCAAGGAGGCCAAGATAGTAAGTGCAATCT  
  42 ATACCAGCTTATTCAATTTGCGGCGGGATGAGGTCGATCAGGCAGAATCTGACGAAGGCAAA--TGCGGAAAAAAGAGGCGAGATAGTAAGTGCAATCT  
  13 ATACCAGCTTATTCAATTTCAGCGGAAGTGAGGCTCGATCAAGGGCTGGGACATCAAATATAATAA-GTATTAGAGAGGGGAGATAGTAAGTGCAATCT  
  88 ATACCAGCTTATTCAATTTAAGTAAGCGTGAGGCTCGGTTAGAAAAAATAGACAAGAAA--------ATTTCAGAGAGGGGAGATAGTAAGTGCAATCT  
  64 ATACCAGCTTATTCAATTTGGCAAGAAGTGAGGATCGATCAAAAAATTACAAGTGTTAAAAAGAAG-AAAGAGTGAGGTGAAGATAGTAAGTGCAATCT  
  18 ATACCAGCTTATTCAATTTGAGGTGGAATGAGGCTCGATCATAGATCGGGTTGGCAAGAACAAAGT-GATAGGGAGAGGGGAGATAGTAAGTGCAATCT  
  49 ATACCAGCTTATTCAATTTCAGGGGGTATGAGGCTCGATCCGCAAGGCAGGACGAGTGTAAGTAA--TACAAAAAGAGGTGAGATAGTAAGTGCAATCT  
  70 ATACCAGCTTATTCAATTTCAGGGAGGTTGAGGCTCGATCTGGGAAAACGTAGGCTTTAAGCGAAG-GTATGAAAGAGGGGAGATAGTAAGTGCAATCT  
  27 ATACCAGCTTATTCAATTTGACGGGACATGAGGCTCGATCCACAGAAGGGTGGAATATGCGTAGTT-AGAGTAAAGAGGGGAGATAGTAAGTGCAATCT  
  69 ATACCAGCTTATTCAATTTGAGGAGGTATGTGGCTCGATCAGAATTGCGAATCAGGGAGCAAAAA--ATCAAGGAGAGGGGAGATAGTAAGTGCAATCT  
  48 ATACCAGCTTATTCAATTTCACCGGATGTGAGGCTCGATCTTCAAAAGGTGGGGAAAGCGGAGAAG-TATGGAAAGAGGTGAGATAGTAAGTGCAATCT  
  16 ATACCAGCTTATTCAATTTGGCGGGGAGTGAGGCTCAATCATACCAAGGAAATCATGACAAAAAAG-CTAAATGATGGGCGAGATAGTAAGTGCAATCT  
   2 ATACCAGCTTATTCAATTTGAGAAGCGTTGAGGCCCGATCAAAAGTGTAGAAAAGGGGAAAAGAAG-GAAACAAAGAGGGGAGATAGTAAGTGCAATCT  
  43 ATACCAGCTTATTCAATTTGAGCGGGGATGAGGTTCGATCAAGCAACAAGAATAACAAAGGAGC---AAAAATATGGGGGGAGATAGTAAGTGCAATCT  
  25 ATACCAGCTTATTCAATTTGAGGTACCATGAGGCTCGATCGGGACCATAGTGAAGCTGAGGTTAAA-TAAGAAATGAGGGGAGATAGTAAGTGCAATCT  
  51 ATACCAGCTTATTCAATTTGAATGGGGATAAGGCTCGATCACCAACAGAGACTGATAGAGTAAAAG-TATAAAATGAGGGGAGATAGTAAGTGCAATCT  
  28 ATACCAGCTTATTCAATTTGACGGGGTATGAGGCTCGATCAGGCAATAAGCGCGATGTAGAAAAAAA-AGAATGAGAGGGGAGATAGTAAGTGCAATCT  
  78 ATACCAGCTTATTCAATTTGACGGGGTATGAGGCTCGATCAGGCAATAAGCGCGATGTAGAAAAAAAAAGAATGAGAGGGGAGATAGTAAGTGCAATCT 
UNIVERSITAT ROVIRA I VIRGILI 





       Forward primer                               Docking site                                                                                                Reverse primer 
     ATACCAGCTTATTCAATT          TGAGGCTCGATC                                        AGATAGTAAGTGCAATCT 
  92 ATACCAGCTTATTCAATTTGTAGGAGAGTAGGCTCGATCAATAAAAAAAATAGGAATGTATATAATTATTTAAGTAGGGGAGATAGTAAGTGCAATCT  
   3 ATACCAGCTTATTCAATTTGAGGAAC-ATGAGGCTCGATCCTATATAGAGATGACGAAGAATGATAGAAAGCGTAGGTGAAGATAGTAAGTGCAATCT  
  15 ATACCAGCTTATTCAATTTGAGGAAC-ATGAGGCTCGATCCTATATAGAGATGACGAAGAATGATAGAAAGCGTAGGTGGAGATAGTAAGTGCAATCT  
   7 ATACCAGCTTATTCAATTTGTAGAATATTAAGGCTCGATCTAAAATGAAATATAGGAAGAATATATAATGATATTAATGGAGATAGTAAGTGCAATCT  
  35 ATACCAGCTTATTCAATTTGAAAGAATATGAGGCTCGATAAACAGTAGAAAATAATTA-A--GTAAGAATTAAAGTTGTAAGATAGTAAGTGCAATCT  
  44 ATACCAGCTTATTCAATTTGAGAAA-TATGAGGCTC-GATAAAAAATAATAGTATAGA-AATATATAAAGTGGTATTTTGAGATAGTAAGTGCAATCT  
  39 ATACCAGCTTATTCAATTTGAGAAAATATGAGGCTCGATAA--AAATAATAGTATAGA-AATATATAAAGTGGTATTTTGAGATAGTAAGTGCAATCT  
   5 ATACCAGCTTATTCAATTTGAGAAAATATGAGGCTCGATAAAAAAATAATAGTATAGA-AATATATAAAGTGGTATTTTGAGATAGTAAGTGCAATCT  
 100 ATACCAGCTTATTCAATTTGAGAAAATATGAGGCTCGATAAA-AAATAATAATATAGA-AATATATAAAGTGGTATTTTGAGATAGTAAGTGCAATCT  
  59 ATACCAGCTTATTCAATTTGAGAAAATATGAGGCTCGATAAA-AAATAATAGTATAGA-AATATATAAAGTGGTATTTTAAGATAGTAAGTGCAATCT  
  58 ATACCAGCTTATTCAATTTGAGAAAATATGAGGCTCGATAAA-AAATAATAGTATAGA-AATATATAAAGTGATATTTTGAGATAGTAAGTGCAATCT  
   2 ATACCAGCTTATTCAATTTGAGAAAATATGAGGCTCGATAAA-AAATAATAGTATAGA-AATATATAAAGTGGTATTTTGAGATAGTAAGTGCAATCT  
  25 ATACCAGCTTATTCAATTTGAGAAAATATGAGGCTCGATAAA-AAATAATAGTATAGA-AATATATAAAGTAGTATTTTGAGATAGTAAGTGCAATCT  
  81 ATACCAGCTTATTCAATTTCAACGGGAGTGAGGCTCGATCTGGGATGATAAGTGACCCT-TGTAACTTATCTTATAGGGGAGATAGTAAGTGCAATCT  
   9 ATACCAGCTTATTCAATTTGAGGGGGGATGAGGCTCGATCTTGCCTGTAAGGTTATTAA-TCAACCTCGGATGTGCTGGGAGATAGTAAGTGCAATCT  
  30 ATACCAGCTTATTCAATTTCAGGTAAGGTGAGGCTCGATCAGTTTGAAGACCTGGGTGAATCAAGAGCTGTATAAAGGTGAGATAGTAAGTGCAATCT  
  22 ATACCAGCTTATTCAATTTGGCGAAACATGAGGCTCGATCCTATAAAGAGGTCGCAGGA-GTTGTAATATCAAGATGGGGAGATAGTAAGTGCAATCT  
  43 ATACCAGCTTATTCAATTTCAGGGTTGGTGAGGCTCGATCGGGGATAAGCGTAGGTGAAATAAGGGTTAACAAATAGTGGAGATAGTAAGTGCAATCT  
  29 ATACCAGCTTATTCAATTTGAGGGCAGATGAGGCTCGATCTTATATGTCA-ACATGGCCGGATATATAATTAAGCGTGGGAGATAGTAAGTGCAATCT  
  45 ATACCAGCTTATTCAATTTGAGGGTAGATGAGGCTCGATCATGGTAAAGGGTCGTGAGAATTGATACTCATAAGCGTGGGAGATAGTAAGTGCAATCT  
  69 ATACCAGCTTATTCAATTTCACAAAGGATGAGGCTCGATCGTAAAGTAAAGTGGGATTTTAAGCGCAGGAAAACAGGAGGAGATAGTAAGTGCAATCT  
  71 ATACCAGCTTATTCAATTTGCGTGAGAATGAGGCTCGATCTAAATAACAAGAAGGGAATTTGGCGTGGATAATGAGGTCAAGATAGTAAGTGCAATCT  
  84 ATACCAGCTTATTCAATTTCCGGGAAAGTGAGGCTCGATCAATATACAAAAGGGATGACTAGGCGTAGGTAGTGAGTTCGAGATAGTAAGTGCAATCT  
  33 ATACCAGCTTATTCAATTTGAGAGGCACTGAGGCTCGATCACAGATAAGGGTGCCGGAGAAATGA-GGTTGGCGTGGGTGAGATAGTAAGTGCAATCT  
  66 ATACCAGCTTATTCAATTTGAGGGGGGATGAGGCTCGATCATGTATTAAAGCGTCGGTTTAAGGTAGGAGAGATAAGTAGAGATAGTAAGTGCAATCT  
  75 ATACCAGCTTATTCAATTTGAGGAGGGATGAGGCTCGATCAAGATAGGGTAAAGTGGCGCCCTTAAGATAAATCCGGACGAGATAGTAAGTGCAATCT  
  16 ATACCAGCTTATTCAATTTGACGGCAAATGAGGCTCGATCCAGGAAAGGGACGTCGTGTAAATTGAGATGTTATGTTGGGAGATAGTAAGTGCAATCT  
  21 ATACCAGCTTATTCAATTTGACGGGCAATGAGGCTCGATCAAGTAAGAAGAACGTCGGGAGGTTAAGAGGGGATTATGTGAGATAGTAAGTGCAATCT  
  55 ATACCAGCTTATTCAATTTGCGGGGATGTGAGGCTCGATCCGACGGGACGTTTACTGTTGAAATGTGAACGTGGGAGGTGAGATAGTAAGTGCAATCT  
  93 ATACCAGCTTATTCAATTTGGGCGGGGATGAGGCTCGATCTTACGGATCGTGTATTATGCATAATTTAATGAGGAAGGGGAGATAGTAAGTGCAATCT  
  18 ATACCAGCTTATTCAATTTAAGCGGGGATGAGGCTCGATCTATACGCAAAAACCGGCATGGGTGTCAGAATAGAGACTCGAGATAGTAAGTGCAATCT  
  57 ATACCAGCTTATTCAATTTAAGCGGGGATGAGGCTCGATCAGTACAGGACACAAAGGTAAAATGTGTAACGTGGGACTGGAGATAGTAAGTGCAATCT  
  61 ATACCAGCTTATTCAATTTAAGGTGGGATGAGGCTCGATCAACGGATAATATCATTGACGTGGTT-CGTATAGAGAGACGAGATAGTAAGTGCAATCT  
  47 ATACCAGCTTATTCAATTTAAGCGGGGATGAGGCTCGATCTGAGGAGAAACAATTAGAGGAATTGTTGGTGTATGGGTCGAGATAGTAAGTGCAATCT  
  63 ATACCAGCTTATTCAATTTAAGCGGGGATGAGGCTCGATCCGCAAAAGGATAAAGATCATGGACG-TTGTGGTAGGGTCGAGATAGTAAGTGCAATCT  
  94 ATACCAGCTTATTCAATTTCACATGGTTTGAGGCTCGATCCCATGGTCAGTAAAGGGGAATTGTTCGAGAGGATGCTGGGAGATAGTAAGTGCAATCT  
  26 ATACCAGCTTATTCAATTTCACAAATGTTGAGGCTCGATCTAAAGATGCAGAAGGGGACATTGGAAAGACCGGGGCTGGGAGATAGTAAGTGCAATCT  
  51 ATACCAGCTTATTCAATTTCAGAAGCAGTGAGGCTCGATCAACCGGTGGAGACGGTATATTAATAATGCGATGGGCTGGGAGATAGTAAGTGCAATCT  
  60 ATACCAGCTTATTCAATTTGGGGGCATGTGAGGCTCGATCGTTGGAAATAGGTTAACGAATTAGTGATTAGGAGGCTGGGAGATAGTAAGTGCAATCT  
  99 ATACCAGCTTATTCAATTTGAGGGGACGTGAGGCTCGATCATGGAAAGACGGC-TTCGAGCAGTTGATTAAAGGCCTGGGAGATAGTAAGTGCAATCT  
  37 ATACCAGCTTATTCAATTTCACGGGCATTGAGGCTCGATCGTTATTATTGGCCAAGAGAGGAATTGGAGTTCAAGATGGGAGATAGTAAGTGCAATCT  
  80 ATACCAGCTTATTCAATTTGGAGGGGAGTGAGGCTCGATCAAAAGTATTGGCGATATACAGAAATGAATGTCAAAGCGGGAGATAGTAAGTGCAATCT  
  41 ATACCAGCTTATTCAATTTGAAGGTGTGTGAGGCTCGATCAGATATAACTACACAGCGAGAGAAGGATGTAAAAGAGGGGAGATAGTAAGTGCAATCT  
  87 ATACCAGCTTATTCAATTTGAACAACGGTGAGGCTCGATCTAGATTTAGGTCTGGGT-GAATTGACATGACATTGCTGGGAGATAGTAAGTGCAATCT  
  14 ATACCAGCTTATTCAATTTCCAAGACGATGAGGCTCGATCAAATAGGAGATGGATGTGGGAGGAGAATAGTGAAGCTGGGAGATAGTAAGTGCAATCT  
  78 ATACCAGCTTATTCAATTTCCAAGACGATGAGGCTCGATCAAATAGGAGATGGATGTGGGAGGAGAATAGTGAGGCTGGGAGATAGTAAGTGCAATCT  
  73 ATACCAGCTTATTCAATTTGCACGACGGTGAGGCTCGATCGAGTGTAGTAATAAGGGAGTCTGGAGAGACAATGGCTGGGAGATAGTAAGTGCAATCT  
   4 ATACCAGCTTATTCAATTTGACAGAAGATGAGGCTCGATCAAGATATGTCATGAAGGAGGATTGGGATAAAACAGCTGGGAGATAGTAAGTGCAATCT  
  90 ATACCAGCTTATTCAATTTGACAGAAGATGAGGCTCGATCAAGATATGTCGTGAAGGAGGATTGGGATAAAACAGCTGGGAGATAGTAAGTGCAATCT  
  85 ATACCAGCTTATTCAATTTGACGGAAACTGAGGCTCGATCTACTAGGAGTTGACGGAGACACTAAGAATAGGGCAAAGGGAGATAGTAAGTGCAATCT  
  11 ATACCAGCTTATTCAATTTCACGGGTGGTGAGGCTCGATCAAAAGGTCTATATCACGTGGGAGAAGAAG-AAGTAATGGGAGATAGTAAGTGCAATCT  
  62 ATACCAGCTTATTCAATTTGACGGGGAATGAGGCTCGATCTGCAGGAAGATATAGGTCCGGAGAAAGGTAAGTCAATGGGAGATAGTAAGTGCAATCT  
  38 ATACCAGCTTATTCAATTTCAGCGAACGTGAGGCTCGATCCAACTGATAGAAGGTGTGATGGATATTGATGAAAGCGGGGAGATAGTAAGTGCAATCT  
  76 ATACCAGCTTATTCAATTTCAAATAACGTGAGGCTCGATCGGTATTCCATTAGGTGATTTGGAAGGGATTTAAAGCGGGGAGATAGTAAGTGCAATCT  
  34 ATACCAGCTTATTCAATTTGAGTAGACTTGAGGCTCGATCAGTAAACAGGATTAACGAGTGTAATAGGCGCAGTATGGGGAGATAGTAAGTGCAATCT  
  24 ATACCAGCTTATTCAATTTGAATAGACATGAGGCTCGATCTTAATAAAGTGAGTACTAGAGGATTGAATGCAAAGATGGGAGATAGTAAGTGCAATCT  
  28 ATACCAGCTTATTCAATTTGAAGAGACTTGAGGCTCGATCTAATTAACTAATGTGTCTGAGAAGAAGATATAGCAAAGGGAGATAGTAAGTGCAATCT  
  10 ATACCAGCTTATTCAATTTCAAGCGGGATGAGGTCGATCAGTAAAGCTCAGTAGATAT-CTACAAGGTGTATGTAGGGCGAGATAGTAAGTGCAATCT  
  31 ATACCAGCTTATTCAATTTGACAGAAGGTGAGGCTCGATCATAGGTGTAGGAAAGTAGATAGGAAACACCGCAAGCTGGGAGATAGTAAGTGCAATCT  
  48 ATACCAGCTTATTCAATTTGAACGGACGTGAGGCTCGATCATAGAAGTAGGGAGAAAGATATTGGAAGCATATAGGGAGGAGATAGTAAGTGCAATCT  
  53 ATACCAGCTTATTCAATTTCAAGCGAGGTGAGGCTCGATCAGTGGAGCGGGCAAGAAATTATAAGAAGGAGAAGAGGACGAGATAGTAAGTGCAATCT  
  86 ATACCAGCTTATTCAATTTCACGAGTGATGAGGCTCGATCGGTGTAAGAAGTCACGTAGTTCAAATGAATGCGGGCTGGGAGATAGTAAGTGCAATCT  
  91 ATACCAGCTTATTCAATTTAAGATGGGATGAGGCTCGATCGGAGTTAGTTGGAACCAAGGGCGAAGATAGAGTTGGAGGGAGATAGTAAGTGCAATCT  
  79 ATACCAGCTTATTCAATTTGAGTGGAAGTGAGGCTCGATCGTAGGAATTCTGACAATCGGTTTAAGGAACACAAGCGGGGAGATAGTAAGTGCAATCT  
  72 ATACCAGCTTATTCAATTTCGCGTAGGATGAGGCTCGATCATAGTGAAAGTGCTTAAGAGGAATGGGGACACCTGCTGGGAGATAGTAAGTGCAATCT  
  82 ATACCAGCTTATTCAATTTGAGACAACTTGAGGCTCGATCGCAACTATAGTGAAGTGTTGTTGAAGAATCCTCAGGTGGGAGATAGTAAGTGCAATCT  
  12 ATACCAGCTTATTCAATTTCAAGCAAAATGAGGCTCGATCAATAAGAGTGTGTGCGCGGTAAATTGGGTAGGGGGCTGGGAGATAGTAAGTGCAATCT  
  23 ATACCAGCTTATTCAATTTGAGACAAAATGAGGCTCGATCCGGAAATATGTGAAGGCTAGAAGAGAATGTTATAGCTGGGAGATAGTAAGTGCAATCT  
  20 ATACCAGCTTATTCAATTTGACGGGCAATGAGGCTCGATCGTGTAAAAAACGGAGAACTACGAGGAAGCAAAAGGTATGGAGATAGTAAGTGCAATCT  
  49 ATACCAGCTTATTCAATTTGGCGGGAAATGAGACTCGATCGGGTTACGATAAAAGATGAAAGTACAAGAAAAATAAGGCGAGATAGTAAGTGCAATCT  
  77 ATACCAGCTTATTCAATTTGGGCAAGCATGAGGCTCGATCTATTGGAAACTTGAACCGGGTT-AGAAAAAGGATGCTGGGAGATAGTAAGTGCAATCT  
  17 ATACCAGCTTATTCAATTTCAACGGGACTGAGGCTCGATCTGAATAAAAGCGCAGTAGGCATGAAAAGATAAATGAGGAGAGATAGTAAGTGCAATCT  
  98 ATACCAGCTTATTCAATTTGAAGAGGAATGAGGCTCGATCCCCAAATAAGCGCAGGTGAAGTAAAATGGAAAGACAATCGAGATAGTAAGTGCAATCT  
  27 ATACCAGCTTATTCAATTTGAAGGAAGTTGAGGCTCGATCCATAAATCCGTCCTGAAGAAAT-GAACGCATAGGGCTGGGAGATAGTAAGTGCAATCT  
  68 ATACCAGCTTATTCAATTTGACAGACAATGAGGCTCGATCTGGGAAAGGATGTCCAAAGGGTTGAATGGTTTGAAGCGGGAGATAGTAAGTGCAATCT  
  42 ATACCAGCTTATTCAATTTCCCGGAGTATGAGGCTCGATCTCTTGGGTAGTTGCGTAGGGCAGGAAGAATAGGCGCAGTGAGATAGTAAGTGCAATCT  
  19 ATACCAGCTTATTCAATTTGGCGGGGACTGAGGCTCGATCTGGAAAGGGGACCCTAAGAAGATGAATGATAAGAGCGGGGAGATAGTAAGTGCAATCT  
  64 ATACCAGCTTATTCAATTTGAGAGGAGGTGAGGCTCGATCTAAAAGTGATAAGGAACGAGAAGGGAACAAAGCCGTGGGGAGATAGTAAGTGCAATCT  
   8 ATACCAGCTTATTCAATTTGAGGGATACTGAGGCTCGATCTTAATGGGAGTAGCGTGCAGAATTGATAGGAAGAGCGGGGAGATAGTAAGTGCAATCT  
UNIVERSITAT ROVIRA I VIRGILI 






Figure S2.4. Multiple sequence alignment of the 100 most abundant sequences in the TTX target pool 
from round 23 of the selection performed with the SiMAG SA-MB. Identical bases are shaded and the 




Table S2.3. Sequences of the selected aptamer candidates. D sequences were identified from the 
selection with Dynabeads and C sequences with the SiMAG SA-MB. 































        Forward primer                             Docking site                                                                                                Reverse primer 
     ATACCAGCTTATTCAATT          TGAGGCTCGATC                                        AGATAGTAAGTGCAATCT 
   6 ATACCAGCTTATTCAATTTGAGGGGACGTGAGGCTCGATCTAAAAGGAAGTAGGACACAAGAGGATGAATTCGAGCAGGGAGATAGTAAGTGCAATCT  
  13 ATACCAGCTTATTCAATTTGAGGGGACGTGAGGCTCGATCTAAAAGGAAGTAGGACACAAGAGGATGAATTCGAGCGGGGAGATAGTAAGTGCAATCT  
  36 ATACCAGCTTATTCAATTTGAGGACGTGTGAGGCTCGATCACATTAATAGTCCGAGTTCGCAATCAAGTAATATGAGGGGAGATAGTAAGTGCAATCT  
  89 ATACCAGCTTATTCAATTTGACACGGATTGAGGCTCGATCAAACGTTTGACATTAAGTGTAGTAGTGATAGTTAGGTGGGAGATAGTAAGTGCAATCT  
  88 ATACCAGCTTATTCAATTTGGCGACAGGTGAGGCTCGATCAGTAAAGTATGTAAGACCGAATTCGTAAACAAAGGCTGGGAGATAGTAAGTGCAATCT  
   1 ATACCAGCTTATTCAATTTGAGGAGGAGTGAGGCTCGATCAATAATTGTACGCTC-TGACGAGGGTGATGTGTGTCTGGGAGATAGTAAGTGCAATCT  
  83 ATACCAGCTTATTCAATTCGAGGAGGAGTGAGGCTCGATCAATAATTGTACGCTC-TGACGAGGGTGATGTGTGTCTGGGAGATAGTAAGTGCAATCT  
  40 ATACCAGCTTATTCAATTTGAGGACAAGTGAGGCTCGATCTATATCTTCGTCGCGGACGAGAAGGGGAAATGGGATAGGGAGATAGTAAGTGCAATCT  
  46 ATACCAGCTTATTCAATTTGTAGACCGGTGAGGCTCGATCAGGAAAGGGATAGGGATAAAGAAGGAAATAACAAGCGGGGAGATAGTAAGTGCAATCT  
  67 ATACCAGCTTATTCAATTTGAGGACCGATGAGGCTCGATCAGGATTTTAGCAAGGAATGAGAATGTGAAACAAAGTGGGGAGATAGTAAGTGCAATCT  
  50 ATACCAGCTTATTCAATTTCAAGGAGATTGAGGCTCGATTTATTTAAATTAAAATAGTATTATTATAACAAAAGTATTAGAGATAGTAAGTGCAATCT  
  52 ATACCAGCTTATTCAATTTGAAGACCGATGAGGCTCGATCAGTTTAGGTTCGTCTTCATCTTTGAATATTAGGGGCTGGGAGATAGTAAGTGCAATCT  
  74 ATACCAGCTTATTCAATTTCCCGATGAATGAGGCTCGATCAATTTAGTACATCGGAACCAAGTGAAAATGTAAAGCGGGGAGATAGTAAGTGCAATCT  
  96 ATACCAGCTTATTCAATTTCACGGAGTATGAGGCTCGATCAAGTTATTAGTGGGGAAATTGACAGCTGTGGAAAAAGAGGAGATAGTAAGTGCAATCT  
  54 ATACCAGCTTATTCAATTTGAGACATGTTGAGGCTCGATCAATACAAATCATAGTCATCGGATGAGAAATAAGTAGGGAGAGATAGTAAGTGCAATCT  
  32 ATACCAGCTTATTCAATTTGAGATGGCTTGAGGCTCGATCGTTTAGTGGACATATCGATAAATTGAGTGTGAAAGCGGGGAGATAGTAAGTGCAATCT  
  97 ATACCAGCTTATTCAATTTACCGGGAGTTGAGGCTCGATCAATTAAGTAGACTACGGATGAAAGTATAGTTGGAGCTGGGAGATAGTAAGTGCAATCT  
  95 ATACCAGCTTATTCAATTTGGCGAAGGGTGAGGCTCGATCAAAGAATGCCGGAAAAAAGTGAAGTAAGAAGGGATAGGGGAGATAGTAAGTGCAATCT  
  56 ATACCAGCTTATTCAATTTCAAGGGAGTTGAGGCTCGATCAAGCAAAAATGACTAGGAGTAATGTCATAAGGTATAGGGGAGATAGTAAGTGCAATCT  
  65 ATACCAGCTTATTCAATTTGAGGGATGTTGAGGCTCGATCCTGGGCTGGGAAAAAGGATACCGTACAAGGTAAGGTGGCGAGATAGTAAGTGCAATCT  
  70 ATACCAGCTTATTCAATTTGACGGAGGTTGAGGCTCGATCAAGGATAAGGAGTGAGGAGAAATGTTAAACTAGGGTAGGGAGATAGTAAGTGCAATCT 
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2.6.3. Characterization of aptamer candidates 
 
 
2.6.3.1 Immobilization of TTX on magnetic beads for affinity assays 
 
TTX was immobilized on magnetic as follows: maleimide-activated magnetic beads (10 
µL of 250 mg/mL suspension) were washed with washing buffer (PBST: 0.1 M PBS, 
0.05 % v/v Tween-20, pH 7.2), resuspended in 500 µL of 1 mM MUAM in binding buffer 
(0.1 M PBS, pH 7.2, 10 % v/v ethanol) and incubated for 3 h at room temperature under 
tilt rotation. The beads were washed again with PBST, followed by resuspension with 
500 µL of TTX (25 µg/mL in 0.1 M PBS, 10 % v/v formaldehyde). After overnight 
incubation at ambient temperature (22-25ºC) under tilt rotation, the beads were 
washed again and blocked with 500 µL of sulfo-NHS-acetate (1 mM in 0.1 M PBS) for 
1 h. After a final washing step, the TTX-beads were resuspended in 100 µL of PBS 
(final suspension of 25 mg/mL). Immobilization of TTX on the beads was verified with 
a bead-ELISA using a monoclonal anti-TTX antibody as described previously1. 
   
2.6.3.2 Initial screening of the aptamer candidates 
 
A displacement assay was designed to screen the aptamer candidates under 
conditions similar to the ones used during the selection process. Specifically, SiMAG 
SA-MB/docking probe complexes were prepared as described in the “Capture-SELEX 
process” section of the manuscript and used to immobilize the individual aptamer 
candidates (100 nM). The aptamer-magnetic beads were then incubated with TTX (1 
µM) or binding buffer alone for 30 min at room temperature under tilt rotation. The 
supernatant was recovered by magnetic separation and was used for PCR 
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amplification to detect eluted sequences. The PCR reactions were analyzed by 
agarose gel electrophoresis as shown in Figure S2.5. The candidates preferentially 
eluting in the presence of TTX compared to buffer alone were selected for 




Figure S2.5. Screening of the aptamer candidates with a displacement assay. Aptamer candidates 
immobilized on docking probe-streptavidin magnetic beads complexes were incubated with 100 µM TTX 
(+) or only binding buffer (-). Aptamer displacing to the solution was detected by PCR amplification and 
agarose gel electrophoresis. ntc: PCR no template control. 
 
 
Figure S2.6. Binding curves of the aptamers determined by (A) APAA and (B) bead-ELAA  
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Figure S2.7. Predicted structures of the five selected TTX aptamers. 
 

















mAb/aptamer - no TTX
aptamer - TTX
aptamer - no TTX
 
Figure S2.8. Screening of antibody-aptamer pairs for sandwich assay development. 
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Table S2.4. Hybrid antibody-aptamer assay precision. Inter-assay coefficients of variation (% CV) were 
calculated from duplicate samples using solutions of different TTX concentration measured on four 




2.6.4.1 Magnetic bead-based colorimetric immunoassay for TTX detection 
 
The MB-based colorimetric immunoassay protocol was similar to that described2 and 
optimized3 in our previous works. Briefly: (1) 10 μL of maleimide-activated MBs were 
rinsed three times with washing buffer (0.1 M PBS, 0.05 % v/v Tween−20, pH 7.2) 
under vigorous mixing; (2) 1 mL of 1 mM cysteamine in binding buffer (0.1 M PBS, 10 
mM EDTA, pH 7.2) was added and incubated for 2 h at room temperature; (3) after 
washing, 1 mL of TTX solution (25 μg/mL) in binding buffer containing 10 % v/v 
formaldehyde was added and incubated overnight at 4°C; (4) the washed TTX-coated 
MBs were resuspended in 1 mL of binding buffer. When amounts of MB varied, 
volumes were adjusted proportionally. Once the MB-TTX conjugate had been 
prepared, (5) 200 μL of the conjugate was taken, the supernatant was removed and 
100 μL of the TTX standard solution or fish extract and 100 μL of anti-TTX mAb at 
1/2000 dilution in 1 % w/v BSA-binding buffer were added and incubated for 30 min at 
room temperature; (6) after washing, 200 μL of 1/1000 IgG-HRP dilution in 1 % w/v 
BSA-binding buffer was incubated for 30 min at room temperature; (7) the washed 
immunocomplex was resuspended in 200 μL of binding buffer; (8) 50 μL of 
immunocomplex was transferred to a new tube and after supernatant removal, 125 μL 




MV ± SD % CV
Average % 
CV
2.420 ± 0.077 3.2
2.416 ± 0.003 0.1
2.357 ± 0.069 2.9
2.334 ± 0.112 4.8
1.371 ± 0.064 4.9
1.702 ± 0.007 0.4
1.219 ± 0.057 4.7
1.615 ± 0.055 3.4
0.443 ± 0.009 2.0
0.782 ± 0.014 1.8
0.361 ± 0.002 0.5
0.436 ± 0.056 12.8
0.157 ± 0.001 0.6
0.160 ± 0.011 6.7
0.095 ± 0.004 4.1









UNIVERSITAT ROVIRA I VIRGILI 




on the magnetic separation stand and 100 μL of TMB liquid substrate was collected 
for colorimetric measurement at 620 nm in a microtiter plate. All incubation steps were 





Table S2.5. Assays and biosensors reported in the literature for TTX detection. 
Platform Sensitivity (LOD) Reference 
Fluorescence assay with aptamer 1 µM (319 ng/mL) 4 
Electrochemical impedance spectroscopy biosensor with 
aptamer immobilized on glassy carbon electrode 
200 pg/mL 5 
Fluorescence assay with aptamer and berberine 0.074 nM (24 pg/mL) 6 
Fluorescence assay with aptamer, berberine and 
exonuclease I 
11 pM (3.5 pg/mL) 7 
Fluorescence assay with FAM-labeled aptamer and 
magnetic reduced graphene oxide 
1.21 ng/mL 8 
Competitive assay with aptamer immobilized on magnetic 
beads, strand displacement amplification with catalytic 
hairpin assembly and fluorescence detection 
0.265 pg/mL 9 
Microplate competitive immunoassay 2.28 ng/mL 10 
Competitive planar wavelength immunosensor 2.5 ng/mL 11 
Inhibition immunoassay with surface plasmon resonance 
sensor 
0.3 ng/mL 12 
Hybrid antibody-aptamer sandwich assay 310 pg/mL (970 pM) This work 
 
 
Table S2.6. TTX and analogues contents (mg TTX or analogue/kg tissue) in L. sceleratus by LC-MS/MS. 
 
 

















Gonads 21.8 4.3 1.1 16.3 0.5 0.9 1.1 0.4 94.3 
Liver 2.3 0.7 0.3 1.3 0.2 - 0.2 0.2 12.4 
Skin 1.2 0.3 0.1 1.1 - - 0.1 - 1.8 
Muscle 0.7 0.3 0.2 0.6 0.1 - 0.1 0.1 1.2 
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Tetrodotoxin (TTX), is a low molecular weight, highly toxic neurotoxin found in 
pufferfish and various shellfish.  Here we describe the development of a dipstick for 
the sensitive detection of tetrodotoxin (TTX) in puffer fish.  The dipstick exploits a hybrid 
sandwich assay, using a monoclonal antibody generated against TTX as the capture 
molecule immobilized on the test line and a gold nanoparticle functionalized aptamer 
as the reporter molecule, with an oligonucleotide complementary to the aptamer 
sequence immobilized on the control line.  The dipstick is highly sensitive and 
reproducible, capable of detecting as low as 3ng/mL TTX, with the assay completed 
within 20 minutes.  The specificity of the assay was demonstrated by a complete lack 
of interaction with other marine toxins such as domoic acid (DA), okadaic acid (OA) or 
saxitoxin (STX). The excellent performance of the dipstick was further demonstrated 
by the reliable determination of TTXs levels in puffer fish extracts (gonads, muscle, 
liver, and skin) with the results obtained in agreement with measurements obtained 
with a competitive magnetic bead-based immunoassay and liquid chromatography-
mass spectrometry. The developed dipstick is the first example of a sandwich assay 
based rapid test for the detection of TTX in pufferfish, as well as being the first to use 





Tetrodotoxin (TTX) is a neurotoxin with a low-molecular weight of approximately 
319.27 g/mol 1 that is found and associated with a variety of species including puffer 
fish, octopuses, seashells, and xanthid crabs 2. Beside this, TTX has been reported in 
terrestrial species including newts, frogs and toads 3,4. Its paralytic toxic effects derive 
from its selective binding to voltage-gated sodium channels, thereby blocking the 
generation of neuronal action potentials and impulse conduction. Even a low dose of 
TTX poising results in severe neurological symptoms including ataxia, cardiac 
arrhythmias, seizures, respiratory failure, and death 5,6. The toxin is approximately 
1200 times more poisonous than cyanide 7. 
Although TTX-poisoning is typical of warm waters and it was regarded as a problem 
confined to Asian countries, in the last decade, due to the worldwide increase in water 
temperature 8,9, TTX has been found also in the European waters through the possible 
migration of these toxic species from the Red Sea to Mediterranean Sea through the 
Suez Canal (Lessepsian migration) 10. TTX has been detected in seafood harvested in 
the United Kingdom, Portugal, Spain, Greece and the Netherlands 10–12. 
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Different approaches are used for TTX detection based on the physicochemical 
properties of the toxin, its antigen specificity and neurotoxic effect. The initial method 
used for TTX detection was the mouse bioassay (MBA). A mouse bioassay (MBA) 
involves aliquots of sample extract being injected into mice and the median death times 
used to calculate the toxicity (in mouse units; MU) 13. MBA has frequently been used 
but due to a lack of specificity and high individual variability across experimental 
animals, the method suffers from accuracy, and furthermore due to ethical concerns, 
it is banned in most developed countries 14, Moreover, positive results could also be 
caused by the presence of saxitoxin-group toxins as both exhibit the same 
symptomology in mice. The tissue culture bioassay (TCBA) was thus developed as an 
alternative to MBA 15. 
Currently, liquid chromatography (LC) is widely used for the analysis of TTX, with the 
LC being combined with  fluorescence detection (HPLC-FLD) 16, or tandem mass 
spectrometry (LC-MS/MS) 9,17. These chromatographic methods are more sensitive, 
specific, and accurate than the bioassays, but they are time and solvent-consuming, 
labor-intensive and cannot be employed at the point-of-need. 
Enzyme-Linked Immunosorbent Assays (ELISA) using antibodies against TTX, which 
provide quantitative and sensitive detection have been developed 18,19. ELISA kits are 
now commercially available and mainly exploit indirect competitive assay formats, with 
immobilized BSA-TTX 20,21.  Antibodies against TTX have also been exploited in 
diverse assays and sensor formats and can potentially be used for rapid screening 
purposes 22–24. Immunochromatographic assays exploiting gold nanoparticles 
(AuNPs), have garnered increasing attention due to their advantages in terms of 
sensitivity, rapidity, portability, robustness and ease-of-use. Thattiyaphong et al., 
proposed a rapid test for the detection of TTX in pufferfish tissues, using a BSA-TTX 
conjugate immobilized at the test line and a monoclonal antibody labelled with AuNPs 
and a competitive assay format, with the higher the level of TTX in the sample the 
lower the intensity of the band at the test line. The assay was successfully applied to 
the analysis of samples from 750 pufferfish, achieving 94.0% sensitivity and 92.4% 
specificity, as compared to LC/MS-MS 25.  Subsequently Shen et al., described a rapid 
test for the detection of TTX, which was coined a “turn-on competitive, lateral-flow 
immunochromatographic strip”. Monoclonal antibodies against TTX were labelled with 
gold nanoflowers, whilst at the test line there was a mixture of BSA-TTX and BSA 
linked with quantum dots (BSA-QD), and just BSA-QD at the control line. In the 
absence of TTX in the sample, the gold labelled antibodies bound at both the test and 
control line, with the gold label acting to quench the fluorescence of the QD. Thus, in 
this approach, increasing levels of TTX resulted in an increasing intensity of the band 
at the test line, a preferred approach in rapid tests in general.  Using spiked pufferfish 
muscle samples, a good degree of correlation was achieved with a commercial ELISA 
test kit 18Li et al., produced their own monoclonal antibodies and pursued an approach 
similar to that of Thattiyaphong, using AuNP labelled monoclonal antibody and a BSA-
TTX bioconjugate, achieving a detection limit of 10 ng/mL. Using spiked crucian and 
clam matrices, a reasonable degree of correlation was observed with LC/MS-MS 28. 
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Whilst the results obtained with these rapid tests are very positive, competitive 
immunoassays are more difficult to optimize, and the preparation of toxin-reporter 
molecule conjugates, required for some types of immunoassays, can also be 
challenging 14. Sandwich assays are more robust, with all reagents in excess, and due 
to this have longer shelf-lives, and often are more sensitive and specific.  
Aptamers are single-stranded, synthetic oligonucleotides (DNA or RNA) which fold into 
3-dimensional shapes capable of binding non-covalently and with high affinity to a 
target molecule. They are generated through the process known as Systematic 
Evolution of Ligands by Exponential enrichment (SELEX) 26. The SELEX method is a 
repetitive process allowing the identification of unique RNA/DNA molecules from 
thousands of random oligonucleotides that bind to the target molecule with high affinity 
and specificity. Once the SELEX process is complete, the aptamer sequence can be 
validated, and unlimited amounts of the aptamer can be subsequently prepared using 
chemical synthesis.  
 
Aptamers have been successfully applied as an alternative to antibodies in lateral flow 
assays 30,31, and whilst there are several examples of lateral flow assays using dual 
aptamers for the detection of target molecules in sandwich formats32-38, or using split-
aptamer formats 39. Whilst aptamers have been selected against many small 
molecules, it is not trivial to identify dual aptamers that bind to different sites of a small 
target molecule, which have limited binding domains for aptamer recognition. To 
address this issue, the possibility of using split aptamers 40 or hybrid antibody-aptamer 
assays for the detection of small molecules has been reported 41-43. 
 
We recently selected high affinity aptamers against TTX and demonstrated that the 
unique cage-like structure of TTX facilitated the formation of an antibody-TTX-aptamer 
complex enabling the detection of TTX with a sandwich assay 44. Here we report the 
implementation of the developed sandwich assay in a dipstick format for the detection 
of TTX in puffer fish.  The tests is based on the use of a capture monoclonal antibody 
immobilized at the test line, and a AuNP labelled aptamer as the reporter molecule, 
with an oligonucleotide sequence partially complementary to the aptamer sequence 
immobilised at the control line. The dipstick was applied to the detection of a range of 
concentrations of TTX and the approximate detection limit established. The 
reproducibility of the dipstick performance was investigated, and the assay applied to 
the analysis of potentially interfering marine toxins.  Finally, the assay was used for the 
detection of TTX in extracts from contaminated and noncontaminated puffer fish. 
 
 
3.2. Materials and methods 
 
3.2.1. Chemicals and reagents 
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Tetrodotoxin (TTX) was purchased from Latoxan (Valence, France) and standard 
solutions at 1 mg/mL were prepared in 0.1 M sodium acetate buffer pH 4.8. Certified 
reference materials of saxitoxin (STX) and domoic acid (DA) were obtained from the 
National Research Council of Canada (NRC, Halifax, Canada). Okadaic acid 
potassium salt (OA) was from Prorocentrum concavum. The mouse monoclonal anti-
TTX antibody (CABT-L3089, CD Creative Diagnostics) was obtained from Deltaclon 
S.L. (Spain), and Streptavidin (Streptomyces avidinii) were purchased from Merck 
(Spain). All oligonucleotides were synthesized by Biomers.net (Germany).  
 
3.2.2 Oligonucleotide sequences 
 
Biotin-modified TTX aptamer: 
5’-biotin-ATA CCA GCT TAT TCA ATT TAA TGC GGG GTG AGG CTC AAT CAA 
GGA AAG ATA TAA GTA AGC AAA AAG GTC AAA CAA GGG CG AGAT AGT AAG 
TGC AAT CT-3’ 
Aminated-modified reverse primer: 
5’-NH2-TTTTTTTTTTTTTTAGA TTG CAC TTA CTA TC T-3’ 
The specific TTX aptamer sequence had previously been chosen as the best aptamer, 
in terms of specificity and affinity, from an in-house capture SELEX previously carried 
out 27. This selected aptamer was biotinylated and linked to streptavidin coated gold 
nanoparticles (described below). The oligonucleotide sequence immobilized at the 
control line was partially complementary to the selected aptamer sequence. 
 
3.2.3 Development of the dipstick assay for TTX 
 
The strip was constructed using 3 different components: the nitrocellulose membrane 
(FF120HP Whatman, Germany), the PVC backing card, and the absorbent pad 
(Whatman, England). The test and control lines were manually placed on the 
nitrocellulose membrane using an Eppendorf tip containing the biomolecule to be 
deposited. Aminated reverse primer sequence (100 µM diluted in water) was linked via 
ultraviolet (UV) cross-linking to the control line on the nitrocellulose via exposure to 
254 nm wavelength for 15 minutes. Monoclonal antibody generated against TTX (1.5 
mg/mL in PBS) was immobilized on test line via adsorption at 37 ᴏC for 2 hours. 
Blocking of the nitrocellulose membrane was achieved using 5% w/v skimmed milk 
powder, 0.5% v/v Empigen detergent, and carbonate buffer (200 mM, pH 9.4) for 15 
min, under rotation conditions. The membrane was then left to dry at 37ᴏC for 
approximately 2 h and then assembled with the backing card, with the absorbent pad 
overlapping the nitrocellulose membrane by 2mm to ensure correct wicking. Following 
assembly, the strips were placed in a sealed bag containing dessicant and then stored 
in the fridge until use. 
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3.2.4 Preparation of gold nanoparticle labelled reporter aptamer conjugates 
 
Gold nanoparticles (AuNPs) with an optical density of 1 and a diameter of 40 nm were 
mixed with Streptavidin (SA) and concentrated to OD-50 for use with the aptamer 
reporter molecules in the dipstick assay. Streptavidin, (12.5 µL of 5 mg/mL in PBS) 
was primarily incubated with 5 mL AuNP solution for 30 min under tilt rotation at room 
temperature (RT), followed by the addition of 500 µL (10% BSA w/v), for 30 min under 
tilt rotation at RT for AuNPs blocking. After the blocking step, the conjugate was 
washed 3 times by centrifugation and resuspension using Buffer A (boric acid 
(100mM), sucrose and bovine serum albumin (BSA)), each step for 30 min, in 
centrifuge at 15000 rpm, at 4 ᴏC. Finally the conjugate was resuspended in the Buffer 
A and stored at 4oC until use. UV-Vis measurement confirmed the formation of the 
complex between -AuNPs and SA and the concentration of the conjugate to have an 
OD of 50. 
 
3.2.5 Calibration Curve 
 
The dipstick assay optimized in this work was evaluated by testing a range of TTX 
standard solutions at concentrations of 200, 100, 50, 25, 12.5, 6.2, 3.1, 1.5, and 0.7 
ng/mL prepared in PBS, and for the control strip was used just PBS buffer. After the 
preparation of all the strips (as described above), in a parallel experiment were used 
20 strips for analysis of each TTX concentration in duplicate samples. In the first step, 
dipstick was dip in a well containing 20 µL of TTX (200-0.7 ng/mL) in PBS. 
Subsequently, after all TTX solution run through the membrane, the strip was transfer 
to a new well containing 20 µL of 2 µM biotinylated aptamer in Binding buffer (PBS with 
1.5 mM MgCl2). In the third step, all the strips were dipped in 20 µL AuNPs-SA 
conjugate (OD-10) prepared in PBS-Tween and let to run until all the solution in the 
well was absorbed. Finally, a washing step of the strips with 20 µL PBS-Tween was 




3.2.6 Sensitivity and specificity of the dipstick assay 
 
The specificity of the dipstick assay was evaluated by the analysis of other potentially 
interfering marine toxins including domoic acid (DA), okadaic acid (OA) or saxitoxin 
(STX) which can be potentially co-detected in pufferfish. All toxins were analyzed at 50 
ng/mL concentration and the image per each strip was captured by a Smartphone 
camera. 
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3.2.7 Fish extracts for TTX detection 
 
For the validation of the dipstick assay, extracts from 2 different species were analysed, 
an oceanic puffer fish (Lagocephalus lagocephalus, Linnaeus, 1758) (TTX-free) and a 
silver-cheeked toadfish (Lagocephalus sceleratus, Gmelin, 1789) (TTX-contaminated). 
Puffer fish were dissected, and the gonads, liver, skin and muscle were retrieved (45). 
A double TTX extraction was performed with 0.1% v/v acetic acid as previously 
described 28. Extracts were obtained at a tissue concentration of 200 mg equiv./mL. 
 
 
3.3. Results and discussions 
 
3.3.1 Optimization of the dipstick assay 
 
For the optimization of the dipstick assay, experimental parameters such as DNA 
length on control line, TTX antibody concentration, TTX concentration and the OD of 
AuNPs-SA were investigated. The TTX aptamer that we used was selected from the 
Capture-SELEX selection 44 by immobilization of ssDNA on streptavidin magnetic 
beads through the aid of a bio-docking probe complementary to ssDNA sequences by 
12 nucleotides 44. Using this advantage, aminated docking probe was linked via UV 
cross-linking to the nitrocellulose membrane for the control line, aiming its 
complementary binding to TTX aptamer. The length of the complementary DNA probe 
is a key factor as it can affect the interaction with the aptamer. If the sequence of the 
DNA probe is too short, the complementary hybridization to the aptamer can be weak, 
conversely, if the DNA probe is too long, the complementary hybridization can be too 
strong, resulting in false-positive results 29. As the complementary region between the 
aptamer and the docking probe was only 12 bases, in this experiment, TTX aptamer 
didn’t bind to the docking probe, so no control line was observed (Figure 3.2A). In the 
next experiment, aminated reverse primer complementary to TTX aptamer was linked 
via UV cross-linking to the nitrocellulose membrane. There is a perfect hybridization 
between the amine-reverse primer and the bio-aptamer for TTX (Figure 3.2B). After 
this, the next step was the preparation of the dipstick membrane with the amine-
reverse primer and TTX-Antibody. Different concentrations and solution volumes were 
used to obtain the best spots on the test line, but in later experiment we used a line 
form instead of the spot one. For paper-based assays, the most common 
immobilization method is direct, physical adsorption of the affinity reagent to the assay 
nitrocellulose membrane. As it is shown in Figure 3.3 the spots diameter differs in size 
between DNA probe and TTX antibody. This difference comes as these molecules are 
quite different, one is a DNA and the other one a protein, consequently the adsorption 
through the membrane will be different. 
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Scheme 3.1. Schematic illustration of the dipstick assay for the simple and rapid detection of TTX. (A) 
Structure of the dipstick strip (B) TTX present in the sample is capture by monoclonal TTX antibody in 
the test line where later is captured by biotinylated aptamer and AuNPs-SA, while the excess of biotin-
aptamer and SA-AuNPs is captured through complementary hybridization on reverse primer 
immobilized in the control line, resulting in two red lines. (C) When TTX is not present, there is no binding 
on monoclonal TTX antibody on the test line and the biotin-aptamer with AuNPs-SA run along the 
nitrocellulose membrane by capillary action and are captured by the reverse primer immobilized on the 
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Figure 3.2. Optimization of control line DNA probe. In this experiment 0.4 µL (100 
µM) of each aminated probe was directly immobilized on control line via UV-







The dipstick assay developed in this work, was based on a sandwich assay using an 
immobilized monoclonal anti-TTX antibody as a capture molecule and a AuNP-labelled 
aptamer as a reporter molecule (Scheme 3.1).  
For optimization of the dipstick parameters, the dipstick was first dipped in a well of a 
microtiter plate, containing TTX standards where complete wicking of the membrane 
is observed. The dipstick was then placed in a microtiter well containing the AuNP-
labelled reporter aptamer that wicks across the membrane, forming complexes at the 
test line (in the case of the presence of TTX) and at the control line.  
To elucidate the optimal parameters of the AuNPs-SA conjugate, three different OD 
(10, 15, 20) were tested using different concentrations of target TTX (0-1-10-100 
ng/mL). As can be seen in Figure 3.3 the intensity of the test and control lines for the 
same target concentration using aptamer-AuNP bioconjugates of different OD, are 
very similar and there was no significant increase in the line intensity, and an OD of 10 
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Figure 3.3. Optimization of AuNPs-SA OD in dipstick format for control and test line.Three different OD 
(10,15,20) of AuNPs-SA were analyzed in order to obtain the best visual intensity spot on the test and 
control line. Moreover, to increase the specificity of the dipstick format 2 different concentration of 
monoclonal TTX antibody were tested, 0.4 uL (of 1.5mg/mL stock) (left) and 0.5 uL (of 1.5mg/mL 
stock)(right).As it is shown here there is no significant difference between the different OD used for the 
same concentration of TTX samples, but there is an improvement of the assay sensitivity when using 
higher volume of monoclonal TTX antibody. 
 
In order to test the sensitivity of the assay, a wide range of TTX concentrations (0−200 
ng/mL) was analyzed using 1 in 2 dilutions of TTX concentration. With all 
concentrations tested, a red colour of deep intensity was observed at the control line, 
inidicative of a successful wicking across the nitrocellulose membrane and 
hybridization of the oligonucleotide at the control line with the aptamer-AuNP 
conjugate. As the dipstick assay is based on a sandwich format, the intensity of the 
band at the control line is directly proportional to the concentration of the TTX. A 
Smartphone camera was used to take an image of all the strips and the colour of the 
red bands can easily be seen by the naked eye (Figure 3.4). 
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Figure 3.4. Image of the dipstick strips demonstrate the sensitivity of the assay using a range of TTX 
concentration starting from 200 ng/ml to 0.7 ng/mL using 1 in 2 dilutions and the control strip (0 ng/mL 
TTX) step. 
 
3.3.2 Cross-reactivity studies. 
 
The specificity of the assay was evaluated using 50 ng/mL of each of domoic acid (DA), 
okadaic acid (OA) and saxitoxin (STX). In this study saxitoxin is the most relevant as 
this toxin is often found with tetrodotoxin in pufferfish, and as it is hydrophilic, is often 
co-extracted with the tetrodotoxin and is also a neurotoxin.  Okadaic acid, a diarrhetic 
toxin, can also be found in pufferfish, but as it is lipophilic, it would possible not be 
extracted using the method of extraction for tetrodotoxin, and is thus not expected to 
be as potentially problematic in terms of false positives, as saxitoxin. Due to the high 
specificity of the hybrid aptamer-antibody sandwich, no cross-reactivity, or non-specific 




Figure 4.5. Cross-reactivity experiment for the dipstick experiment using 4 different marine toxins (OA, 




3.3.2 Analysis of TTX in puffer fish samples 
 
The dipstick was finally employed for the analysis of fish samples. Extracts from 
different tissues (gonads, liver, skin and muscle) of Lagocephalus lagocephalus, 
Linnaeus, 1758 (TTX-free) and one silver-cheeked toadfish, Lagocephalus sceleratus, 
Gmelin, 1789 (TTX-containing) were diluted 1 in 25in PBS. As can be seen in Figure 
6 the developed dipstick was able to detect TTX in all four positive extracts whilst giving 
no false positives with the negative extracts, highlighting not only the absence of any 
matrix effects, but also the sensitivity of the dipstick for the detection of TTX in 
pufferfish (Figure 4.6). 
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Figure 4.6. The successful application of the dipstick assay was evaluated by analysing 4 different fish 





3.4. Conclusions  
 
To best of our knowledge, we have presented the first report of a dipstick based on a 
hybrid antibody-aptamer for the detection of TTX in extracts from puffer fish. The ease-
of-use and high-sensitivity of this paper-based format facilitates the rapid, on-site, cost-
effective detection of TTX in field samples. The developed dipstick was demonstrated 
to be specific, able to detect as low as 3ng/mL, with the assay being complete within 
20 minutes and with no need for trained personnel. Ongoing work is focused on 
integrating the dipstick into an integrated lateral flow assay, evaluating the long-term 
stability of this LFA and the optimal storage conditions, and developing a facile and 
rapid methodology for the extraction of TTX from pufferfish, in order to realise a rapid 
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The illicit use of anabolic androgenic steroids (AAS) as performance-enhancing drugs 
remains a global issue threatening not only the credibility of competitive sports but also public 
health because of the well-documented adverse effects they elicit. Despite the existence of 
strict rules and continuous anti-doping controls, doping scandals continue to surface, 
suggesting that the fight against doping is far from over. AAS abuse however is not restricted 
only to professional sports, but it also extends to recreational athletes and adolescents as 
well as in livestock production as growth-promoting agents. Testosterone and nandrolone are 
among the AAS most frequently exploited for these purposes. Gas chromatography-mass 
spectrometry is the reference method for AAS detection, but it is strictly laboratory-based and 
cannot be performed on-site. The great potential of aptamers in bioanalytical applications 
and specifically for the development of simple biosensors suitable for on-site analysis has 
been well demonstrated. In this report, we describe the selection and identification of 
aptamers binding nandrolone exhibiting affinity dissociation constants in the low nanomolar 
range and cross-reactivity with testosterone. A label-free colorimetric assay was finally 
developed using one of these novel aptamers for AAS detection based on gold nanoparticles 
and their aggregation in the presence of target molecules after salt addition. The assay could 
be deployed for rapid on-site screening of suspicious samples and provide qualitative visual 
results with a red to purple/blue color change to indicate the presence of both nandrolone 
and testosterone as doping biomarkers.  
 
4. 1. Introduction 
Anabolic androgenic steroids (AAS) are synthetic derivatives of testosterone, the main male 
sex hormone, with clinical and illicit uses. Their anabolic effects are related to their ability to 
increase lean body mass, muscle size and strength, and to improve protein and bone 
metabolism1. On the other hand, their androgenic properties cause masculinization. 
Clinically, AAS, and especially testosterone, have been traditionally prescribed to treat male 
hypogonadism2. However, the potential benefits of their anabolic properties to certain patient 
populations have encouraged the therapeutic use of AAS for several conditions including 
growth impairment, infertility and depression as well as to treat cachexia related to chronic 
diseases such as HIV, burns, renal failure, pulmonary disorders, muscular dystrophies, 
breast cancer and anemia3-6. Unfortunately, the illicit use of AAS as performance-
enhancement drugs, a practice commonly known as doping, has also been known for many 
decades1. Doping has been reported among not only competing athletes but also amateurs 
and recreational athletes as well as adolescents with the main objective to increase muscle 
mass and improve bodily appearance4, 7, 8. However, a plethora of adverse effects have been 
associated with AAS use/abuse including hypertension, hepatic damages, reproductive 
disorders as well as neuropsychiatric and behavioral disorders1, 4, 8. The use of AAS is 
prohibited in professional sports and the World Anti-Doping Agency (WADA) publishes a 
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yearly list with prohibited substances, in- and out-of-competition, in an effort to contain the 
abuse9.  
Nandrolone is among these substances whose use in sports as well as in horse racing is 
prohibited at all times10. Nandrolone (19-nortestosterone) is a synthetic testosterone 
analogue and one of the most frequently abused AAS together with testosterone, stanozolol 
and methandienone7,8. Its anabolic properties though are more potent than those of 
testosterone, since it exhibits an anabolic:androgenic ratio of 10 compared to 1 for 
testosterone1,11. Besides its potential therapeutic uses as an AAS, nandrolone has also been 
used as a growth promoting agent in livestock intended for human consumption12,13. Its use 
however for this purpose is banned in the EU14. On the other hand, several studies report the 
presence of nandrolone in dietary supplements as a cross-contaminant and consumption of 
such supplements could lead to accidental doping15-17. It is therefore evident that monitoring 
the presence of nandrolone in human and animal biological fluids, meat products and 
nutritional supplements is essential to protect public health and discourage doping practices 
in sports. 
According to WADA regulations, gas chromatography-mass spectrometry (GC-MS) and gas 
chromatography-isotope ratio mass spectrometry (GC-IRMS) are the official methods for the 
detection of endogenous (such as testosterone)18 and exogenous AAS (like nandrolone)19, 
respectively. Indeed, gas chromatography combined with mass spectrometry has been 
widely exploited in the literature as well to analyze different types of samples potentially 
containing AAS16, 20-23. The use of other techniques has also been reported, such as ultra-
high-performance liquid chromatography coupled with mass spectrometry (UHPLC-MS) 
which is garnering increased interest24,25, high-performance thin-layer chromatography 
(HPTLC)-densitometry26 and nuclear magnetic resonance (NMR)27. These techniques, even 
though highly accurate, are expensive and laboratory-based requiring significant 
infrastructure, specific equipment and trained personnel. Immunoassays have also been 
developed as simpler, lower cost and more user-friendly alternatives to the above-mentioned 
techniques10, 28-32. Due to the small size of the steroids, the ELISAs are typically performed 
in an indirect competitive format, and they require the preparation of haptens for animal 
immunization and antibody production or for signal generation. Depending on their specific 
design, ELISAs can be very sensitive with limits of detection (LOD) in the (sub)nanomolar 
range. For example, an LOD of 4 pg/mL ( 15 pM) was reported when a linker-optimized 
biotin derivative of nandrolone was used in conjunction with avidin as an immobilized 
competitor32. ELISA kits are also available in the market for various AAS with LODs in the 
low picomolar range. The high sensitivity and specificity demonstrated by immunoassays 
emphasize the potential of biorecognition molecules in AAS detection and their compatibility 
with anti-doping drug testing. 
Aptamers are biorecognition molecules considered as the chemical alternatives to antibodies. 
They are single stranded DNA or RNA molecules with specific three-dimensional structures 
able to bind their cognate targets with high affinity and specificity. Starting from highly diverse 
oligonucleotide libraries, specific sequences binding to target molecules are identified using 
an in vitro repetitive process called Systematic Evolution of Ligands by Exponential 
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Enrichment (SELEX)33,34. Advantages of aptamers such as facile and reproducible chemical 
synthesis, straightforward modification, reversible denaturation, small size and stability have 
expanded their application to bioanalytical applications for the detection of a plethora of 
targets35 including small molecules36. In fact, there are a few reports in the literature regarding 
the selection of aptamers binding steroids, such as estradiol37-39, progesterone39, 40, cortisol41 
and testosterone39,42. There is no report though demonstrating the selection of aptamers 
binding nandrolone. There is only one study in which a previously reported estradiol aptamer 
was split in two fragments and repurposed for the detection of nandrolone in a sandwich 
fluorescence resonance energy transfer (FRET) assay43. In this work, we describe the first 
selection designed for the identification of nandrolone aptamers. Using Next Generation 
Sequencing to analyze the last selection round, aptamer candidates were selected and their 
binding affinity for nandrolone was verified using different assays. Finally, a homogenous 
colorimetric assay was developed using gold nanoparticles (AuNPs) with a red-to-blue color 
change to indicate the presence of nandrolone as a proof-of-concept of an assay suitable for 
fast screening of suspicious samples. 
 
 
4. 2. Experimental 
 
4. 2. 1 Materials 
Nandrolone (NAND), trenbolone (TREN), 17β-estradiol (ESTR), 17β-estradiol-6-one 6-(O-
carboxymethyloxime) (ESTR-CMO), progesterone (PROG), progesterone-3-(O-
carboxymethyl)oxime (PROG-CMO), testosterone (TEST), testosterone-3-(O-
carboxymethyl)oxime (TEST-CMO), 11-amino-1-undecanethiol hydrochloride (MUAM), O-
(carboxymethyl)hydroxylamine hemihydrochloride and rabbit anti-mouse-HRP conjugate 
were purchased from Merck (Spain). Nortestosterone Sepharose 6B (10-14 μmole/mL, 
NAND-resin) was obtained from Polysciences (Germany). Epoxy-activated sepharose 6B, 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC), N-hydroxysuccinimide 
(NHS), sulfo-NHS-acetate, maleimide-activated microtiter plates, DreamTaq DNA 
polymerase and lambda exonuclease were from Fisher Scientific (Spain). The DNA 
purification kits (Oligo Clean & Concentrator kit and DNA Clean & Concentrator kit) were from 
Zymo Research (supplied by Ecogen, Spain). Monoclonal antibodies to ESTR (clone 9F9), 
PROG (clone 9F44) and TEST (clone 5E801) were provided from US Biological Life Sciences 
(acquired through VWR, Spain). Streptavidin-polyHRP80 was purchased from SDT-
Reagents (supplied by Bionova, Spain) and TMB Super Sensitive One Component HRP 
Microwell Substrate from Surmodics (USA). The ssDNA library (5’-
TAGGGAAGAGAAGGACATATGAT-N40-TTGACTAGTACATGACCACTTGA-3’, 86 nt) was 
obtained from TriLink Biotechnologies (USA) whereas all other oligonucleotides were 
synthesized by Biomers.net (Germany). All other reagents were obtained from Fisher 
Scientific (Spain), Scharlau (Spain) and Sigma (Spain). MilliQ-grade water was used for all 
experiments. 
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4. 2. 2 In vitro selection 
Commercially available nandrolone sepharose 6B resin (NAND-resin) was used for the 
positive selection. Epoxy-activated sepharose 6B was used to prepare control-resin for the 
negative selection and counter-selection resins with each of the four counter selection 
steroids (PROG, ESTR, TEST, TREN) as detailed in the Supplementary Information. For the 
first round, 300 pmol of the ssDNA library containing a 40 nucleotide-long random region was 
dissolved in 100 μL of selection buffer (10 mM Tris-HCl pH 7.5, 100 mM NaCl, 2 mM MgCl2), 
heated for 5 min at 95 ºC and cooled slowly to room temperature. The ssDNA library was 
then transferred to a microspin column containing 20 μL of the NAND-resin to perform the 
first selection round. For the second and third rounds, the ssDNA pool was first incubated 
with 20 μL of control-resin before incubation with the NAND-resin. Rounds 4 – 7 were 
performed with sequential incubations with the control-resin, PROG-resin, ESTR-resin, 
TEST-resin, TREN-resin and finally the NAND-resin. All selection rounds were performed 
using 30 min incubation steps at room temperature under rotation. For the counter selection 
steps, 20 μL of each resin was used for round 4 whereas 10 μL were used for rounds 5 – 7. 
At the end of each selection round, unbound sequences from each resin were removed by 
centrifugation for 30 sec at 10,000 rpm followed by washing four times with 400 μL of water 
and four times with 400 μL of selection buffer. The resins were resuspended in 50 μL of water 
and stored for further experiments, whereas ssDNA bound on the NAND-resin was used for 
the preparation of ssDNA for succeeding rounds. This was achieved by the amplification of 
resin-bound sequences using library-specific forward and phosphorylated reverse primers 
and a combination of asymmetric PCR with lambda exonuclease digestion. The evolution of 
the selection was monitored during the selection by PCR to ensure enrichment in sequences 
binding the target NAND-resin. After PCR amplification of resin-bound sequences and 
agarose gel electrophoresis, the intensity of the bands was estimated with the ImageJ 
software using the gel analysis option. 
 
4. 2.3 Next Generation Sequencing (NGS) and identification of aptamer candidates 
The ssDNA pool from the last selection round (round 7) was amplified and sequenced by Ion 
Torrent Next Generation Sequencing (Centre for Omic Sciences, Eurecat Technology 
Centre, Reus, Spain). The Galaxy web server was used for the analysis of the raw data. The 
length of the sequences was constrained to library-length (80 – 95 nt) and the filtered 
sequences were collapsed in order to identify unique sequences. The 100 most abundant 
sequences were aligned for the identification of sequence families using the Clustal Omega 
multiple sequence alignment tool (https://www.ebi.ac.uk/Tools/msa/clustalo/). Sequence 
motifs within these sequences were also identified using the MEME tool (https://meme-
suite.org/meme/tools/meme). The UNAFold webserver was finally used to predict potential 
secondary structures of the selected aptamer candidates adjusting the conditions to the ones 
used during selection (100 mM NaCl, 2 mM MgCl2, 25ºC) and the RNAComposer 3D 
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modeling server (http://rnacomposer.cs.put.poznan.pl/) to build three-dimensional models of 
aptamers. 
 
4. 2. 4 Apta-PCR affinity assay (APAA) 
The binding properties of the aptamer candidates were first evaluated by APAA. To this end, 
nandrolone was immobilized on magnetic beads (NAND-beads) as described in the 
Electronic Supplementary Material (ESM). NAND-beads (1.5 μL of 30 mg/mL) were 
incubated with 50 μL of the desired concentration of each aptamer candidate (10 nM down 
to 15.6 pM performing serial two-fold dilutions in selection buffer) for 30 min at room 
temperature under rotation. The beads were thoroughly washed with selection buffer and 
finally resuspended in 10 μL of water. The amount of bound aptamer was determined after 
PCR amplification, agarose gel electrophoresis and analysis of the intensity of the bands 
using the ImageJ program and the gel analysis option. Duplicate measurements were 
performed for all samples. The relative band intensities were plotted against the aptamer 
concentration using the GraphPad software. The “One site - specific binding with Hill slope” 
model was finally used to construct the binding curves and calculate the affinity dissociation 
constants (KD).     
 
4. 2. 5 Bead-Enzyme Linked Aptamer Assay (bead-ELAA) 
NAND-beads (1.5 μL of 30 mg/mL) were incubated with 50 μL of each biotinylated aptamer 
candidate (100 nM down to 6.4 pM performing serial five-fold dilutions in selection buffer) for 
15 min at room temperature under rotation. For the motif sequence, a range of concentrations 
from 400 nM to 1.6 nM were prepared with serial two-fold dilutions. The beads were washed 
with PBS containing 0.05 % Tween-20 (PBST), resuspended in 50 μL of 0.05 μg/mL 
streptavidin-polyHRP in PBST and incubated for 15 min. Finally, the beads were thoroughly 
washed with PBST and resuspendend in 50 μL of TMB substrate solution. Color development 
was terminated by the addition of 50 μL of 1 M H2SO4 and absorbance was read at 450 nm. 
The KD values were calculated as described above in the “APAA” section, by plotting the 
absorbance at 450 nm against aptamer concentration. Duplicate samples were analyzed for 
each concentration. To evaluate the specificity of the aptamers, 2 μL of each bead type 
(NAND-beads, TEST-beads, TREN-beads, PROG-beads, ESTR-beads or control-beads, 
prepared as detailed in the ESM) were incubated with 50 μL of 0.5 nM of Nand1 or Nand2 
aptamer, 1 nM of Nand3 aptamer or 100 nM of the motif sequence in binding buffer for 30 
min at room temperature under rotation. Detection of bound aptamers was performed as 
described above. 
 
4. 2. 6 Enzyme Linked Aptamer Assay (ELAA) 
For this assay, nandrolone was immobilized on microtiter plates as detailed in the ESM 
employing maleimide activated microplates and MUAM crosslinker. Solutions with different 
concentrations of the biotinylated aptamers (50 μL of 20 nM down to 10 pM, two-fold serial 
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dilutions in selection buffer) were added to the wells and incubated for 15 min at room 
temperature under mild agitation and then washed with PBST. Then, 50 μL of 0.05 μg/mL 
streptavidin-polyHRP in PBST were added for another 15-min incubation. The wells were 
finally washed with PBST and 50 μL of TMB solution were added, followed by the addition of 
50 μL of 1 M H2SO4 after approximately 5 min to stop color development. Absorbance was 
read at 450 nm and the KD values were determined as described above.   
 
4. 2. 7 Gold nanoparticles (AuNPs)-aptamer assay for NAND detection  
AuNPs (diameter of  16 nm) were synthesized with the sodium citrate reduction method as 
previously described [44]. AuNPs (50 μL of OD 2) were incubated with the aptamer (15 μL) 
for 30 min under rotation at room temperature. Then, 10 μL of solutions containing different 
concentrations of NAND were added and the mixtures were incubated further for 15 min. 
Finally, 25 μL of NaCl were added and after 1 min, the spectra of the samples were acquired 
in the range of 350 – 750 nm. The concentrations of the aptamer and NaCl in the final 100 
μL mixtures were initially optimized in the absence of NAND, using the aptamer at 0 – 300 
nM and NaCl at 0 – 200 mM. A narrower range of concentrations of the aptamer (100 – 200 
nM) and NaCl (50 – 150 mM) was then studied in the absence and presence of NAND (200 
M). Optimized conditions were finally used for the construction of a calibration curve using 
NAND in the range of 0.2 – 200 M. The absorbance ratio of aggregated/dispersed AuNPs 
was plotted against the logarithm of NAND concentration using the GraphPad Prism software 
and a four-parameter sigmoidal model was used to fit the data. The limit of detection (LOD), 
defined as the bottom of the fitted curve plus three times its standard deviation (bottom + 
3xSDbottom), was finally calculated after interpolation from the calibration curve.  
 
4. 3. Results and Discussion 
 
4. 3. 1 Selection process 
The selection of nandrolone aptamers was based on the use of nandrolone-sepharose affinity 
resin (NAND-resin) and a highly diverse ssDNA library with a 40 nucleotide-long random 
region. The selection was completed in seven rounds and a summary of the conditions used 
can be seen in Figure 4. 1A. Commercially available NAND-resin was employed for the 
positive selections, whereas control sepharose resin was used for the negative selections as 
well as for the preparation of counter selection resins with each of the four counter-SELEX 
molecules, progesterone (PROG), estradiol (ESTR), testosterone (TEST) and trenbolone 
(TREN). The structures of the target nandrolone and the other steroids used in the selection 
can be seen in Figure S4.1 of the ESM. The immobilization of these steroids on sepharose 
resin is described in the ESM (Figure S4.2). For the first round, the ssDNA library was 
incubated with the NAND-resin (Figure S4.1B) and bound sequences were amplified and 
used for the preparation of ssDNA for the next round. For the second round, the ssDNA pool 
prepared from the first round was first incubated with the control-resin to remove any 
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sequences binding non-specifically to the matrix (sepharose resin). Unbound ssDNA was 
recovered and incubated with the NAND-resin for the positive selection. The amount of 
target-bound sequences during the second round decreased compared to the first one as a 
consequence of the negative selection which effectively removed part of the ssDNA pool 
interacting non-specifically with the control-resin (Figure 4.1B). After completion of the third 
round, which was performed in the same way as the second one, the ssDNA pool appeared 
to be enriched in NAND-resin-binding sequences with insignificant binding to the control-
resin. Counter selection molecules were thus introduced in the following selection round 3. 
After a negative selection step, sequential incubations with the PROG-resin, ESTR-resin, 
TEST-resin and TREN-resin were performed for counter-SELEX followed by the positive 
selection with the NAND-resin. This procedure was followed for rounds 4 – 7, with the only 
difference being the use of less resin per counter selection molecule in rounds 5 – 7 
compared to round 4 (Figure 4.1A). By the final round 7, PCR amplification of bound 
sequences to each resin type followed by agarose gel electrophoresis showed the specific 
binding of the enriched ssDNA pool to the NAND-resin and no binding to the other steroid-
resins (Figure 4.1C).  
 
Figure 4.1. Selection strategy and evolution of the process. (A) Conditions used for SELEX. (B) Evolution of 
the selection. (C) Specificity of the last selection round.   
 
4. 3. 2 NGS and identification of aptamer candidates 
The last selection round was analyzed by Ion Torrent Next Generation Sequencing to identify 
aptamer candidates. The raw data was imported in the Galaxy webserver and the length of 
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sequences was constrained to library length (80 – 95 nt) to remove artefacts resulting from 
PCR amplification and sequencing. Unique sequences were then identified after collapsing 
the filtered dataset. Out of the 117225 total reads, 54.5 % were sequences with library length 
and approximately half of those (51.5 %) were unique (Figure 4.2A). The ranking and copy 
number of the 100 most abundant unique sequences, corresponding to 16.3 % of the total 
unique sequences (Figure 4.2B), can be found in Table S1. The next step was to perform 
multiple sequence alignment of these 100 sequences using Clustal Omega as well as 
analyze them with MEME for sequence motif discovery. No sequence families were identified 
as it can be seen in Figure S4.3. Interestingly, a short sequence motif of 11 nt was identified 
in 52 of the 100 most abundant unique sequences (Figure S4.3 and S4.4). It was also found 
in 50 % of the 500 most over-represented sequences (data not shown). The first three most 
abundant sequences were denoted as Nand1, Nand2 and Nand3 and they constituted 5.9, 
4.1 and 3.9 %, respectively of the top 100 most over-represented sequences dataset (Figure 
4.2B). These sequences together with the sequence motif were finally chosen for further 
characterization and their sequences can be found in Table S4.2.  
 
 
Figure 4.2. NGS analysis of round 7 from the nandrolone selection. (A) General statistics. (B) Composition of 
the top 100 most abundant unique sequences. 
 
4. 3. 3 Affinity and specificity of the aptamers 
Once the aptamer candidates were identified, different assays were performed to evaluate 
their binding properties. APAA, bead-ELAA and ELAA were employed, based on the use of 
magnetic beads and maleimide-activated microtiter plates to immobilize nandrolone. We 
have previously reported the use of these three assays for the characterization of aptamers 
binding to small molecules like steroids [39, 42, 45] and biogenic amines [46]. They are easy 
to perform in any laboratory as opposed to more sophisticated methods like MicroScale 
Thermophoresis (MST) and isothermal titration calorimetry (ITC) which require special 
equipment and trained personnel. For APAA and bead-ELAA, a carboxyl-derivative of 
nandrolone (NAND-CMO) was directly conjugated to magnetic beads. The beads were 
modified with amine groups through a short hydrophilic linker and cross-linking was achieved 
using classic carbodiimide chemistry via EDC/NHS. On the other hand, an 11 carbon-long 
crosslinker (MUAM) was used as a spacer to facilitate the immobilization of NAND-CMO on 
maleimide-activated microtiter plates and perform the ELAA. For APAA, unmodified aptamers 
were used whereas biotinylated aptamers (with a biotin added to the 5’ end of the aptamers) 
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were required for bead-ELAA and ELAA. The binding curves of the aptamers obtained from 
each of the assays are shown in Figure 4.3A-C and the affinity dissociation constants (KDs) 
in Figure 4.3D. All three assays verified the high binding affinity of the three full length 
aptamers (Nand1, Nand2 and Nand3) with KDs in the low (sub)nanomolar range. The use of 
different surfaces for NAND immobilization, the length of the spacer used to spatially separate 
NAND from the surface, or the modification of the aptamers did not appear to affect their 
binding properties.  
   
 
Figure 4.3. Evaluation of the affinity of the aptamer candidates for nandrolone. Binding curves obtained by (A) 
APAA, (B) bead-ELAA and (C) ELAA. (D) Affinity dissociation constants. 
 
The motif, which is present in the sequences of the Nand2 and Nand3 candidates but not in 
Nand1, was analyzed next (Figure S4.5). A DNA-based spacer (T15) was introduced at the 
5’-end of this 11-mer motif sequence to provide more structural flexibility and prevent any 
potential interference of the biotin added to facilitated detection on NAND-motif complex 
formation. A KD of 27 nM was calculated for the motif by bead-ELAA (Figure 4.3B and 4.3D). 
As mentioned earlier, this sequence was found in 52 % of the top 100 and in half of the top 
500 sequences from the last selection round, indicating that the selection process resulted in 
the enrichment of this sequence as a NAND binding motif. Considering the small size of the 
steroids, a binding pocket formed in a three-dimensional structure of the motif predicted using 
the RNAComposer webserver could potentially accommodate NAND binding (Figure S4.6).  
The specificity of the aptamers was finally studied by bead-ELAA. This assay is very easy to 
perform and is quite useful in evaluating the binding properties of aptamers. It must be 
commented though that variations in the immobilization level of each steroid on the magnetic 
beads could potentially affect the accuracy of the assay when evaluating aptamer specificity. 
Naturally occurring steroids like testosterone, progesterone and estradiol, as well as the 
synthetic anabolic steroid trenbolone were immobilized on magnetic beads and bound 
aptamers were detected via the biotin modification introduced at the 5’ end of the aptamers 
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as detailed earlier. As shown in Figure 4.4, the three full-length aptamers as well as the motif 
showed preferential binding to both NAND and TEST, while lower binding was observed to 
the other steroids. Certain level of cross-reactivity of the aptamers with other steroids is 
reasonable considering the extremely high structural similarities these molecules exhibit 
(Figure S4.1). Regardless, taking into account that PROG and ESTR are encountered in low 
(sub)nanomolar concentrations in biological samples, their presence is not expected to affect 
the analysis of doping-related samples.  
 
 
Figure 4.4 Specificity of the aptamers using bead-ELAA. 
 
4. 3. 4 AuNP-aptamer assay for NAND detection 
A label-free colorimetric assay employing the Nand3 aptamer and gold nanoparticles 
(AuNPs) was finally designed for the detection of NAND and its principle is demonstrated in 
Fig. 5A. The negatively charged ssDNA (unmodified) aptamer is adsorbed on the surface of 
the AuNPs, resulting in the stabilization of the particles and prevention of aggregation after 
the addition of NaCl salt and the increase of the ionic strength of the suspension. The AuNPs 
are thus maintained well-dispersed and exhibit their characteristic red wine color. When the 
target molecule is added to the suspension though, the folding of the aptamer changes 
provoking its desorption from the particles and displacement to the solution phase to bind the 
target. In this case, when salt is added, the AuNPs aggregate since their surface is no longer 
protected by the aptamer and the color of the suspension changes to purple/blue. This assay 
has been widely exploited for small molecule detection because of the several advantages it 
provides; it is facile and rapid, provides a clear visual result with a red-to-purple/blue color 
change to indicate target presence, does not require any labels to generate signal, the 
aptamer is used unmodified (thus maintaining its binding properties) and as a homogenous 
assay performed in a single tube does not require any separation/washing steps44, 47, 48. 
There are already a few studies in the literature using this assay for steroid detection, such 
as cortisol41, estradiol49 and progesterone50.  
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Figure 4.5. AuNP-aptamer assay for NAND detection. (A) Principle of the assay. (B) Representative spectra of 
samples containing different concentrations of NAND. (C) Calibration curve for NAND quantification. 
 
Herein we sought to apply the novel aptamers to NAND detection using this AuNP-based 
assay. The concentrations of the Nand3 aptamer, which was chosen for assay development, 
and NaCl were optimized to enhance assay performance. Initially the assay was performed 
without NAND to evaluate the conditions providing better discrimination of the AuNPs with 
and without aptamer. These were found to be 100 – 200 nM of Nand3 aptamer and 50 – 150 
mM of NaCl (Fig. S7A). These conditions were further explored in the presence of NAND 
which was better detected after the addition of 75 mM and 100 mM of NaCl (Fig. S7B). The 
sensitivity of the assay was then evaluated for different combinations of concentrations of 
aptamer and NaCl. As shown in Table S3, 200 nM of Nand3 aptamer with 100 mM NaCl was 
the most successful combination resulting in the lowest limit of detection (LOD of 1.1 μM) and 
wider span (absorbance ratio of aggregated to dispersed AuNPs), which can improve the 
analytical sensitivity of the assay. Representative images of samples containing increasing 
concentrations of NAND showing the red-to-purple/blue color change can be found in Fig. 
S8. Finally, a range of NAND concentrations (0.2 – 200 μM) were analyzed with the assay 
under the optimized conditions. The spectra acquired are shown in Fig. 5B and the calibration 
curve constructed using the absorbance ratios of aggregated to dispersed AuNPs in Fig. 5C. 
The LOD of the assay was calculated at 1.4 μM NAND. The relatively low sensitivity of the 
assay might be attributed to the length of the aptamer (86 nt) limiting its efficient displacement 
to the solution phase. Truncation of the aptamer to remove non-essential bases could 
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potentially improve assay performance, a strategy previously demonstrated for a bisphenol 
A aptamer51. In that work, > 250-fold improvement of the LOD was achieved with an 
equivalent AuNP-based assay when the aptamer length was reduced from 63 nt to 38 nt. 
Additionally, removing certain parts of the sequence potentially forming secondary structures 
with low free energy could also improve the assay sensitivity as shown previously for an 
estradiol aptamer 52. Truncations were not pursued in this work as this process was not within 
the scope of the study. The alternative use of the short 11-mer motif sequence for this assay 
was evaluated. However, it was not considered compatible since high concentrations of the 
sequence were required to efficiently protect the particles from salt-induced aggregation 
which are expected to decrease assay sensitivity (data not shown). As mentioned earlier, 
there is only one study in the literature demonstrating the use of an aptamer for nandrolone 
detection43. Using a split estradiol aptamer modified with a fluorophore and a quencher in 
each fragment, a FRET assay was developed with an LOD of 5 μM. The sensitivity of the 
assay developed in this work is in the same low micromolar range as the one previously 
described. Even though not optimal, the assay can serve as an example of an aptamer-based 
rapid homogenous assay suitable for on-site monitoring of AAS levels in suspicious samples.  
 
4. 5. Conclusions 
 
Doping refers to the illicit use of prohibited substances with the objective of gaining 
competitive advantage especially in professional sports. Anabolic androgenic steroids (AAS) 
are one category of these substances including testosterone and one of its synthetic 
derivatives called nandrolone. AAS abuse though poses serious health concerns because of 
the numerous adverse effects they can cause, and international organizations are dedicated 
to improving global monitoring and prevention strategies to manage the problem. Even 
though highly sensitive gas chromatographic-mass spectroscopic methods have been 
established for the specific detection of these substances, they are limited to laboratory use 
and they cannot be deployed on-site for fast screening of suspicious samples. The numerous 
advantages of aptamers as alternative biorecognition elements successfully applied for the 
detection of a plethora of small molecules make them particularly attractive for the 
development of an assay for AAS detection suitable for on-site analysis. In this work, we 
report the first selection performed for the identification of nandrolone aptamers assisted by 
next generation sequencing. Three aptamer candidates and a highly enriched 11-mer 
sequence motif were chosen for characterization and their specific binding to nandrolone was 
verified with different assays. Their affinity dissociation constants were calculated in the low 
(sub)nanomolar range, and all sequences exhibited cross-reactivity with testosterone but not 
with other potentially interfering steroids. Finally, a facile and rapid colorimetric assay was 
developed as a proof-of-concept employing one of the full-length aptamers and gold 
nanoparticles, allowing the detection of 1.4 μM of nandrolone. Considering the high cross-
reactivity of the novel nandrolone aptamers with testosterone, the assay could serve as a 
simple on-site screening tool with the red-to-purple/blue color change to indicate the potential 
presence of both nandrolone and testosterone in the sample as doping biomarkers. 
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Nandrolone can only be found in a sample when it is administered exogenously (doping) 
whereas > 0.7 μM (200 ng/mL) of testosterone in urine samples are considered suspicious 
for doping according to WADA regulations. Taking into account that the normal endogenous 
levels of testosterone are low (< 42 nM) and are not expected to interfere with the assay, only 
samples with significantly higher amounts of the two AAS can produce a positive result and 
suggest doping practices. Further analysis by GC-MS/GS-IRMS can finally confirm the 
steroid(s) in the sample, their concentration and source. Future work will focus on the 
improvement of the sensitivity of the assay (e.g. by aptamer truncation and/or splitting) and 
evaluation of its performance with appropriate real samples. 
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4.6 Supplementary information 
 
4.6.1. Materials and methods 
4.6.1.1 Structures of the molecules 
 
 
Figure S4.1. Structures of the steroids used in this work. (A) The target steroid nandrolone. (B) Nandrolone-
sepharose® 6B resin used for SELEX. (C) Other steroids used for counter-SELEX. The asterisks () denote 
the carbon atoms on the steroid structures carrying the carboxymethyloxime (CMO) modification facilitating 
steroid immobilization on amine-modified magnetic beads.   
 
4.6.1.2 Preparation of carboxymethyloxime (CMO) derivatives of steroids 
 
Carboxymethyloxime derivatives of nandrolone (NAND) and trenbolone (TREN) were prepared 
according to a previous report 1. Briefly, each steroid (100 mg) and O-(carboxymethyl) 
hydroxylamine hemihydrochloride (113 mg) were dissolved in 10.2 mL of anhydrous pyridine 
under argon atmosphere and the mixtures were heated at 50ºC for two days. Pyridine was then 
removed under vacuum and the crude solids were dissolved in a mixture of ethyl acetate and 
water (20 mL each). Following, HCl (10 %) was added until pH 1 was achieved yielding two 
phases. The lower ethyl acetate layers were separated and washed two times with water (20 mL 
per wash) and then dried over sodium sulfate. Finally, they were filtered and concentrated under 
vacuum yielding light yellow solids.  
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4.6.1.3 Preparation of sepharose media for negative and counter selection steps 
 
Epoxy-activated sepharose 6B resin ( 143 mg) was transferred in a micro-spin column and 
washed three times with water (1 mL per wash) by resuspending the resin in the appropriate 
volume followed by centrifugation for 30 sec at 10,000 rpm. Next, the resin was resuspended in 
30 µL of 25 mg/mL of each steroid solution [progesterone (PROG), estradiol (ESTR), testosterone 
(TEST) or trenbolone (TREN), prepared in DMSO] and 470 µL of PBS for the preparation of the 
counter-selection media or in plain coupling buffer for the negative selection resin (control-resin). 
The resins were incubated overnight at room temperature under rotation, followed by washing and 
blocking of any remaining active groups with 1 mM of sulfo-NHS-acetate in PBS for 2 h at room 
temperature under rotation. Finally, the resins were washed with water and resuspended in 2 mL 
of water. The immobilization of the steroids on the resins was confirmed by bead-ELISA. 
Specifically, 50 µL of each steroid-sepharose resin were incubated with 50 µL of 5 µg/mL of the 
respective steroid antibody in PBS for 30 min at room temperature under rotation. The TEST 
antibody was used to detect both TEST and TREN. The resins were washed three times with 200 
µL of water, resuspended in 50 µL of rabbit anti-mouse-HRP antibody conjugate ( 3 µg/mL) in 
PBST followed by a 30-minute incubation at room temperature under rotation. Finally, the resins 
were washed and resuspended in 50 µL of TMB solution. After 2 minutes, color development was 
stopped by the addition of 50 µL of 1 M H2SO4 and absorbance of the supernatants was read at 




Figure S4.2. Confirmation of the immobilization of various steroids on sepharose resin. 
 
4.6.1.4 Preparation of steroid-magnetic beads  
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Immobilization of steroids on magnetic beads was performed as previously described [2]. 
Amine-activated magnetic beads (200 µL of Dynabeads M-270 Amine, 30 mg/mL) were 
washed with 100 mM MES pH 5.3 and then resuspended in 40 µL of 25 mg/mL NAND-
CMO, TEST-CMO, TREN-CMO, PROG-CMO or ESTR-CMO (in DMSO), 40 µL of 10 
mg/mL EDC, 40 µL of 75 mg/mL NHS, 80 µL of 100 mM MES pH 5.3 and 10 µL of ethanol. 
The suspensions were incubated overnight at room temperature under rotation. The 
beads were then washed with PBS and blocked with 5 % skim milk in PBST for 1 h at 
room temperature under rotation. Finally, the beads were blocked with 1 mM sulfo-NHS-
acetate in PBS for 1 h, washed with PBST and resuspended in 200 µL of PBS. The 
control-beads were prepared in the same manner by using only DMSO instead of the 
steroid. The modified magnetic beads were kept at 4ºC until use. The immobilization of 
the steroids on the magnetic beads was verified by bead-ELISA as detailed above for the 
sepharose resins. The ESTR antibody was used for the detection of ESTR and NAND, 
the TEST antibody for TEST and TREN and the PROG antibody for PROG. 
4.6.1.5 Immobilization of nandrolone on microtiter plates for binding studies 
 
The preparation of nandrolone-functionalized microtiter plates was based on a previous 
report [3]. Maleimide-activated microtiter plate strips were washed with PBS and then 
incubated with 50 μL of 100 μM of 11-amino-1-undecanethiol hydrochloride (MUAM, in 
PBS) overnight at 4ºC. The plates were washed with PBS and 50 μL of a mixture of NDR-
CMO (300 μM, in PBS), EDC (4 mM, equivalent to 0.62 mg/mL) and NHS (1 mM, 
equivalent to 0.115 mg/mL) was added to the wells and let to incubate for 3 h at room 
temperature. After washing, any remaining active groups were blocked with 50 μL of sulfo-
NHS-acetate (1 mM in PBS) for 1 h. The plates were finally washed with PBS and kept 
dry at 4ºC until use.  
 
 
4.6. 2. Next Generation Sequencing for aptamer identification 
 
Table S4.1 Abundance (%) of the 100 most over-represented unique sequences. 
Sequence % Sequence % Sequence % Sequence % 
1 5,94 26 1,08 51 0,73 76 0,58 
2 4,07 27 1,05 52 0,71 77 0,58 
3 3,86 28 1,05 53 0,71 78 0,54 
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4 2,56 29 1,01 54 0,71 79 0,54 
5 2,11 30 0,99 55 0,69 80 0,52 
6 2,04 31 0,97 56 0,69 81 0,52 
7 1,96 32 0,97 57 0,69 82 0,50 
8 1,89 33 0,95 58 0,69 83 0,50 
9 1,87 34 0,93 59 0,67 84 0,50 
10 1,87 35 0,91 60 0,67 85 0,50 
11 1,85 36 0,91 61 0,65 86 0,50 
12 1,76 37 0,91 62 0,63 87 0,50 
13 1,66 38 0,91 63 0,63 88 0,49 
14 1,51 39 0,90 64 0,63 89 0,49 
15 1,49 40 0,90 65 0,63 90 0,49 
16 1,46 41 0,86 66 0,63 91 0,49 
17 1,34 42 0,86 67 0,63 92 0,47 
18 1,31 43 0,82 68 0,63 93 0,47 
19 1,31 44 0,82 69 0,62 94 0,47 
20 1,31 45 0,80 70 0,60 95 0,47 
21 1,19 46 0,78 71 0,60 96 0,45 
22 1,19 47 0,77 72 0,60 97 0,45 
23 1,18 48 0,77 73 0,60 98 0,45 
24 1,16 49 0,75 74 0,60 99 0,45 
25 1,10 50 0,75 75 0,58 100 0,45 
 
 
Figure S4.3. Multiple sequence alignment of the 100 most abundant unique sequences of library-length (80 
– 95 bp) using Clustal Omega 4. The first number denotes the ranking of the sequence and the second one 
the number of copies. The common sequence motif is underlined. 
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Figure S4.4. Sequence motif encountered in 52 % of the 100 most abundant sequences using the MEME 




4.6.3. Aptamer characterization 
 
Table S4.2 Sequences of the selected aptamer candidates and the motif sequence. 
 















Motif CTTCTCTGACC 11 
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Figure S4.5. Secondary structures of the nandrolone aptamer candidates predicted by the UNAFold 
webserver [6] (100 mM NaCl and 2 mM MgCl2, at 25ºC). The sequence motif encountered in Nand2 and 





Figure S4.6. Predicted structure of the motif sequence and comparison of its size with NAND. The motif 
structure was predicted with the RNAComposer webserver 7. 
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Figure S4.7. Optimization of Nand3 aptamer and NaCl concentrations. (A) Nand3 aptamer (0 – 300 nM) 
was used in combination with NaCl (0 – 200 mM) in the absence of NAND. (B) The aptamer (100 and 200 
nM) was used in combination with NaCl (50 – 150 mM) in the absence and presence of NAND (200 μM). 
 
Table S4.3 Sensitivity of the AuNP-aptamer assay for NAND detection using different concentrations of 
aptamer and NaCl. 
Nand3 aptamer 
(nM) 
75 mM NaCl 100 mM NaCl 
LOD (μM) R2 Span LOD (μM) R
2
 Span 
100 3.4 0.9810 0.62 0.8 0.9935 0.41 
150 3.5 0.9868 0.81 4.8 0.9701 0.42 
200 13.4 * 0.9834 na 1.1 0.9940 0.50 
* ambiguous fit of the calibration curve; n.a.: not available 
 
 
Figure S4.8. Color change of samples containing increasing concentration of nandrolone analyzed with the 
AuNPs-Nand3 aptamer assay. 
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Table 2.1. NGS data analysis of selected pools from the two selections. 
Table 2.2. Affinity dissociation constants of the aptamer candidates determined by APAA 
and bead-ELAA. 
Table 2.3. Detection of TTX in puffer fish extracts. Recovery (%) of TTX spiked in diluted 
extracts from a TTX-free fish (L. lagocephalus). TTXs content (mg TTX equiv./kg of tissue) 
in extracts from a TTX-containing fish (L. sceleratus) were determined using calibration 
curves constructed in PBS buffer and in the respective extract from the TTX-free fish. 
Table S2.1. Conditions used for the selections. 
Table S2.2. Distribution (%) of highly abundant sequences in the different pools from the 
two selections. Sequences were ranked according to their abundance in the TTX pool 
from round 23.  
Table S2.3. Sequences of the selected aptamer candidates. D sequences were identified 
from the selection with Dynabeads and C sequences with the SiMAG SA-MB. 
Table S2.4. Hybrid antibody-aptamer assay precision. Inter-assay coefficients of variation 
(% CV) were calculated from duplicate samples using solutions of different TTX 
concentration measured on four different days (n=4).  
Table S2.5. Assays and biosensors reported in the literature for TTX detection. 
Table S2.6. TTX and analogues contents (mg TTX or analogue/kg tissue) in L. sceleratus 
by LC-MS/MS. 
Table S4.1. Abundance (%) of the 100 most over-represented unique sequences. 
Table S4.2. Sequences of the selected aptamer candidates and the motif sequence. 
Table S4.3. Sensitivity of the AuNP-aptamer assay for NAND detection using different 




SELEX Systematic Evolution of Ligands by EXponential Enrichment 
 KD Dissociation constants 
 FDA Food and Drug Administration 
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AMD Age-related Macular Degeneration 
PEG Polyethylene glycol 
ELISA Enzyme-Linked Immunosorbent Assay 
EGFR Epidermal growth factor receptor 
Bn-dU 2-deoxyuridine 
Nap-dU 5-[N-(1-naphthylmethyl) carboxamide]-2-deoxyuridine 
PKC Protein kinase C 
bFGF basic Fibroblast Growth Factor 
VEGF Vascular Endothelial Growth Factor 
HNE Human Neutrophil Elastase 
IL-1 Inhibit Interleukin-1 
ASO Antisense Oligonucleotide 
AML Acute Myeloid Leukemia 
AMV RT Avian Myeloblastosis Virus reverse transcriptase 
A  Adenine 





SDS Sodium Dodecyl Sulfate 
EDTA Ethylenediaminetetraacetic acid 
dsDNA Double stand DNA 
HEGL Hexaethylene Glycol 
poly A adenine nucleotides 
SPR Surface Plasmon Resonance 
ELONA Enzyme-Linked Oligonucleotide Assay 
EMSA Electrophoretic Mobility Shift Assay 
FACS Fluorescence-Activated Cell Sorting 
PCR-RFLP PCR-restriction, fragment length polymorphism 
NMR Nuclear Magnetic Resonance 
NGS Next Generation Sequence 
MST MicroScale Thermophoresis 
GO-SELEX Graphene Oxide-SELEX 
CE Capillary Electrophoresis 
NECEEM Non-Equilibrium Capillary Electrophoresis of Equilibrium Mixtures 
ECEEM Equilibrium capillary electrophoresis of equilibrium mixtures 
FFE Free Flow Electrophoresis 
M-SELEX Microfluidic SELEX 
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CRC intrahepatic colorectal cancer 
BSA Bovine serum albumin 
OVA Ovalbumin 
KLH Keyhole limpet hemocyanin 
NHS N-hydroxy succinimide 
GO Graphene oxide 
PAGE Polyacrylamide gel electrophoresis 
OA Okadaic acid 
PAT Patulin 
APAA Apta-PCR affinity assay 
ELAA Enzyme linked aptamer assay 
ITC isothermal titration colorimetry 
TTMB Tetramethylbenzidine 
OD Optical density 
DON Deoxynivalenol 
IgE Human immunoglobulin E 
MST Microscale Thermophoresis 
ATP Adenosine triphosphate 
APPA Apta-PCR affinity assay 
ITC Isothermal Titration Calorimetry 
KD equilibrium binding constant 
ΔH Enthalpy 
ΔS Entropy 
BLI Biolayer interferometry 
CCD Charge coupled device 
cAMP Cyclic monophosphate 
QDs Quantum dots 
FRET Fluorescence resonance energy transfer 
AuNPs Gold nanoparticles 
FRET Fluorescence resonance energy transfer 
Cy5/FAM Cy5/Fluorescein Amidite 
RQ/BHQ Low Black Hole Quencer 
TAMRA Carboxytetramethylrhodamine 
GMPs Gold capped magnetic nanoparticles 
CNTs Carbon nanotubes 
CPs Conducting polymers 
MNPs Metal nanoparticles 
SPE Screen-printed electrode 
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GNPs-GNSs Gold nanoparticles-graphene nanosheets 
EFSA European Food Safety Authority 
TEF Toxicity equivalency factors 
LC-MS/MS Liquid chromatography coupled with mass spectrometry 
SA-MB Streptavidin-magnetic beads  
DA Domoic acid 
STX Saxitoxin 
APAA Apta-PCR Affinity Assay 
MBA Mouse bioassay 
TCBA Tissue culture bioassay 
AAS Anabolic androgenic steroids 
WADA World Anti-Doping Agency 
GC-MS Gas chromatography-mass spectrometry 
GC-IRMS Gas chromatography-isotope ratio mass spectrometry 
UHPLC-MS Ultra-high-performance liquid chromatography coupled with mass 
spectrometry 
HPTLC High-performance thin-layer chromatography  
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